US4624962A - Substituted derivatives of 2-azabicyclo-[3.3.0]octanes - Google Patents
Substituted derivatives of 2-azabicyclo-[3.3.0]octanes Download PDFInfo
- Publication number
- US4624962A US4624962A US06/697,340 US69734085A US4624962A US 4624962 A US4624962 A US 4624962A US 69734085 A US69734085 A US 69734085A US 4624962 A US4624962 A US 4624962A
- Authority
- US
- United States
- Prior art keywords
- sub
- atoms
- phenyl
- hydrogen
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- ADKDJHASTPQGEO-UHFFFAOYSA-N 1,2,3,3a,4,5,6,6a-octahydrocyclopenta[b]pyrrole Chemical class C1CNC2CCCC21 ADKDJHASTPQGEO-UHFFFAOYSA-N 0.000 title claims description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 70
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 63
- -1 hydroxphenylalkyl Chemical group 0.000 claims abstract description 60
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 49
- 239000001257 hydrogen Substances 0.000 claims abstract description 49
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 36
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 34
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 26
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 23
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 16
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 11
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 10
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 8
- 125000001624 naphthyl group Chemical group 0.000 claims abstract description 7
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims abstract description 5
- 125000006193 alkinyl group Chemical group 0.000 claims abstract description 5
- 125000004344 phenylpropyl group Chemical group 0.000 claims abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 29
- 229910052736 halogen Inorganic materials 0.000 claims description 23
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 19
- 150000002367 halogens Chemical class 0.000 claims description 16
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 12
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 12
- 125000001424 substituent group Chemical group 0.000 claims description 10
- 125000001072 heteroaryl group Chemical group 0.000 claims description 8
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 claims description 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 230000001077 hypotensive effect Effects 0.000 claims description 5
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
- 208000001953 Hypotension Diseases 0.000 claims description 4
- 125000005518 carboxamido group Chemical group 0.000 claims description 4
- 208000021822 hypotensive Diseases 0.000 claims description 4
- 206010020772 Hypertension Diseases 0.000 claims description 3
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 3
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 3
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 3
- 125000002883 imidazolyl group Chemical group 0.000 claims description 3
- 125000001041 indolyl group Chemical group 0.000 claims description 3
- 125000004076 pyridyl group Chemical group 0.000 claims description 3
- 125000000335 thiazolyl group Chemical group 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 2
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 2
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 claims description 2
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 abstract description 6
- 229920006395 saturated elastomer Polymers 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 4
- 125000002619 bicyclic group Chemical group 0.000 abstract description 3
- 125000000547 substituted alkyl group Chemical group 0.000 abstract description 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract description 2
- 125000006350 alkyl thio alkyl group Chemical group 0.000 abstract description 2
- 125000004103 aminoalkyl group Chemical group 0.000 abstract description 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract description 2
- 125000005358 mercaptoalkyl group Chemical group 0.000 abstract description 2
- 125000005359 phenoxyalkyl group Chemical group 0.000 abstract description 2
- 125000003884 phenylalkyl group Chemical group 0.000 abstract description 2
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 101150035983 str1 gene Proteins 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 50
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 36
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 34
- 239000000243 solution Substances 0.000 description 27
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 21
- 238000005481 NMR spectroscopy Methods 0.000 description 17
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 239000002904 solvent Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000005160 1H NMR spectroscopy Methods 0.000 description 10
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 125000005843 halogen group Chemical group 0.000 description 7
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 5
- 101150065749 Churc1 gene Proteins 0.000 description 5
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 5
- 102100038239 Protein Churchill Human genes 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 4
- PDELQDSYLBLPQO-UHFFFAOYSA-N 2,3,3a,4,5,6,7,7a-octahydro-1h-indole Chemical compound C1CCCC2NCCC21 PDELQDSYLBLPQO-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 4
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 4
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 4
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 4
- LCEAZWWUDCMUQG-UHFFFAOYSA-N ethyl 2-methylidene-4-phenylbutanoate Chemical compound CCOC(=O)C(=C)CCC1=CC=CC=C1 LCEAZWWUDCMUQG-UHFFFAOYSA-N 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- NENLYAQPNATJSU-UHFFFAOYSA-N 1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline Chemical compound C1NCCC2CCCCC21 NENLYAQPNATJSU-UHFFFAOYSA-N 0.000 description 3
- BWKMGYQJPOAASG-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid Chemical compound C1=CC=C2CNC(C(=O)O)CC2=C1 BWKMGYQJPOAASG-UHFFFAOYSA-N 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 235000019445 benzyl alcohol Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 3
- 238000007327 hydrogenolysis reaction Methods 0.000 description 3
- 239000012948 isocyanate Substances 0.000 description 3
- 150000002513 isocyanates Chemical class 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- MFMXOGATUSTFOL-UHFFFAOYSA-N 1,3,3a,4-tetrahydrothieno[3,4-c]pyridine Chemical compound C1=NCC2CSCC2=C1 MFMXOGATUSTFOL-UHFFFAOYSA-N 0.000 description 2
- OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 2
- DKASUYIOUPPQSY-UHFFFAOYSA-N 2,3,3a,4-tetrahydrothieno[2,3-c]pyridine Chemical compound C1C=NC=C2SCCC21 DKASUYIOUPPQSY-UHFFFAOYSA-N 0.000 description 2
- OJYDKYKQCVPTFG-UHFFFAOYSA-N 2,3,3a,4-tetrahydrothieno[3,2-c]pyridine Chemical compound C1N=CC=C2SCCC21 OJYDKYKQCVPTFG-UHFFFAOYSA-N 0.000 description 2
- YWVQGUBCAUFBCP-UHFFFAOYSA-N 2-phenylmethoxycarbonyl-3,4-dihydro-1h-isoquinoline-3-carboxylic acid Chemical compound OC(=O)C1CC2=CC=CC=C2CN1C(=O)OCC1=CC=CC=C1 YWVQGUBCAUFBCP-UHFFFAOYSA-N 0.000 description 2
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- 101800000734 Angiotensin-1 Proteins 0.000 description 2
- 102400000344 Angiotensin-1 Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 238000006929 Pictet-Spengler synthesis reaction Methods 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- ORWYRWWVDCYOMK-HBZPZAIKSA-N angiotensin I Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 ORWYRWWVDCYOMK-HBZPZAIKSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 2
- YPKCKVKGAXFKEH-UHFFFAOYSA-N benzenesulfonic acid;benzyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate Chemical compound OS(=O)(=O)C1=CC=CC=C1.C1C2=CC=CC=C2CNC1C(=O)OCC1=CC=CC=C1 YPKCKVKGAXFKEH-UHFFFAOYSA-N 0.000 description 2
- MZFDTDRHNOUNSF-UHFFFAOYSA-N benzyl 2-carbonochloridoyl-3,4-dihydro-1h-isoquinoline-3-carboxylate Chemical compound ClC(=O)N1CC2=CC=CC=C2CC1C(=O)OCC1=CC=CC=C1 MZFDTDRHNOUNSF-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- LMFLGETWXFOVMQ-UHFFFAOYSA-N diethyl 2-(2-phenylethyl)propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)CCC1=CC=CC=C1 LMFLGETWXFOVMQ-UHFFFAOYSA-N 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- WEPBJXKRVFSOKE-UHFFFAOYSA-N ethyl 4-phenyl-2-[(propan-2-ylamino)methyl]butanoate Chemical compound CCOC(=O)C(CNC(C)C)CCC1=CC=CC=C1 WEPBJXKRVFSOKE-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 2
- LPAGFVYQRIESJQ-UHFFFAOYSA-N indoline Chemical compound C1=CC=C2NCCC2=C1 LPAGFVYQRIESJQ-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 2
- 125000004372 methylthioethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])* 0.000 description 2
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- POTIYWUALSJREP-UHFFFAOYSA-N 1,2,3,4,4a,5,6,7,8,8a-decahydroquinoline Chemical compound N1CCCC2CCCCC21 POTIYWUALSJREP-UHFFFAOYSA-N 0.000 description 1
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- QCJLSCRVJRTFKT-UHFFFAOYSA-N 1,3-thiazolidine-5-carboxylic acid Chemical group OC(=O)C1CNCS1 QCJLSCRVJRTFKT-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical compound BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102000005862 Angiotensin II Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 101100177155 Arabidopsis thaliana HAC1 gene Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 238000006720 Favorskii reaction Methods 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical class OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 238000006683 Mannich reaction Methods 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229910004809 Na2 SO4 Inorganic materials 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 101100434170 Oryza sativa subsp. japonica ACR2.1 gene Proteins 0.000 description 1
- 101100434171 Oryza sativa subsp. japonica ACR2.2 gene Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 101150108015 STR6 gene Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- OPFURXRZISKMJV-UHFFFAOYSA-N azepan-1-ium-2-carboxylate Chemical compound OC(=O)C1CCCCCN1 OPFURXRZISKMJV-UHFFFAOYSA-N 0.000 description 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
- QXNDZONIWRINJR-UHFFFAOYSA-N azocane Chemical compound C1CCCNCCC1 QXNDZONIWRINJR-UHFFFAOYSA-N 0.000 description 1
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Inorganic materials [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- WKRGHSSBSIQHSX-UHFFFAOYSA-N ethyl 2-(ethylaminomethyl)-4-phenylbutanoate Chemical compound CCNCC(C(=O)OCC)CCC1=CC=CC=C1 WKRGHSSBSIQHSX-UHFFFAOYSA-N 0.000 description 1
- GDUSSNLOHILDAH-UHFFFAOYSA-N ethyl 2-(methylaminomethyl)-4-phenylbutanoate Chemical compound CCOC(=O)C(CNC)CCC1=CC=CC=C1 GDUSSNLOHILDAH-UHFFFAOYSA-N 0.000 description 1
- FUMSECFLYZLFAI-UHFFFAOYSA-N ethyl 2-[[carbonochloridoyl(methyl)amino]methyl]-4-phenylbutanoate Chemical compound CCOC(=O)C(CN(C)C(Cl)=O)CCC1=CC=CC=C1 FUMSECFLYZLFAI-UHFFFAOYSA-N 0.000 description 1
- IOGJNGUIYNNHGS-UHFFFAOYSA-N ethyl 5-(ethylamino)-2-phenylpentanoate Chemical compound CCNCCCC(C(=O)OCC)C1=CC=CC=C1 IOGJNGUIYNNHGS-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- FXHCFPUEIDRTMR-UHFFFAOYSA-N hydron;1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid;chloride Chemical compound Cl.C1=CC=C2CNC(C(=O)O)CC2=C1 FXHCFPUEIDRTMR-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000002993 phenylalanine derivatives Chemical class 0.000 description 1
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical compound C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- DBDCNCCRPKTRSD-UHFFFAOYSA-N thieno[3,2-b]pyridine Chemical class C1=CC=C2SC=CC2=N1 DBDCNCCRPKTRSD-UHFFFAOYSA-N 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- 230000002541 vasodepressive effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
- C07C323/44—X or Y being nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Definitions
- n denotes a whole number between 0 and 3 inclusive, R 1 and R 1' , being the same or different, denote hydrogen; alkyl or alkenyl having 1-8 C atoms; phenyl or benzyl, each substituted if desired by methyl, halogen, methoxy or nitro; R 2 denotes hydrogen, alkyl or alkenyl having 1-8 C atoms; R 3 denotes hydrogen; alkyl having 1-10 C atoms; hydroxyalkyl, alkoxyalkyl or aminoalkyl each having 1-5 C atoms; alkanoylaminoalkyl having 1-7 C atoms; guanidinoalkyl, imidazolylalkyl, indolylalkyl, mercaptoalkyl or alkylthioalkyl each having 1-6 alkyl C atoms; phenylalkyl having 1-5 alkyl C
- n is 0 to 2
- R 1 and R 1' are hydrogen, alkyl or alkenyl having 1 to 4 C atoms, or benzyl optionally substituted in the phenyl nucleus by methyl, halogen, methoxy or nitro
- R 2 is hydrogen, alkyl, alkenyl or alkinyl having 1 to 5 C atoms
- R 3 is the radical of a natural aminoacid, acetylaminobutyl, methoxymethyl, methoxyethyl, phenoxymethyl, methylthiomethyl, methylthioethyl or phenylthiomethyl
- R 2 and R 3 can be, together with the carbon or nitrogen atom carrying them, part of a saturated or unsaturated 4- to 8-membered monocyclic or 8- to 10-membered bicyclic ring system, which, apart from carbon, can also contain an oxygen, sulfur and/or 1 to 3 nitrogen atoms in
- n is 0 or 1
- R 1 and R 1' are hydrogen, methyl, ethyl, n-butyl, t-butyl, benzyl or p-nitrophenyl
- R 2 is hydrogen, methyl, ethyl or n-butyl
- R 3 is the radical of a natural aminoacid or acetylaminobutyl, methoxymethyl, methoxyethyl, phenoxymethyl, methylthiomethyl, methylthioethyl or phenylthiomethyl
- R 2 and R 3 can be, together with the carbon or nitrogen atom carrying them, part of a saturated or unsaturated 5- to 7-membered monocyclic or 8- to 10-membered bicyclic ring system which, apart from carbon, can also contan an oxygen or sulfur atom and/or 1 to 2 nitrogen atoms in each case, and suitable ring systems are: as monocyclic systems
- n 1
- R 1 denotes hydrogen
- R 2 and R 3 together with the C and N atoms carrying them, denote the 1,2,3,4-tetrahydroisoquinoline system, the octahydroindole system or the 2-azabicyclo[3.3.0]octane system
- R 4 denotes ethyl
- R 5 denotes hydrogen
- R 6 denotes ⁇ -phenylethyl.
- the compounds of the formula I contain several asymmetric C atoms and thus they are in the form of enantiomers and diastereomers.
- the invention comprises the pure isomers and their mixtures. Those compounds are preferred which have the S-configuration at the carbon atom which carries the substituent R 3 . Those compounds are particularly preferred which have the S-configuration both at the carbon atom carrying the substituent R 3 and at that carrying the COOR 1' group.
- the isomers can be prepared pure, for example by crystallization of suitable salts, such as the cyclohexylamine or dicyclohexylamine salts or by chromatography on silica gel or ion exchangers. Where appropriate, the separations are carried out on suitable precursors.
- the invention comprises the free acids, their alkali metal and alkaline earth metal salts and also the salts with pharmaceutically acceptable amines, such as cyclohexylamine or dicyclohexylamine and basic aminoacids, such as lysine and arginine.
- pharmaceutically acceptable amines such as cyclohexylamine or dicyclohexylamine
- basic aminoacids such as lysine and arginine.
- the invention further relates to a process for the preparation of the compounds of the formula I.
- the process comprises reacting an aminoacid ester of the formula II ##STR3## in which R 7 has the same meaning as R 1 , but is not hydrogen, with phosgene and then with a compound of the formula IV ##STR4## in which R 8 has one of the meanings of R 7 , or reacting a compound of the formula IV with phosgene and then with a compound of the formula II, and, if appropriate, subjecting the products obtained to hydrolysis.
- R 7 in formula (I-a) denotes benzyl or 4-nitrobenzyl
- a compound of the formula (I-a) can be converted into a compound of the formula (I-c) by hydrogenolysis.
- reaction of the compound of the formula (II) with phosgene is carried out in an aprotic organic solvent, with or without the addition of an acid-binding agent;
- suitable acid-binding agents are basic compounds, in particular organic nitrogen bases, for example, triethylamine, tripropylamine, N-methylmorpholine, pyridine and the like.
- suitable solvents are methylene chloride, chloroform, tetrahydrofuran and dioxane.
- the reaction is carried out at a temperature which is low to slightly elevated, in general between -50° C. and +40° C., preferably at -30° C. to 0° C.
- reaction of a compound of the formula (III) with a compound of the formula (IV) is carried out under similar conditions but at a somewhat higher temperature, for instance 0° C. to 80° C., preferably 30° C. to 50° C. Apart from the solvents mentioned, dimethylformamide is also very suitable.
- Hydrolysis of a compound of the formula (I-a) to give a compound of the formula (I-b) can be carried out by various means.
- R 7 and R 8 in formula (I-a) denote alkyl, but not t-butyl
- the reaction can advantageously be carried out with an alkali metal hydroxide or carbonate in a mixture of water and a lower alcohol.
- a suitable temperature is 0° C. to 100° C., preferably 20° C. to 40° C.
- R 7 and R 8 denote t-butyl
- the reaction is carried out with the aid of an acid, preferably a strong acid, such as trifluoroacetic acid, hydrochloric acid or sulfuric acid, without adding a solvent or in methanol or ethanol at 0° to 80° C., preferably at 20° C. to 40° C.
- an acid preferably a strong acid, such as trifluoroacetic acid, hydrochloric acid or sulfuric acid
- Suitable catalysts for the hydrogenolysis are noble metal catalysts, such as palladium black, palladium on charcoal or platinum dioxide.
- the reaction is carried out at a slightly elevated temperature, for instance at 20° C. to 80° C., preferably at 20° C. to 40° C., and under a slightly raised pressure of hydrogen, for instance 1 to 50 atmospheres, preferably under 1 to 8 atmospheres.
- a compound of the formula (V) or (V-a) is then reacted with a compound of the formula (II) under the conditions described above for the preparation of compounds of the formula (I-a) to give a compound of the formula (I-a).
- aminoacid esters of the formula (II) necessary as starting materials for this process are prepared from the corresponding aminoacids by customary methods (cf. the methods listed in Houben-Weyl/Muller, Methoden der Organischen Chemie (Methods of Organic Chemistry), volume 15/1, pages 315-370). If the relevant aminoacids do not occur naturally, as a rule they are readily accessible by synthesis.
- Hexahydroazepine-2-carboxylic acid and its highers homologs are obtained from the lactam having the corresponding ring size by chlorination and Favorskii reaction with potassium tert.-butylate (J. Med. Chem. 14, 501 (1971)).
- Tetrahydroisoquinoline-3-carboxylic acid and its substituted derivatives are readily accessible by a Pictet-Spengler reaction from the corresponding phenylalanine derivatives and formaldehyde (J. Amer. Chem. Soc. 70, 180 (1948)).
- Dihydroindole-2-carboxylic acid and its substituted derivatives are prepared in accordance with Aust. J. Chem. 20, 1,935 (1967).
- the corresponding decahydroisoquinoline and octahydroindole derivatives respectively are obtained by hydrogenation under pressure on a rhodium catalyst.
- tetrahydroimidazo[2,3-c]pyridinecarboxylic acid is obtained from histidine (Hoppe-Seyler's Z. physiol. Chem. 284, 131 (1949)) and the thienopyridine derivatives are obtained from the corresponding thienoalanines (Heterocycles 16, 35 (1981)).
- Thiazolidine-5-carboxylic acids substituted in the 2-position are easily obtained by a ring closure reaction from cysteine and the appropriate aldehyde (Japanese Patent No. 5 5011-547).
- the starting materials of the formula (IV-a) ##STR12## (corresponding to formula (IV) with n being 0), are obtained by esterification of the corresponding ⁇ -amino-acids under customary conditions (see above).
- Starting materials of the formula (IV-b) ##STR13## (corresponding to formula (IV) with n being 1), are obtained by addition of a primary amine of the formula (VI) ##STR14## to an ⁇ -alkylenecarboxylate of the formula (VII) ##STR15##
- the ⁇ -alkylenecarboxylates of the formula (VII) are readily accessible from the corresponding alkylated malonic acid hemiesters of the formula (VIII) ##STR16## by Mannich reaction with formaldehyde and diethylamine (Arch. Pharm. 314, 197 (1981)).
- the new compounds of the formula (I) have a long-lasting and strong hypotensive activity. This activity is developed by inhibition of the angiotensin converting enzyme (ACE). This enzyme converts the decapeptide angiotensin I into the octapeptide angiotensin II which has pressor activity; dysregulation of this enzymic reaction is a factor which induces various forms of hypertension in mammals and humans. Furthermore, ACE inactivates, by degradation, bradykinin, which has vasodepressor activity; this inactivation is also inhibited by the new compounds. Various groups have recently described compounds which are effective inhibitors of ACE (review, for example, J. Med. Chem. 24, 355 (1981)).
- the new compounds compete advantageously with the inhibitors described therein. In vitro, they inhibit the converting enzyme with IC 50 values of 5 ⁇ 10 -9 to 10 -6 mole/l, and in vivo, on normotensive rats, the pressor reflex elicited by injection of angiotensin I is inhibited long-term by intravenous administration of doses at and above 0.1 mg/kg.
- the new compounds and their physiologically tolerated salts can be used to control high blood pressure of various etiologies by themselves or combined with other compounds which have hypotensive, vasodilator or diuretic activities. They can be used either alone or mixed with physiologically tolerated auxiliaries or vehicles.
- the compounds can be administered orally or parenterally in an appropriate pharmaceutical formulation.
- the active compounds are mixed with the additives customary for this purpose, such as vehicles, stabilizers or inert diluents and converted by customary methods into suitable forms for administration, such as tablets, coated tablets, hard capsules, aqueous-alcoholic or oily suspensions or aqueous-alcoholic or oily solutions.
- Inert excipients which can be used are, for example, gum arabic, magnesium carbonate, potassium phosphate, lactose, glucose or starch, in particular corn starch.
- formulation can be as dry or as moist granules.
- suitable oily vehicles or solvents are plant and animal oils, such as sunflower oil or cod-liver oil.
- the active compounds or their physiologically tolerated salts are converted as desired, with the substances customary for this purpose, such as solubilizers, emulsifiers or other auxiliaries, into solutions, suspensions or emulsions.
- suitable solvents for the new active compounds and the corresponding physiologically tolerated salts are: water, physiological saline or alcohols, for example ethanol, propanediol or glycerol, in addition sugar solutions, such as glucose or mannitol solutions, and also a mixture of the various solvents mentioned.
- the daily dose for compounds of the formula (I) and their salts is 20 mg to 3 g, preferably 50 mg to 1 g per patient. No toxic effects of the substances have been observed hitherto.
- the crude benzyl N-chlorocarbonyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylate (from 1.2) was taken up in 10 ml of CH 2 Cl 2 , a solution of 2.6 g of N-isopropyl-N-(2-carboethoxy-4-phenylbutyl)amine and 1.2 ml of triethylamine in 10 ml of methylene chloride were added dropwise and the mixture was heated at 35° C. for 20 hours, then evaporated to dryness, the residue was taken up in ethyl acetate, the solution was washed with 1N hydrochloric acid, saturated sodium bicarbonate solution and water, dried and evaporated. The crude product was separated into the two diastereomers of the product on silica gel.
- Lysine salt 0.57 g of 1.7.2. was dissolved in 10 ml of methanol, 0.21 g of lysine in 5 ml of water were added, the mixture was evaporated to dryness and solidified with ether, colorless powder.
- Bisdicyclohexylamine salt 0.65 g of 2.2 was dissolved in 10 ml of methylene chloride, 0.6 ml of dicyclohexylamine was added, the mixture was evaporated and the residue was triturated with n-hexane; colorless crystals.
- Lysine salt colorless powder IR 1730, 1610 cm -1 .
- Lysine salt 0.87 g of 5.3 was dissolved in 10 ml of methanol and 0.28 g of lysine in 5 ml of water was added. The solvent was removed and the residue was triturated with ether; colorless powder.
- Sodium salt 0.876 g of 6.3 was dissolved in 10 ml of ethanol, 1.9 ml of 1N sodium hydroxide solution were added. The mixture was evaporated and triturated with ether; colorless powder.
- Example 6.3 0.39 g of the compound from Example 6.3 was saponified with sodium hydroxide solution by the process described in Example 2.
- Bisdicyclohexylamine salt 0.31 g was dissolved in 10 ml of methylene chloride, 0.29 ml of dicyclohexylamine was added, the mixture was evaporated and triturated with diisopropyl ether; colorless powder.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compounds of the formula I ##STR1## in which n denotes 0-3,
R1 and R1' are the same or different and denote hydrogen, alkyl or alkenyl, phenyl or benzyl, each substituted as desired;
R2 denotes hydrogen, alkyl or alkenyl;
R3 denotes hydrogen, alkyl, hydroxyalkyl, alkoxyalkyl or aminoalkyl, alkanoylaminoalkyl, guanidinoalkyl, imidazolylalkyl, indolylalkyl, mercaptoalkyl or alkylthioalkyl, phenylalkyl, hydroxphenylalkyl, phenoxyalkyl or phenylthioalkyl, or R2 and R3, together with the C and N atoms carrying them, denote a saturated or unsaturated 4- to 8-membered monocyclic or 8- to 10-membered bicyclic isocycle or heterocycle, optionally monosubstituted or disubstituted by hydroxyl, alkoxy having 1 to 3 C atoms or alkyl,
R4 denotes hydrogen, alkyl, alkenyl, alkadienyl, alkinyl, alkeninyl or alkadiinyl, cycloalkyl, phenyl, benzyl, phenethyl or phenylpropyl, each of which can be optionally monosubstituted or disubstituted;
R5 denotes hydrogen or alkyl, hydroxyl or alkoxy and
R6 denotes hydrogen, optionally substituted alkyl, cycloalkyl, alkenyl, optionally monosubstituted or disubstituted phenyl or naphthyl, their salts, a process for their preparation and their use as medicaments.
Description
This application is a division of application Ser. No. 413,663, filed Sept. 1, 1982 now U.S. Pat. No. 4,515,803.
The invention relates to compounds of the formula (I) ##STR2## in which: n denotes a whole number between 0 and 3 inclusive, R1 and R1', being the same or different, denote hydrogen; alkyl or alkenyl having 1-8 C atoms; phenyl or benzyl, each substituted if desired by methyl, halogen, methoxy or nitro; R2 denotes hydrogen, alkyl or alkenyl having 1-8 C atoms; R3 denotes hydrogen; alkyl having 1-10 C atoms; hydroxyalkyl, alkoxyalkyl or aminoalkyl each having 1-5 C atoms; alkanoylaminoalkyl having 1-7 C atoms; guanidinoalkyl, imidazolylalkyl, indolylalkyl, mercaptoalkyl or alkylthioalkyl each having 1-6 alkyl C atoms; phenylalkyl having 1-5 alkyl C atoms; hydroxyphenylalkyl having 1-5 alkyl C atoms; phenoxyalkyl or phenylthioalkyl each having 1-4 alkyl C atoms, or R2 and R3 together with the C and N atoms carrying them form a saturated or unsaturated 4-8-membered monocyclic or 8-10-membered bicyclic ring system, which contains 1-2 oxygen, 1-2 sulfur and/or 1-4 nitrogen atoms and can be monosubstituted or disubstituted by hydroxyl, alkoxy having 1-3 C atoms, alkyl having 1-3 C atoms or phenyl; R4 denotes hydrogen, alkyl, alkenyl, alkadienyl, alkinyl, alkeninyl or alkadiinyl having 1-8 C atoms, cycloalkyl having 3-6 C atoms; phenyl, benzyl, phenethyl or phenylpropyl, each of which can be monosubstituted or disubstituted by halogen, hydroxyl, acetoxy, carboxy, carboxamido, sulfonamido, nitro, methyl, ethyl, methoxy, ethoxy or methylenedioxy; R5 denotes hydrogen or alkyl having 1-5 C atoms, hydroxyl or alkoxy having 1-3 C atoms; R6 denotes hydrogen; alkyl having 1-12 C atoms; cycloalkyl having 3-12 C atoms; alkenyl having 1-12 C atoms; phenyl or naphthyl, each of which can be monosubstituted or disubstituted by halogen, hydroxyl, acetoxy, carboxy, carboxamido, sulfonamido, nitro, methyl, ethyl, methoxy, ethoxy or methylenedioxy; or alkyl having 1-6 C atoms, which is substituted by halogen, hydroxyl, alkoxy having 1-3 C atoms, phenoxy, amino, dialkylamino having 1-6 C atoms, alkanoylamino having 1-3 C atoms, mercapto, alkylthio having 1-3 C atoms, phenylthio, phenylsulfinyl, phenylsulfonyl, phenyl, biphenylyl, naphthyl or heteroaryl, it being possible for the phenyl or naphthyl in turn to be monosubstituted or disubstituted by halogen, methyl, ethyl, methoxy, ethoxy, nitro, amino, alkylamino, dialkylamino, acetylamino, cyano, methylenedioxy or sulfonamido and the heteroaryl to be substituted by the substituents mentioned and additionally by phenyl, and their salts.
Compounds of the formula I are preferred in which the substituents have the following meaning: n is 0 to 2, R1 and R1' are hydrogen, alkyl or alkenyl having 1 to 4 C atoms, or benzyl optionally substituted in the phenyl nucleus by methyl, halogen, methoxy or nitro; R2 is hydrogen, alkyl, alkenyl or alkinyl having 1 to 5 C atoms; R3 is the radical of a natural aminoacid, acetylaminobutyl, methoxymethyl, methoxyethyl, phenoxymethyl, methylthiomethyl, methylthioethyl or phenylthiomethyl; R2 and R3 can be, together with the carbon or nitrogen atom carrying them, part of a saturated or unsaturated 4- to 8-membered monocyclic or 8- to 10-membered bicyclic ring system, which, apart from carbon, can also contain an oxygen, sulfur and/or 1 to 3 nitrogen atoms in each case, and suitable ring systems of this type are: as monocyclic systems, azetidine, dihydropyrrole, pyrrolidine, piperidine, the latter two being optionally monosubstituted or disubstituted by methoxy, ethoxy, methyl, ethyl or phenyl, hexahydroazepine, octahydroazocine, morpholine, N'-alkylpiperazine having 1 to 3 C atoms, N'-phenylpiperazine and thiazolidine, optionally substituted in the 2-position by methyl, ethyl, phenyl, hydroxyphenyl or methoxyphenyl, and as bicyclic systems, tetrahydroquinoline, tetrahydroisoquinoline, decahydroquinoline, decahydroisoquinoline, dihydroindole, octahydroindole, 2-azabicyclo[3.3.0]octane, all of which being optionally monosubstituted or disubstituted by methyl or methoxy, tetrahydroimidazolo[2,3-c]pyridine, tetrahydrothieno[2,3-c]pyridine, tetrahydrothieno[3,2-c]pyridine and tetrahydrothieno[3,4-c]pyridine; R4 is hydrogen; straight-chain or branched alkyl, alkenyl or alkinyl having 1 to 5 C atoms; cycloalkyl, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl; phenyl; benzyl or phenethyl; R5 is hydrogen, methyl, ethyl, hydroxyl, methoxy or benzyl; R6 is hydrogen, alkyl having 1 to 8 carbon atoms or phenyl which can be monosubstituted or disubstituted by methyl, halogen, methoxy, acetoxy or nitro; substituted alkyl having 1 to 4 C atoms, suitable substituents being: halogen, hydroxyl, methoxy, ethoxy, phenoxy, amino, methylamino, dimethylamino, anilino, acetylamino, benzamido, mercapto, phenylthio, phenylsulfinyl, phenylsulfonyl; phenyl which is optionally monosubstituted or disubstituted by halogen, methyl, ethyl, methoxy, ethoxy, nitro, amino, methylamino, dimethylamino, acetylamino, cyano, methylenedioxy or sulfonamido; biphenylyl, heteroaryl, such as pyridyl, thienyl, indolyl, benzothienyl, imidazolyl, pyrazolyl and thiazolyl, optionally substituted by halogen, methyl, methoxy and phenyl.
Compounds of the formula (I) are particularly preferred in which the substituents have the following meaning: n is 0 or 1, R1 and R1' are hydrogen, methyl, ethyl, n-butyl, t-butyl, benzyl or p-nitrophenyl, R2 is hydrogen, methyl, ethyl or n-butyl, R3 is the radical of a natural aminoacid or acetylaminobutyl, methoxymethyl, methoxyethyl, phenoxymethyl, methylthiomethyl, methylthioethyl or phenylthiomethyl; R2 and R3 can be, together with the carbon or nitrogen atom carrying them, part of a saturated or unsaturated 5- to 7-membered monocyclic or 8- to 10-membered bicyclic ring system which, apart from carbon, can also contan an oxygen or sulfur atom and/or 1 to 2 nitrogen atoms in each case, and suitable ring systems are: as monocyclic systems, dihydropyrrole; pyrrolidine, piperidine, the latter two being optionally substituted by methoxy, methyl, or phenyl, hexahydroazepine, thiazolidine, optionally substituted in the 2-position by methyl, phenyl or hydroxyphenyl, and as bicyclic systems, tetrahydroisoquinoline, decahydroisoquinoline, dihydroindole, octahydroindole, 2-azabicyclo[3.3.0]octane, all optionally monosubstituted or disubstituted by methyl or methoxy, tetrahydroimidazolo[2,3-c]pyridine, tetrahydrothieno[2,3-c]pyridine, tetrahydrothieno[3,2-c]pyridine and tetrahydrothieno[3,4-c]pyridine, R4 is methyl, ethyl, n-propyl, n-butyl, isopropyl, isobutyl, cyclopropyl, cyclobutyl, allyl, butenyl, propargyl, butinyl or tert.-butyl, R5 is hydrogen, methyl or benzyl, R6 is hydrogen, straight-chain or branched alkyl or alkenyl having 1 to 6 C atoms or cycloalkyl having 3 to 6 C atoms; substituted alkyl having 1 to 3 C atoms, suitable substituents being: methoxy, ethoxy, phenoxy, dimethylamino, anilino, benzamido, phenylthio, phenylsulfinyl, phenylsulfonyl and phenyl optionally monosubstituted or disubstituted by halogen, methyl, methoxy, nitro, amino, methylamino, dimethylamino, acetylamino, cyano or methylenedioxy; biphenylyl; heteroaryl, such as pyridyl, thienyl, indolyl, benzothienyl, imidazolyl or thiazolyl, optionally substituted by chlorine, methyl, methoxy or phenyl.
Special attention is drawn to compounds of the formula I in which n is 1, R1 denotes hydrogen, R2 and R3, together with the C and N atoms carrying them, denote the 1,2,3,4-tetrahydroisoquinoline system, the octahydroindole system or the 2-azabicyclo[3.3.0]octane system, R4 denotes ethyl, R5 denotes hydrogen and R6 denotes β-phenylethyl.
The compounds of the formula I contain several asymmetric C atoms and thus they are in the form of enantiomers and diastereomers. The invention comprises the pure isomers and their mixtures. Those compounds are preferred which have the S-configuration at the carbon atom which carries the substituent R3. Those compounds are particularly preferred which have the S-configuration both at the carbon atom carrying the substituent R3 and at that carrying the COOR1' group. In compounds of the formula I, in which R2 and R3, together with the C and N atoms carrying them, represent a saturated bicyclic ring system with carbon atoms as bridgehead atoms, the cis-configuration with an endo-orientation of the COOR1 group relative to the bicyclic ring system is preferred. Particularly preferred bicyclic ring systems are endo-cis-octahydroindole and endo-cis-2-azabicyclo[3.3.0]octane.
The isomers can be prepared pure, for example by crystallization of suitable salts, such as the cyclohexylamine or dicyclohexylamine salts or by chromatography on silica gel or ion exchangers. Where appropriate, the separations are carried out on suitable precursors.
If the compounds of the formula I have acid character, the invention comprises the free acids, their alkali metal and alkaline earth metal salts and also the salts with pharmaceutically acceptable amines, such as cyclohexylamine or dicyclohexylamine and basic aminoacids, such as lysine and arginine.
The invention further relates to a process for the preparation of the compounds of the formula I. The process comprises reacting an aminoacid ester of the formula II ##STR3## in which R7 has the same meaning as R1, but is not hydrogen, with phosgene and then with a compound of the formula IV ##STR4## in which R8 has one of the meanings of R7, or reacting a compound of the formula IV with phosgene and then with a compound of the formula II, and, if appropriate, subjecting the products obtained to hydrolysis.
In the process variant first mentioned, a compound of the formula II, in which R7 has the same meaning as R1 in formula I, but is not hydrogen, is reacted with phosgene to give the N-chlorocarbonyl derivative of the formula (III). ##STR5##
In cases where R2 denotes hydrogen, an isocyanate of the formula (III-a) can form in this reaction, particularly at an elevated temperature. ##STR6##
The compound of the formula (III) or (III-a) is reacted with a compound of the formula (IV) in which R8 has one of the meanings of R7 in formula (II) to give a compound of the formula (Ia). ##STR7##
In cases where R7 and R8 denote alkyl or phenyl, if desired, a compound of the formula (I-a) can be hydrolyzed to give a compound of the formula (I-b). ##STR8##
If R7 in formula (I-a) denotes benzyl or 4-nitrobenzyl, a compound of the formula (I-a) can be converted into a compound of the formula (I-c) by hydrogenolysis. ##STR9##
The reaction of the compound of the formula (II) with phosgene is carried out in an aprotic organic solvent, with or without the addition of an acid-binding agent; suitable acid-binding agents are basic compounds, in particular organic nitrogen bases, for example, triethylamine, tripropylamine, N-methylmorpholine, pyridine and the like. Examples of suitable solvents are methylene chloride, chloroform, tetrahydrofuran and dioxane. The reaction is carried out at a temperature which is low to slightly elevated, in general between -50° C. and +40° C., preferably at -30° C. to 0° C.
The reaction of a compound of the formula (III) with a compound of the formula (IV) is carried out under similar conditions but at a somewhat higher temperature, for instance 0° C. to 80° C., preferably 30° C. to 50° C. Apart from the solvents mentioned, dimethylformamide is also very suitable.
The reaction of a compound of the formula (IV) with an isocyanate of the formula (III-a) is carried out in a corresponding manner.
Hydrolysis of a compound of the formula (I-a) to give a compound of the formula (I-b) can be carried out by various means. In cases in which R7 and R8 in formula (I-a) denote alkyl, but not t-butyl, the reaction can advantageously be carried out with an alkali metal hydroxide or carbonate in a mixture of water and a lower alcohol. A suitable temperature is 0° C. to 100° C., preferably 20° C. to 40° C.
In cases in which R7 and R8 denote t-butyl, the reaction is carried out with the aid of an acid, preferably a strong acid, such as trifluoroacetic acid, hydrochloric acid or sulfuric acid, without adding a solvent or in methanol or ethanol at 0° to 80° C., preferably at 20° C. to 40° C.
In cases in which either R7 or R8 denotes t-butyl and the other radical denotes alkyl or phenyl, the processes described above can also be carried out sequentially in any desired sequence. Catalytic hydrogenolysis of a compound of the formula (I-a) wherein R7 denotes benzyl or 4-nitrobenzyl can be brought about in a lower alcohol as the solvent, with the addition of a catalyst.
Suitable catalysts for the hydrogenolysis are noble metal catalysts, such as palladium black, palladium on charcoal or platinum dioxide. The reaction is carried out at a slightly elevated temperature, for instance at 20° C. to 80° C., preferably at 20° C. to 40° C., and under a slightly raised pressure of hydrogen, for instance 1 to 50 atmospheres, preferably under 1 to 8 atmospheres.
In analogy to the process indicated for the preparation of compounds of the formula (III), a compound of the formula (IV) can also be reacted with phosgene to give a compound of the formula (V). ##STR10##
In cases where R4 denotes hydrogen, an isocyanate of the formula (V-a) ##STR11## can be formed in this reaction, particularly at an elevated temperature.
A compound of the formula (V) or (V-a) is then reacted with a compound of the formula (II) under the conditions described above for the preparation of compounds of the formula (I-a) to give a compound of the formula (I-a).
The aminoacid esters of the formula (II) necessary as starting materials for this process are prepared from the corresponding aminoacids by customary methods (cf. the methods listed in Houben-Weyl/Muller, Methoden der Organischen Chemie (Methods of Organic Chemistry), volume 15/1, pages 315-370). If the relevant aminoacids do not occur naturally, as a rule they are readily accessible by synthesis.
Hexahydroazepine-2-carboxylic acid and its highers homologs are obtained from the lactam having the corresponding ring size by chlorination and Favorskii reaction with potassium tert.-butylate (J. Med. Chem. 14, 501 (1971)).
Tetrahydroisoquinoline-3-carboxylic acid and its substituted derivatives are readily accessible by a Pictet-Spengler reaction from the corresponding phenylalanine derivatives and formaldehyde (J. Amer. Chem. Soc. 70, 180 (1948)). Dihydroindole-2-carboxylic acid and its substituted derivatives are prepared in accordance with Aust. J. Chem. 20, 1,935 (1967).
From the latter two, the corresponding decahydroisoquinoline and octahydroindole derivatives respectively are obtained by hydrogenation under pressure on a rhodium catalyst. Again using Pictet-Spengler cyclization with formaldehyde, tetrahydroimidazo[2,3-c]pyridinecarboxylic acid is obtained from histidine (Hoppe-Seyler's Z. physiol. Chem. 284, 131 (1949)) and the thienopyridine derivatives are obtained from the corresponding thienoalanines (Heterocycles 16, 35 (1981)).
Thiazolidine-5-carboxylic acids substituted in the 2-position are easily obtained by a ring closure reaction from cysteine and the appropriate aldehyde (Japanese Patent No. 5 5011-547).
The starting materials of the formula (IV-a) ##STR12## (corresponding to formula (IV) with n being 0), are obtained by esterification of the corresponding α-amino-acids under customary conditions (see above). Starting materials of the formula (IV-b) ##STR13## (corresponding to formula (IV) with n being 1), are obtained by addition of a primary amine of the formula (VI) ##STR14## to an α-alkylenecarboxylate of the formula (VII) ##STR15## The α-alkylenecarboxylates of the formula (VII) are readily accessible from the corresponding alkylated malonic acid hemiesters of the formula (VIII) ##STR16## by Mannich reaction with formaldehyde and diethylamine (Arch. Pharm. 314, 197 (1981)).
The new compounds of the formula (I) have a long-lasting and strong hypotensive activity. This activity is developed by inhibition of the angiotensin converting enzyme (ACE). This enzyme converts the decapeptide angiotensin I into the octapeptide angiotensin II which has pressor activity; dysregulation of this enzymic reaction is a factor which induces various forms of hypertension in mammals and humans. Furthermore, ACE inactivates, by degradation, bradykinin, which has vasodepressor activity; this inactivation is also inhibited by the new compounds. Various groups have recently described compounds which are effective inhibitors of ACE (review, for example, J. Med. Chem. 24, 355 (1981)). The new compounds compete advantageously with the inhibitors described therein. In vitro, they inhibit the converting enzyme with IC50 values of 5×10-9 to 10-6 mole/l, and in vivo, on normotensive rats, the pressor reflex elicited by injection of angiotensin I is inhibited long-term by intravenous administration of doses at and above 0.1 mg/kg.
Because of these properties, the new compounds and their physiologically tolerated salts can be used to control high blood pressure of various etiologies by themselves or combined with other compounds which have hypotensive, vasodilator or diuretic activities. They can be used either alone or mixed with physiologically tolerated auxiliaries or vehicles.
The compounds can be administered orally or parenterally in an appropriate pharmaceutical formulation. For a form for oral use, the active compounds are mixed with the additives customary for this purpose, such as vehicles, stabilizers or inert diluents and converted by customary methods into suitable forms for administration, such as tablets, coated tablets, hard capsules, aqueous-alcoholic or oily suspensions or aqueous-alcoholic or oily solutions. Inert excipients which can be used are, for example, gum arabic, magnesium carbonate, potassium phosphate, lactose, glucose or starch, in particular corn starch. For this purpose, formulation can be as dry or as moist granules. Examples of suitable oily vehicles or solvents are plant and animal oils, such as sunflower oil or cod-liver oil.
For subcutaneous or intravenous administration, the active compounds or their physiologically tolerated salts are converted as desired, with the substances customary for this purpose, such as solubilizers, emulsifiers or other auxiliaries, into solutions, suspensions or emulsions. Examples of suitable solvents for the new active compounds and the corresponding physiologically tolerated salts are: water, physiological saline or alcohols, for example ethanol, propanediol or glycerol, in addition sugar solutions, such as glucose or mannitol solutions, and also a mixture of the various solvents mentioned.
The daily dose for compounds of the formula (I) and their salts is 20 mg to 3 g, preferably 50 mg to 1 g per patient. No toxic effects of the substances have been observed hitherto.
Unless another process is indicated, the compounds described in the following Examples were subjected to HPLC purification for analysis and biological determination.
Since all the compounds according to the invention have been prepared by only two methods, these two processes are to be presented in detail in four Examples in the following text. The other derivatives prepared analogously are compiled in a Table with their NMR data.
53 g (0.3 mole) of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 150 ml of benzyl alcohol and 53.3 g (0.33 mole) of benzenesulfonic acid were heated at 140° C. for 1 hour, then 100 ml of toluene were added and the mixture was boiled under a water separator until the theoretical amount of water had formed. Thereafter, the solvent was removed, the residue was digested with ether, the precipitate was filtered off with suction and recrystallized from ethanol/ether.
Melting point 165°-166° C.
[α]D -42.1°, c=1 (DMF)
4.25 g of the above benzyl ester benzenesulfonate were dissolved in 100 ml of saturated sodium bicarbonate solution and this was extracted with methylene chloride, dried over sodium sulfate and the solvent was removed. The residue (2.67 g/0.01 mole) was dissolved, together with 1.5 g (0.015 mole) of triethylamine, in 10 ml of dry methylene chloride. The solution was added dropwise at -20° to -30° C. to 11.5 ml of a 15% strength solution of phosgene in methylene chloride, the mixture was stirred for 30 minutes and then evaporated to dryness.
45 g of diethyl malonate and 30 g of phenethyl bromide were mixed and added dropwise, cooling in ice, to a solution of sodium ethylate prepared from 6.5 g of sodium and 130 ml of absolute ethanol. The mixture was then boiled under reflux for 6 hours and allowed to cool down overnight. The major part of the ethanol was removed in vacuo, the residue was taken up in water, extracted with ether, this was dried over Na2 SO4, evaporated and distilled.
Boiling point0.1 90° C.
26.6 g (0.1 mole) of diethyl phenethylmalonate were added dropwise in the course of an hour, with stirring, to 5.6 g of KOH in 65 ml of absolute ethanol, the mixture was stirred at room temperature for 15 hours and then boiled for 5 minutes. The ethanol was removed in vacuo, ice-water was added and the mixture was extracted with ether. The aqueous phase was acidified with 2N hydrochloric acid and extracted with ether. The second extract was dried and evaporated and then neutralized with 8.8 ml of diethylamine. 12 ml of 30% strength formaldehyde solution were added, the mixture was stirred for 3 hours, then saturated with potassium carbonate, extracted with ether, the extract was washed with dilute hydrochloric acid, dried and evaporated.
NMR (CDCl3) δ=7.05 s (5H); 6.02 s (1H); 5.4 s (1H); 4.15 q (4H); 2.65 bs (4H); 1.25 t (3H).
14.2 g of ethyl 2-methylene 4-phenylbutyrate and 5.7 ml of isopropylamine were stirred in 25 ml of absolute ethanol at room temperature for 12 days, the solvent was removed, the residue was taken up in 1N hydrochloric acid, extracted with ether and the aqueous phase was made alkaline with sodium carbonate, extracted with ether and this was dried and evaporated.
NMR (CDCl3): δ=7.1 s (5H), 4.1 q (2H); 3.0-2.2 m (6H); 2.05-1.5 m (3H); 1.22 t (3H); 1.0 d (6H).
The crude benzyl N-chlorocarbonyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylate (from 1.2) was taken up in 10 ml of CH2 Cl2, a solution of 2.6 g of N-isopropyl-N-(2-carboethoxy-4-phenylbutyl)amine and 1.2 ml of triethylamine in 10 ml of methylene chloride were added dropwise and the mixture was heated at 35° C. for 20 hours, then evaporated to dryness, the residue was taken up in ethyl acetate, the solution was washed with 1N hydrochloric acid, saturated sodium bicarbonate solution and water, dried and evaporated. The crude product was separated into the two diastereomers of the product on silica gel.
Isomer 1: NMR: (CDCl3) δ7.3-6.8 m (14H); 5.05 s+t (3H); 4.48 s (2H), 4.2-3.5 m (4H); 3.4-2.4 m (6H); 2.0-1.6 m (2H); 1.3-0.9 m (9H).
Isomer 2: NMR (CDCl3) δ7.3-6.9 m (14H); 5.0 s (2H); 4.8 t (1H); 4.52 s (2H); 4.2-3.5 m (4H); 3.3-2.4 m (6H); 2.0-1.6 m (2H), 1.3-1.0 m (9H).
1.35 g of 1.6 (isomer 1) were hydrogenated in 30 ml of absolute ethanol with 0.7 g of Pd/C (10% strength) under 1 atmosphere pressure of hydrogen for 4 hours. After completion of uptake of hydrogen, the mixture was filtered and evaporated.
NMR δ=7.4-6.9 m (9H); 6.5 bs (1H); 4.66 t (1H); 4.4 s (2H); 4.2-3.5 m (3H); 3.4-2.3 m (7H); 2.0-1.6 m (2H); 1.3-0.9 m (9H).
Sodium salt: 0.35 g of 1.7.1 was taken up in 10 ml of H2 O, heated with 63 mg of sodium bicarbonate for 30 minutes, the mixture was evaporated and solidified with ether; colorless powder.
IR 1730, 1620 cm-1.
1.62 g of 1.6 (isomer 2) were hydrogenated in 30 ml of absolute ethanol with 0.7 g of Pd/C (10% strength) under 1 atmosphere pressure of hydrogen for 1.5 hours. After completion of uptake of hydrogen, the mixture was filtered and evaporated.
NMR=δ7.3-6.9 m (9H); 5.1 bs (1H); 4.60 t (1H); 4.30 s (2H); 4.2-3.5 m (3H); 3.3-2.4 m (7H); 2.0-1.5 m (2H); 1.4-1.0 m (9H).
Lysine salt: 0.57 g of 1.7.2. was dissolved in 10 ml of methanol, 0.21 g of lysine in 5 ml of water were added, the mixture was evaporated to dryness and solidified with ether, colorless powder.
IR 1730, 1610 cm-1.
0.55 g of 1.7.1 was dissolved in 6 ml of ethanol, 6 ml of 6N sodium hydroxide solution were added and the mixture was allowed to stand overnight, the ethanol was removed, the residue was acidified with 1N hydrochloric acid, extracted with methylene chloride and this was dried over magnesium sulfate, evaporated and the residue was crystallized from chloroform/petroleum ether.
Melting point 118°-120° C.
NMR (DMSO)=δ7.1 s (9H); 4.5 t (1H); 4.43 s (2H); 4.0-2.8 m (7H); 1.9-1.5 m (2H), 1.05 dd (6H).
0.68 g of 1.7.2 was dissolved in 10 ml of ethanol, 10 ml of 6N sodium hydroxide solution were added and the mixture was stirred for 2 hours, the ethanol was removed, the residue was acidified with 1N hydrochloric acid, extracted with methylene chloride, and this was dried and evaporated to a colorless foam.
NMR (CDCl3)=δ7.0 s (9H); 4.65 t (1H); 4.44 s (2H); 4.0-3.0 m (7H), 2.1-1.6 m (2H); 1.1 dd (6H).
Bisdicyclohexylamine salt: 0.65 g of 2.2 was dissolved in 10 ml of methylene chloride, 0.6 ml of dicyclohexylamine was added, the mixture was evaporated and the residue was triturated with n-hexane; colorless crystals.
Melting point 67°-70° C. (decomposition).
IR 1630 cm-1.
26.3 g of ethyl 2-methylene-4-phenylbutyrate (1.4) and 4 g of methylamine in 150 ml of ethanol in an autoclave were heated at 80° C. for 10 hours. After cooling down, the ethanol was removed, the residue was taken up in 1N HCl, this was extracted with ether, made alkaline with sodium carbonate and again extracted, dried and evaporated.
NMR (CDCl3)=7.1 s (5H); 4.1 q (2H); 3.1 s (3H); 3.0-2.2 m (6H); 2.0-1.5 m (2H); 1.22 t (3H).
2.35 g of 3.1 were dissolved in 10 ml of dry methylene chloride together with 1.5 g of triethylamine. This solution was added dropwise to 11.5 ml of a 15% strength solution of phosgene in methylene chloride at -20° to -30° C., the mixture was stirred for 30 minutes and then evaporated to dryness.
188 g (1.05 moles) of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid were added to 1,050 ml of 1N NaOH at 0° and then at this temperature, 100 ml of benzyl chlorocarbonate and a further 1,050 ml of 1N NaOH were added dropwise simultaneously. The mixture was then stirred at room temperature for 2 hours, then extracted three times with ether and acidified with concentrated HCl to pH 1. The oil which separated out was extracted into ethyl acetate. The ethyl acetate solution was washed with water until the water phase had a pH of 3. After drying, the product crystallized on evaporation and scratching. 1.5 liters of diisopropyl ether were added and the mixture was stirred at room temperature for one hour. The product was then filtered off with suction; melting point 138°-139°.
312 ml of tert.-butanol and 8 g of 4-dimethylaminopyridine were added to a solution of 248.8 g (0.8 mole) of 3.3 in 1.6 liters of methylene chloride. The mixture was cooled down to -5° C. and a solution of 176 g of dicyclohexylcarbodiimide in 350 ml of methylene chloride was added in portions. After 21 hours at room temperature, the precipitated dicyclohexylurea was filtered off with suction. The filtrate was extracted three times with saturated sodium bicarbonate solution. The organic phase was dried over magnesium sulfate and evaporated in vacuo at room temperature. A yellowish oil remained.
NMR: 7.3 s (5H); 7.2 s (4H); 5.1-4.3 m (3H); 5.0 s (2H); 1.46 s (9H).
284 g of 3.4. (0.775 mole) were dissolved in 3 liters of methanol, 15 g of 10% Pd-barium sulfate catalyst were added and the mixture was hydrogenated with hydrogen under normal pressure. The pH was maintained at 4.0 by dropwise addition of 1N methanolic HCl. When the uptake of hydrogen was complete, the mixture was filtered with suction, the filtrate was evaporated and the residue triturated with ether.
Melting point 180° C. (decomposition)
2.7 g of 3.5. were dissolved in 30 ml of saturated sodium bicarbonate solution, the solution was extracted with methylene chloride and the extract was dried and evaporated. The residue was dissolved in 10 ml of methylene chloride and 1.2 g of triethylamine and added dropwise to 3.2. in 10 ml of methylene chloride. The mixture was warmed at 35° C. for 20 hours, then evaporated to dryness and the residue was taken up in ethyl acetate, washed with saturated sodium bicarbonate solution, 1N HCl and water, dried over magnesium sulfate and evaporated; pale yellow resin.
NMR: 7.3-6.8 m (14H); 5.0 s (2H); 5.0-4.8 m (1H); 4.5 s (2H); 4.2-3.5 m (3H); 3.0 s (3H); 3.3-2.4 m (6H); 2.0-1.6 m (2H); 1.1 t (3H).
3 g of 3.6. were stirred with 40 ml of trifluoroacetic acid at room temperature for 2 hours and then evaporated to dryness. The residue was taken up in ethyl acetate, washed three times with water, dried and evaporated.
NMR 7.4-6.9 m (9H); 6.8 bs (1H); 4.6 t (1H); 4.4 s (2H); 4.2-3.5 m (2H); 3.4-2.3 m (7H); 3.0 s (3H); 2.0-1.6 m (2H); 1.1 t (3H).
Lysine salt: colorless powder IR 1730, 1610 cm-1.
1.3 g of 3.7. were dissolved in 20 ml of ethanol, 20 ml of 6N sodium hydroxide solution were added, the mixture was stirred at room temperature for 3 hours, the ethanol was removed in vacuo and the residue was acidified with 1N hydrochloric acid, extracted with methylene chloride and dried over magnesium sulfate, and then evaporated.
NMR 7.6-6.9 m (9H); 6.0 bs (2H); 4.6 t (1H); 4.4 s (2H); 3.4-2.3 m (7H); 3.0 s (3H); 2.0-1.6 m (2H).
17 g of ethyl 2-methylene-4-phenylbutyrate (Example 1.4) and 3.6 g of ethylamine were dissolved in 50 ml of absolute ethanol and heated under 40 atmospheres of nitrogen at 105° C. for 20 hours. After the solvent had been removed, the residue was taken up in 5 normal hydrochloric acid, extracted with ether and the aqueous solution was adjusted to pH 9.5 with potassium carbonate, again extracted with ether, and this was dried with potassium carbonate and evaporated.
NMR (CDCl3): 7.1 s (5H); 4.1 q (2H); 3.0-2.2 m (6H); 2.0-1.4 m (2H); 1.1 d+t (6H).
4.25 g of benzyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate benzenesulfonate were reacted with phosgene and 2.5 g of N-ethyl-N-(carboethoxy-4-phenylbutyl)amine by the process described in Example 1.2. and 1.6. After chromatography on silica gel (eluting with ethyl acetate/cyclohexane 1:5), 1.99 g of isomer 1 and 2.45 g of isomer 2 were obtained.
Isomer 1: NMR (CDCl3) 7.3-6.8 m (14H); 5.05 s (2H); 4.95 t (1H); 4.48 s (2H); 4.2-3.5 m (4H); 3.4-2.4 m (6H); 2.0-1.6 m (3H); 1.1 t (6H);
Isomer 2: NMR (CDCl3) 7.3-6.8 m (14H); 5.05 s (2H); 4.82 t (1H); 4.4 s (2H); 4.2-3.5 m (4H); 3.4-2.4 m (6H); 2.0-1.5 m (3H); 1.1 t (6H).
1.9 g of isomer 1 from Example 5.2. were hydrogenated by the process described in Example 1.7.
1H-NMR 7.4-6.9 m (9H); 6.5 bs (1H); 4.6 t (1H); 4.4 s (2H); 4.2-3.5 m (3H); 3.4-2.3 m (6H); 2.0-1.6 m (2H); 1.3-0.9 m (6H).
Lysine salt: 0.87 g of 5.3 was dissolved in 10 ml of methanol and 0.28 g of lysine in 5 ml of water was added. The solvent was removed and the residue was triturated with ether; colorless powder.
3 g of (2S)-cis-endo-octahydroindole-2-carboxylic acid (prepared according to European Patent Application No. 37,231) were added to a solution of 3 ml of thionyl chloride in 28.5 ml of benzyl alcohol prepared at -10° C. After 15 hours, the benzyl alcohol was distilled off and the product was triturated with diisopropyl ether, melting point 140° C.
2.96 g of the compound from Example 6.1 were reacted with phosgene and 2.5 g of the compound from Example 5.1 in accordance with the process described in Example 1.2 and 1.6. Separation of the diastereomers was carried out on silica gel using ethyl acetate/cyclohexane 1:4 as the eluant.
Isomer 1: [α]D 20 +7.0° (c=1, CH3 OH).
1 H-NMR (CDCl3) 7.3 s (5H); 7.2 s (5H); 5.2-4.7 m (3H); 4.1 q (2H); 3.9-1.4 m (20H); 1.2 t (3H); 1.0 t (3H).
Isomer 2: [α]D 20 -4.6° C. (c=1, CH3 OH).
1 H-NMR (CDCl3): 7.3 s (5H); 7.15 s (5H); 5.1 s (2H); 5.0-4.6 m (1H); 4.1 q (2H); 3.9-1.4 m (20H); 1.2 t (3H); 1.0 t (3H).
1.5 g of the isomer 2 from Example 6.2 were hydrogenated by the process described in Example 1.7.
[α]D 20 +23.3° (c=1, CH3 OH).
1 H-NMR (CDCl3) 7.15 s (5H); 4.5 m (1H); 4.1 q (2H); 3.9-1.4 m (20H); 1.0 t (6H).
Sodium salt: 0.876 g of 6.3 was dissolved in 10 ml of ethanol, 1.9 ml of 1N sodium hydroxide solution were added. The mixture was evaporated and triturated with ether; colorless powder.
0.72 g of the compound from Example 5.3 was saponified with 10 ml of 6N sodium hydroxide solution by the process described in Example 2.
1 H-NMR: 7.1 s (9H); 4.5 t (1H); 4.4 s (2H); 4.0-2.8 m (8H); 1.9-1.5 m (2H); 1.05 t (3H).
0.39 g of the compound from Example 6.3 was saponified with sodium hydroxide solution by the process described in Example 2.
[α]D 20 +15.8° (c=1, CH3 OH).
1 H-NMR (CDCl3) 7.15 s (5H); 4.5 m (1H); 3.9-1.4 m (20H); 1.0 t (3H).
Bisdicyclohexylamine salt: 0.31 g was dissolved in 10 ml of methylene chloride, 0.29 ml of dicyclohexylamine was added, the mixture was evaporated and triturated with diisopropyl ether; colorless powder.
Prepared from cis-endo-2-azabicyclo[3.3.0]octane-3-carboxylic acid by the process described in Example 6.1.
2.82 g of the compound from Example 9.1 were reacted with phosgene and 2.5 g of the compound from Example 5.1 by the processes described in Example 1.2 and 1.6. Separation of the diastereomers was carried out on silica gel using ethyl acetate/cyclohexane (1:3) as eluant.
Isomer 1 1 H-NMR (CDCl3): 7.3 s (5H); 7.2 s (5H); 5.3-4.7 m (3H); 4.1 q (2H); 3.9-1.4 m (18H); 1.2 t (3H); 1.05 t (3H).
Isomer 2 1 H-NMR (CDCl3): 7.3 s (5H); 7.15 s (5H); 5.1 s (2H); 4.8 m (1H); 4.15 q (2H); 4.0-1.5 m (18H); 1.15 t (3H); 1.0 t (3H).
Prepared from 1 g of isomer 2 from Example 9.2 by the process described in Example 6.2.
1 H-NMR (CDCl3) 7.1 s (5H); 4.4 m (1H); 4.1 q (2H); 3.8-1.4 m (18H); 1.0 t (6H).
Prepared from 0.32 g of the compound from Example 9.3 by the process described in Example 5.3.
1 H-NMR (CDCl3) 7.1 s (5H); 4.5 m (1H); 3.8-1.4 m (18H); 1.0 t (3H).
The compounds listed in the following table were prepared by analogous processes using the appropriate starting materials.
##STR17## n R.sup.1 R.sup.1' R.sup.2 R.sup.3 R.sup.4 R.sup.5 R.sup.6 11 0 H H H CH.sub.3 CH.sub.3 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.4m(1H); 3.8-2.8m (3H); 3.02s(3H); 2.0-1.7m(2H); 1.2d(5H) 12 1 H H H CH.sub.3 C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.4m(1H); 3.5-2.8m (7H); 2.0-1.7m(2H); 1.2d + t(6H) 13 1 H C.sub.2 H.sub.5 H CH.sub.3 C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.4m(1H); 4.2q(2H) 3.5-2.8m(7H); 2.0-1.7m(2H); 1.2d + t(9H) 14 1 H H H (CH.sub.3).sub.2 CH CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-OCH.sub.3 7.0-6.5m(4H); 4.8-4.4m(1H); 3.5-2.8m(5H); 3.02s(3H); 1.9-1.3m(3H); 1.2-0.9d(6H ) 15 0 H H H (CH.sub.3).sub.2 CH C.sub.2 H.sub.5 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.3m(2H); 3.8-2.9m (2H); 2.8- 2.0m(2H); 1.8-1.3m(3H); 1.3-0.9m(9H) 16 0 H C.sub.2 H.sub.5 H (CH.sub.3).sub.2 CH C.sub.2 H.sub.5 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.3m(2H); 4.1q(2H) 3.9-2.9m(2H); 2.8-2.0m(2H); 1.8-1.3m(3H); 1.3-0.9m(12H) 17 1 H H CH.sub.3 (CH.sub.3).su b.2 CH CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.4m(1H); 3.8-2.8m(4H); 3.0s(3H); 2.0-1.7m(2H); 1.6-1.3m(3H) ; 1.2-0.9m(12H) 18 1 H H H (CH.sub.3).sub.2 CHCH.sub.2 ##STR18## H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.2-6.9m(4H); 4.7-4.4m(1H); 3.8-2.6m(4H); 2.8-2.0m(2H); 1.9-1.4m(5H); 1.2-0.6m(10H) 19 1 H C.sub.2 H.sub.5 H (CH.sub.3).sub.2 CHCH.sub.2 ##STR19## H CH.sub.2CH.sub.2C.sub.6 H.sub.44-F 7.2-6.9m(4H); 4.7-4.4m(1H); 4.2q(2H)3.8-2.6m(4H); 2.8-2.0m(2H); 1.9-1.4m(5H);1.2-0.6m + t(13H) 20 1 H H CH.sub.3 (CH.sub.3).sub.2 CHCH.sub.2 HCCCH.sub.2 H CH.sub.2 CH.sub.2C.sub.6 H.sub.3(OCH.sub.3).sub.23.4 6.8-6.4m(3H); 4.7-4.4m(1H); 3.8-2.6m(5H); 3.9s(6H); 3.0s(3H); 2.8-2.0m(2H); 1.9-1.4m(6H);1.1-0.9m(6H) 21 0 H H H (CH.sub.3).sub.2 CHCH.sub.2 CH.sub.3 CH.sub.2 CH.sub.2 -- CH.sub.2CH.sub.2C.sub.6 H.sub.44-F 7.2-6.9m(4H); 4.7-4.4m(2H); 3.8-2.6m (2H); 2.8-2.0m(2H); 2.0-1.4m(7H); 1.1d + t(9H) 22 1 H H H CH(CH.sub.3)CH.sub.2 CH.sub.3 C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); 4.7-4.4m(1H); 3.8-2.6m(5H); 2.8-2.0m (2H); 2.2s(3H); 1.9-1.4m(5H); 1.1d + 2t(9H) 23 1 H C.sub.2 H.sub.5 H CH(CH.sub.3)CH.sub.2 CH.sub.3 C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); 4.7-4.4m(1H); 4.2q(2H); 3.8-2.6m (5H); 2.8-2.0m(2H); 2.2s(3H); 1.9-1.4m(5H); 1.3-0.9m(12H) 24 1 H H H CH.sub.2 CONH.sub.2 C.sub.2 H.sub.5 H ##STR20## 7.3-6.9m(3H); 4.7-4.4m(1H); 3.8-2.6m(5H);2.8-2.0m(4H); 1.9-1.4m(2H); 1.0t(3H) 25 1 H C.sub.2 H.sub.5 H CH.sub.2 CONH.sub.2 C.sub.2 H.sub.5 H ##STR21## 7.3-6.9m(3H); 4.7-4.4m(1H); 4.2q(2H); 3.8-2.6m(5H); 2.8-2.0m(4H); 1.9-1.4m(2H)1,2t(3H);1.0t(3H) 26 0 H C.sub.2 H.sub.5 H CH.sub.2 CONH.sub.2 C.sub.2 H.sub.5 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.43-CN 7.6-7.0m(4H); 4.8-4.3m(2H); 4.2q(1H); 2.8- 2.0m(4H); 1.9-1.4m(2H ); 1.2t(3H) 27 1 H H H CH.sub.2 CH.sub.2 C COOH CH.sub.3 H CH.sub.2CH.sub.2.sub.6 H.sub.5 7.2s(5H); 4.7-4.4m(1H); 3.6-2.8m(3H); 2.8- 2.0m(4H); 2.0s(3H);1.8-1.4m(4H) 28 1 H H H CH.sub.2 CH.sub.2 CONH.sub.2 CH.sub.3 H CH.sub.2 CH.sub.2C.sub.6 H.sub.5 7.2s(5H); 4.7-4.4m(1H); 3.6-2.8m(3H); 2.8- 2.0m(4H); 2.0s(3H)1.8 -1.4m(4H) 29 1 H C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 CONH.sub.2 C.sub.2 H.sub.5 H ##STR22## 8.6-7.2m(4H); 4.7-4.4m(1H); 4.2q(2H); 3.6-2.8m(5H); 2.8-2.0m(4H); 1.8-1.4m(4H); 1.22t(6H) 30 1 H H H (CH.sub.2).sub.4 NH.sub.2 C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2C.sub.6 H.sub.5 7.25(5H); 4.7-4.4m(1H); 3.6-2.8m(5H); 2.8- 2.0m(4H); 1.9-1.3m(8H); 1.1t(3H) 31 1 H C.sub.2 H.sub.5 H (CH.sub.2).sub.4 NH.sub.2 ##STR23## CH.sub.3 CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.4m(1H); 3.6-2.8m(4H); 2.8-2.0m(4H); 4.2(2H); 1.9-1.1m(14H)1.2-1.02t + d(9H) 32 1 H H CH.sub.3 CH.sub.2 SH CH.sub.2CHCH.sub.2 H CH.sub.2CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); .8m(1H); 5.0-4.3m(5H); 3.6- 2.7m(3H); 2.8-2.0m(4H)2.1s(3H); 1.9-1.4m(2H) 33 1 H H H CH.sub.2 SH CH.sub.2 CH.sub.2 CH.sub.3 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-NHCOCH.sub.3 7.1-6.7m(4H); 4.8-4.3m(1H); 3.6-2.7m(5H); 2.8- 2.0m(4H); 2.0s(3H); 1.9-1.4m(4H); 1.1t(3H) 34 0 H C.sub.2 H.sub.5 H CH.sub.2 SH C.sub.2 H.sub.5 -- CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2s(5H); 4.0-4.3m(2H); 4.2q3.8-2.8m (2H); 2.8-2.0m(4H); 1.9-1.4m(2H); 1.2t(3H) 35 1 H H H CH.sub.2 SC.sub.6 H.sub.5 C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(10H); 4.8-4.3m(1H); 3.8-2.8m(6H); 3.4- 2.8m(1H); 1.9-1.4m(2H)1.1t(3H) 36 1 H C.sub.2 H.sub.5 H CH.sub.2 SC.sub.5 H.sub.5 C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(10H); 4.8-4.3m(1H); 4.2q(2H); 3.8-2.8m (6H); 3.4-2.8m(1H); 1.9-1.4m(2H); 1.3-1.0m(6H) 37 1 H H H CH.sub.2 CH.sub.2 SCH.sub.3 CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.4m(1H); 3.8-2.8m(3H); 2.8- 2.0m(4H); 2.2s(3H); 2.1s(3H); 1.9-1.4m(4H) 38 1 H C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 SCH.sub.3 CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2C.sub.6 H.sub.5(OCH.sub.3).sub.23.4 6.8-6.3m(3H); 4.7-4.4m(1H); 4.2q(2H); 4.0s(6H); 3.8-2.8m(4H),2.8-2.0m(4H); 2.2s(3H); 1.9- 1.4m(4H); 1.0d(6H) 39 1 H H CH.sub.3 CH.sub.2 CH.sub.2 SCH.sub.3 CH.sub.2 CH.sub.2 CH.sub.3 CH.sub.3 CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2s(5H); 4.7-4.4m(1H); 3.8-2.8m(3H); 2.8- 2.0m(4H); 2.2s(3H)2.0 s(3H)1.9-1.4m(6H); 1.0d + t(6H) 40 0 H C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 SCH.sub.3 CH.sub.2 CH.sub.2 CH.sub.3 -- CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2s(5H); 4.8-4.3m(2H); 4.2q(2H); 3.8- 2.8m(2H); 2.8-2.0m(4H)2.2s(3H); 1.9-1.4m (6H); 1.2t(3H)1.0t(3H) 41 1 H H H CH.sub.2 C.sub.6 H.sub.5 CH.sub.3 H (CH.sub.2).sub.3CH.sub.3 7.2s(5H); 4.7-4.3m(1H); 3.8-2.6m(3H); 2.8- 2.0m(2H); 2.0s(3H); 1.9-1.3m(6H); 1.2t(3H) 42 1 H H H CH.sub.2 C.sub.6 H.sub. 5 C.sub.2 H.sub.5 H CH.sub.2SC.sub.6 H.sub.5 7.2-6.9m(10H); 4.7-4.3m(1H); 3.8- 2.6m(6H), 2.8-2.0m(2H ); 1.0t(3H) 43 1 H H H CH.sub.2 C.sub.6 H.sub.5 C.sub.2 H.sub.5 H CH.sub.2SOC.sub.6 H.sub.5 7.4-6.9m(10H); 4.7-4.3m(1H); 3.8- 2.6m(6H); 2.8-2.0m(2H); 1.0t(3H) 44 1 H C.sub.2 H.sub.5 H CH.sub.2 C.sub.6 H.sub.5 CH.sub.2CHCH.sub.2 CH.sub.3 CH.sub.2NHC.sub.6 H.sub.5 7.1-6.4m(10H); 5.8m(1H); 4.8-4.3m(5H); 4.2q(2H); 3.8-2.6m(5H)2.8 -2.0m(2H); 1.3t(3H) 45 1 H H CH.sub.3 CH.sub.2 C.sub.6 H.sub.5 ##STR24## H ##STR25## 8.0s(1H); 7.8-6.9m(10H); 4.7-4.3m(1H); 3.9-2.8m(4H); 2.8-2.0m(4H); 2.1s(3H); 1.9-1.4m(10H) 46 1 H C.sub.2 H.sub.5 H CH.sub.2 C.sub.6 H.sub.5 CH(CH.sub.3).sub.2 H ##STR26## 7.3-6.9m(6H); 4.7-4.4m(1H); 4.2q(2H); 3.8-2.6m(4H); 2.7s(3H); 2.3s(3H); 2.8-2.0m(4H);1.3t(3H); 1.1d(6H) 47 1 H H H CH.sub.2 C.sub.6 H.sub.5 C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2C.sub.6 H.sub.5 7.2s(10H); 4.7-4.4m(1H); 3.8-2.6m(5H); 2.8-2.0m(4H); 1.9-1.4m(2H); 1.1t(3H) 48 0 H H H CH.sub.2 C.sub.6 H.sub.5 C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2s(10H); 4.8-4.3m(2H); 3.8-2.6m (2H); 1.9-1.4m(2H); 1.2t(3H) 49 0 H C.sub.2 H.sub.5 H CH.sub.2 C.sub.6 H.sub.5 CH.sub.2 CH.sub.2 CH.sub.3 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-F 7.3-6.9m(9H); 4.8-4.3m(2H); 3.8-2.6m(2H); 4.2q(2H); 1.9-1.4m(4H); 1.2t(3H); 1.0t(3H) 50 0 H C.sub.2 H.sub.5 H CH.sub.2 C.sub.6 H.sub.5 CH.sub.2CHCHCH.sub.3 H CH.sub.2 CH.sub.2C.sub.6 H.sub.5 7.2s(10H); 5.5-5.1m(2H); 4.8-4.1m(4H); 4,2q (2H); 2.8-2.0m(4H); 2.2d(3H); 1.9- 1.4m(2H); 1.2t(3H) 51 1 H H H ##STR27## CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.6d(1H); 6.7d(1H); 7.2s(5H); 4.7-4.3m(1H);3.8-2.6m(3H); 2.3s(3H); 2.8-2.0m(4H);1.9-1.4m(2H) 52 1 H C.sub.2 H.sub.5 H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.6d(1H); 7.2s(5H); 6.7d(1H); 4.7-4.3m(1H); 4.2q(2H); 3.8-2.6m(5H); 2.8-2.0m(4H); 1.9- 1.4m(2H);1.2t(3H) 53 1 H H H CH.sub.2 OH CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(1H); 3.8-2.6m(5H); 2.8-2.0m(2H); 2.2s(3H); 1.9-1.4m(2H) ; 54 1 H C.sub.2 H.sub.5 H CH.sub.2 CH C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 6.9-6.5m(4H); 4.7-4.3m(1H); 4.2q(3H); 4.0s (3H); 3.8-2.6m(7H); 2.8-2.0m(2H); 1.9- 1.4m(2H); 1.0t(3H); 1.1t(3H) 55 1 H H H CH.sub.2 OCH.sub.3 CH(CH.sub.3).sub.2 H CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(1H); 3.9-2.6m + s(9H); 2.8-2.0m(2H); 1.1d(6H) 56 1 H H H CH.sub.2 OCH.sub.3 CH(CH.sub.3).sub.2 H CH.sub.3 4.7-4.3m(1H); 3.9-2.6m + s(9H); 1.2d(9H) 57 1 H H H CH.sub.2 OCH.sub.3 CH(CH.sub.3).sub.2 H H 4.7-4.3m(1H); 3.9-2.6m + s(9H); 2.4-2.0m (2H); 1.2d(6H) 58 1 H C.sub.2 H.sub.5 H ##STR28## CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 8.0s(1H); 7.8-6.8m(10H); 4.7-4.3m(1H); 4.2q(2H); 3.8-2.7m(3H); 2.8-2.0m(4H);1.9-1.3m(2H); 2.0s(3H)1.2t(3H) 59 1 H H H " C.sub.2 H.sub.5 H ##STR29## 8.0s(1H); 7.8-6.8m(10H); 4.7-4.3m(1H); 3.8-2.7m(5H); 2.8-2.0m(4H); 1.9-1.3m(2H); 1.1t(3H) 60 1 H H H CH.sub.2 CH.sub.2 OCH.sub.3 CH.sub.3 H CH.sub.2 CH.sub.3 4.7-4.3m(1H); 3.8-2.7m + s(8H); 2.3s(3H); 1.9-1.4m(4H); 1.1t(3H) 61 1 H C.sub.2 H.sub.5 CH.sub.3 CH.sub.2 CH.sub.2 OCH.sub.3 CH.sub.2CHCH.sub.2 H CH.sub.2 CH(CH.sub.3).sub.2 5.8m(1H); 4.9-4.1m(5H); 3.7-2.9m + s (8H); 4.2q(2H)1.9-1.4m(5H); 1.0d(9H) 62 0 H C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 OCH.sub.3 C.sub.2 H.sub.5 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2m(5H); 4.9-4.3m(2H); 3.7-2.9m + s (7H); 4.2q(2H); 2.8-2.0m(2H)1.9-1.4m(4H); 1.3t(3H); 1.0t(3H) 63 1 H H CH.sub.3 (CH.sub.2).sub.4 NHCOCH.sub.3 CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.4m(1H); 3.7-2.9m(2H); 2.8- 2.0m(4H); 2.1s(9H); 1.9-1.3m(8H); 1.1d(3H) 64 1 H C.sub.2 H.sub.5 H (CH.sub.2).sub.4 NHCOCH.sub.3 CH(CH.sub.3).sub.2 H (CH.sub.2).sub.4 CH.sub.3 4.7-4.4m(1H); 4.2q(2H); 3.7-2.9m(6H); 2.0- 1.2m(14H); 1.3t(3H); 1.1-0.9m(9H)
##STR30## n R.sup.1 R.sup.1' R.sup.2 -R.sup.3 R.sup.4 R.sup.5 R.sup.6 65 1 H H (CH.sub.2).sub.3 CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2.s(5H); 4.9-4.4m(1H); 3.8-2.9m (5H); 2.8-2.0m(2H); 2.0s(3H); 1,9-1.4m(6H) 66 1 H H (CH.sub.2).sub.3 C.sub.2 H.sub.5 H CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.9-4.4m(1H); 3.8-2.9m (7H); 2.8-2.0m(2H); 1.9-1.4m(4H)1.1t(3H) 67 1 H H (CH.sub.2).sub.3 CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3 4.8-4.4m(1H); 3.8-2.9m(6H); 1.9-1.3m(10H); 1.2-0.9m(9H) 68 1 H H (CH.sub.2).sub. 3 CH.sub.2CHCH.sub.2 H CH.sub.2CH.s ub.2CH(CH.sub.3).sub.2 5.8m(1H); 4.8-4.2m(5H); 3.8-2.9m (5H); 1.9-1.3m(9H); 1.0d(6H) 69 1 H H (CH.sub.2).sub.3 CH.sub.2CCH H CH.sub.2 CH.sub.2C(CH.sub.3).sub.3 4.8-4.2m(1H); 3.8-2.9m(7H); 1.9-1.3m(9H ); 0.9s(9H) 70 1 H H (CH.sub.2).sub.3 ##STR31## H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.3-6.8m(4H); 4.7-4.3m(1H);3.8-2.7m(6H); 2.8-2.0m(2H);1.9-1.3 m(6H); 1.0-0.6m(4H) 71 1 H H (CH.sub.2).sub.3 C.sub.2 H.sub.5 H C CH.sub.2H.sub.2C.sub.6 H.sub.32.6-Cl.sub.2 7.3s(3H); 4.7-4.3m(1H); 3.7-2.7m (7H); 2.8-2.0m(2H); 1.9-1.3m(6H)1.1t(3H) 72 1 H H (CH.sub.2).sub.3 C.sub.2 H.sub.5 H ##STR32## 8.0s(1H); 7.6-6.7m(5H)4.7-4.3m(1H); 3.7- 2.7m(7H); 2.8-2.0m(2H); 1.1t(3H) 73 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.3 CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(1H); 3.7-2.7m (5H); 4.2q(2H); 2.8-2.0m(2H); 2.1s (3H); 1.9-1.4m(6H); 1.3t(3H) 74 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.3 C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(1H); 4.2q(2H) 3.7-2.7m(7H); 2.8-2.0m(2H); 1.9- 1.4m(6H); 1.3t(3H); 1.0t(3H) 75 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.3 CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(1H); 4.2q(2H) 3.7-2.7m(6H); 2.8-2.0m(2 H); 1.9-1.3m(6H); 1.3t(3H); 0.9d(6H) 76 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.3 CH.sub.2CHCH.sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 5.8m(1H); 4.8-4.1m(5H) 4.2q(2H); 3.7-2.7m(5H); 2.8-2.0m (2H); 1.9-1.4m(6H); 1.3t(3H) 77 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.3 ##STR33## H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.6-4.2m(1H); 4.2q(2H)3.8-2.7m(6H); 2.8-2.0m(2H); 1 1.9-.4m(12H); 1.3t(3H) 78 1 H C.sub.2 C H.sub.5 (CH.sub.2).sub.3 CH.sub.2CH H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(1H); 4.2q(2H) 3.8-2.7m(7H); 2.8-2.0m(2H); 1.9-1.4m(7H); 1.3t(3H) 79 0 H H (CH.sub.2).sub.3 CH.sub.3 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.9-4.3m(2H); 3.8-2.7m (2H); 2.3s(3H); 2.8-2.0m(2H); 1.9-1.4m(6H) 80 0 H C.sub.2 H.sub.5 (CH.sub.2).sub.3 C.sub.2 H.sub.5 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.2-6.8m(4H); 4.9-4.3m(2H); 4.2q (2H); 3.8-2.7m(4H); 2.8-2.0m(2H) ; 1.9-1.4m(6H); 1.3t(3H); 1.1t(3H) 81 0 H C.sub.2 H.sub.5 (CH.sub.2).sub.3 C.sub.2 H.sub.5 -- CH.sub.2CH.sub.2CH.sub.3 4.9-4.3m(2H); 4.2q(2H); 3.8-2.7m (4H); 1.9-1.4m(8H); 1.1t(6H) 82 0 H H (CH.sub.2).sub.3 (CH(CH.sub.3) .sub.2 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 6.9-6.3m(4H); 4.9-4.3m(2H); 3.8-2.7m(3H); 3.9s(3H); 2.8-2.0m (2H); 1.9-1.4m(6H); 1.0d(6H) 83 0 H H (CH.sub.2).sub.3 CH.sub.2CHCH.sub.2 -- CH.sub.2CH.sub.2C.sub.6 H.sub.3(OCH.sub.3).sub.23.4 6.8-6.0m(3H); 5.8m(1H); 4.9-4.3m (6H); 4.0s(6H); 3.8-3.1m(2H); 2.8-2.0m(2H); 1.9-1.4m(6H) 84 0 H H (CH.sub.2).sub.3 CH.sub.2CCCH.sub.3 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub. 5 7.2s(5H); 4.9-4.3m(2H); 3.8-2.7m (4H); 2.8-2.0m(2H); 1.8s(3H); 1.8-1.3m(6H) 85 1 H H CH.sub.2CH(OCH. sub.3)CH.sub.2 C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.3m(1H); 4.1-2.9m (8H); 3.2s(3H); 2.8-2.0m(2H); 2.0-1.3m(6H); 1.0t(3H) 86 1 H C.sub.2 C H.sub.5 CH.sub.2CH(OCH.sub.3)H.sub.2 CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.3m(1H); 4.1-2.9m (6H); 4.2q(2H); 3.2s(3H); 2.4s (3H); 2.8-2.0m(2H); 2.0-1.4m(6H); 1.3t(3H) 87 1 H H CH.sub.2CHCH C.sub.2 H.sub.5 CH.sub.3 CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 6.4.5.5m(3H); 4.3-2.9m (6H); 2.8-2.0m(2H); 1.9-1.4m(2H); 1.2d + t(6H) 88 1 H C.sub.2 H.sub.5 CH.sub.2CHCH CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 6.4-5.5m(3H); 4.3-2.9m (8H); 2.8-2.0m(2H); 1.6-1.2m(2H); 1.3t(3H); 1.0d(6H) 89 1 H H CH(CH.sub.3)CH.sub.2CH. sub.2 CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(1H); 3.7-2.8m (5H); 2.8-2.0m(2H); 1.6-1.3m(5H); 2.1s(3H); 1.0d(3H) 90 1 H H CH.sub.2CH(CH.sub.3)CH. sub.2 C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(1H); 3.7-2.8m (7H); 2.8-2.0m(2H); 1.7-1.3m(5H); 1.0d + t(6H) 91 1 H C.sub.2 H.sub.5 CH.sub.2CH(C.sub.6 H.sub.5)CH.sub.2 C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(10H); 4.7-4.3m(1H); 4.2q (2H); 3.7-2.8m(8H); 2.8-2.0m(2H); 1.8-1.4m(6H); 1.3t(3H); 1.0t(3H) 92 1 H H CHC.sub.6 H.sub.5CH.sub.2CH.sub.2 C.sub.3 H.sub.7 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(10H); 4.7-4.3m(1H); 3.7-2.8m (8H); 2.8-2.0m(2H); 1.8-1.4m(8H); 1.0t(3H) 93 1 H H (CH.sub.2).sub.4 CH.sub.3 H ##STR34## 7.3-6.9m(3H); 4.7-4.4m(1H); 3.6-2.8m(5H); 2.2s(3H); 2.8-2.0m(2H)1.9-1.4m (8H) 94 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.4 CH.sub.3 H CH.sub.3 4.7-4.4m(1H); 4.2q(2H); 3.6-2.8m (5H); 2.2s(3H); 1.9-1.4m(6H); 1.1d(3H) 95 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.4 C.sub.2 H.sub.5 CH.sub.3 CH.sub.2CH.sub.3 4.7-4.4m(1H); 4.2q(2H); 3.6-2.8m (6H); 1.9-1.4m(8H); 1.3t(3H); 1.0m(9H) 96 1 H H (CH.sub.2).sub.4 CH(CH.sub.3).s ub.2 H CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2s(5H); 4.7-4.4m(1H); 3.6-2.8m (6H); 2.8-2.0m(2H); 1.9-1.4m(8H); 1.0d(6H) 97 1 H H (CH.sub.2).sub.4 C.sub.2 H.sub.5 H ##STR35## 7.4-6.8m(5H); 4.7-4.4m(1H);3.6-2.8m(7H); 2.8-2.0m(2H); 1.9-1.4m(6H); 1.0t(3H) 98 1 H H (CH.sub.2).sub.4 C.sub.2 H.sub.5 H ##STR36## 7.6d(1H); 6.7d(1H); 4.7-4.4m(1H)3.6-2.8m(7H); 2.8-2.0m(2H); 1.9-1.4m(8H) ; 1.0t(3H) 99 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.4 CH.sub.2CHCH.sub.2 H CH.sub.2CH.sub.2C.sub.6 H.sub.32.6-Cl.sub.2 7.3s(3H); 5.8m(1H); 4.9-4.3m (5H); 4.2q(2H); 3.6-2.8m(5H); 2.8-2.0m(2H); 1.9-1.5m(8H) 100 1 H H (CH.sub.2).sub.4 CH.sub.2CCH H CH.sub.2CH.sub.2C.sub.6 H.sub.3Cl2-OCH.sub.34 7.3-6.6m(3H); 4.7-4.3m(1H); 3.8- 2.8m(7H); 4.0s(3H); 2.8-2.0m(2H) 1.9-1.5m(9H) 101 1 H C.sub.2 H.sub.5 (CH.sub.2 ).sub.4 CH.sub.2CH.sub.3 CH.sub.3 ##STR37## 7.4s(1H); 4.7-4.3m(1H); 4.2q(2H)3.8-2.8m(6H); 2.3s(3H); 2.1s(3H)2.8-2.0m (2H); 1.9-1.4m(8H); 1.3t(3H); 1.0d(3H) 102 1 H H (CH.sub.2).sub.4 CH.sub.3 H CH.sub.2C.sub.6 H.sub.5C.sub.6 H.sub.5 7.4.-6.8m(9H); 4.7-4.3m(1H); 3.8- 2.8m(5H); 2.2s(3H); 2.8-2.0m(2H) 1.9-1.4m(6H) 103 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.4 ##STR38## H CH.sub.3 4.7-4.3m(1H); 4.2q(2H); 3.8-2.8m(6H); 1.9-1.3m(14H); 1.3t(3H); 1.0d(3H) 104 1 H H (CH.sub.2).sub.4 C.sub.2 H.sub.5 H ##STR39## 7.5s(1H); 7.1s(5H); 4.7-4.3m(1H)3.8-2.8m(7H); 2.8-2.0m(2H); 1.9-1.4m(8H) ; 1.0t(3H) 105 1 H H (CH.sub.2).sub.4 C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(1H); 3.8-2.9m (7H); 2.8-2.0m(2H); 1.9-1.4m (10H); 1.0t(3H) 106 0 H H (CH.sub.2).sub.4 CH.sub.3 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.9-4.2m(2H); 3.8-2.9m (2H); 2.8-2.0m(2H); 2.2s(3H); 1.9-1.5m(8H) 107 0 H H (CH.sub.2).sub.4 C.sub.2 H.sub.5 -- CH.sub.2CH.sub.2C.sub.6 H.sub.44-F 7.2-6.8m(4H); 4.9-4.2m(2H); 3.8- 2.9m(4H); 2.8-2.0m(2 H); 2.0-1.5m (8H); 1.0t(3H) 108 0 H C.sub.2 H.sub.5 (CH.sub.2).sub.4 CH(CH.sub.3).sub.2 -- CH.sub.2CH.sub.2C.sub.6 H.sub.3(OCH.sub.3).sub.23.4 6.9-6.2m(3H); 4.9-4.2m(2H); 4.2q (2H); 4.0s(6H); 3.8-2.9m(3H); 2.8- 2.0m(2H); 1.9-1.4m(8H); 1.0d (6H); 1.3t(3H) 109 0 H C.sub.2 C H.sub.5 (CH.sub.2).sub.4 CH.sub.2CHH.sub.2 -- CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2s(5H); 4.9-4.2m(6H); 4.2q(2H) 5.8m(1H); 2.8-2.1m(2H); 1.9-1.4m (8H); 1.3t(3H) 110 1 H H (CH.sub.2).sub.5 CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(1H); 3.8-2.8m (5H); 2.8-2.0m(2H); 2.3s(3H); 1.9-1.4m(10H) 111 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.5 C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); 4.7-4.3m(1H); 4.2q(2H) 3.8-2.8m(7H); 2.2s(3H); 2.8-2.0m (2H); 1.9-1.4m(10H); 1.3t(3H)1.1t(3H) 112 1 H H (CH.sub.2).sub.5 CH(CH.sub.3).sub.2 H CH.sub.2CH.sub.2C.sub.6 H.sub.32-Cl4-OCH.sub.3 7.1-6.5m(3H); 4.7-4.3m(1H); 3.8-2.8m(6H); 4.0s(3H); 2.8-2.0m (2H); 1.9-1.4m(10H); 1.1d(6H); 113 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.5 ##STR40## H CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(1H); 3.8-2.8m(6H); 4.2q(2H); 2.8-2.0m(2H);1.9-1.4m(16H); 1.3t(3H) 114 1 H H (CH.sub.2).sub.5 ##STR41## H CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2s(5H); 4.7-4.4m(1H); 3.8-2.8m(6H); 2.8-2.0m(2H); 1.9-1.4m(18H) 115 1 H H (CH.sub.2).sub.5 CH.sub.2CHCHCH.sub.3 H ##STR42## 8.6-7.2m(4H); 5.8-5.4m(2H); 4.9-4.2m(5H); 3.8-2.9m(5H); 2.8-2.1m(2H); 1.9-1.4m + s(13H) 116 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.5 CH.sub.2CH(CH.sub.3).sub.2 H CH.sub.2CH.sub.2C. sub.6 H.sub.5 7.2s(5H); 4.7-4.4m(1H); 4.2q(2H) 3.8-3.1m(7H); 2.9-2.4m(2H); 1.9-1.4m(11H); 1.1d(6H) 117 1 H H (CH.sub.2).sub.5 CH.sub.3 CH.sub.3 .sub.-n-C.sub.4 H.sub.9 4.7-4.4m(1H); 3.8-3.1m(4H); 2.2s (3H); 1.9-1.4m(14H); 1.0d + t(3H) 118 1 H H (CH.sub.2).sub.5 C.sub.2 H.sub.5 H CH.sub.2CH.sub.2CH(CH.sub.3).sub.2 4.7-4.4m(1H); 3.8-3.1m(7H); 1.9- 1.4m(13H); 1.0d + t(9H) 119 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.5 CH(CH.sub.3).sub.2 H CH.sub.2SO.sub.2C.sub.6 H.sub.5 7.4-6.8m(5H); 4.7-4.4m(1H); 4.2q (2H); 3.8-3.0m(8H); 1.9-1.4m(8H); 1.3t(3H); 1.1d(6H) 120 1 H H ##STR43## CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-F 7.3-6.9m(8H); 4.7-4.2m(3H); 3.5-2.9m(3H); 2.8-2.3m(4H); 1.9-1.4m(2H); 2.2s(3H) 121 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2 CH.sub.2 C.sub. 6 H.sub.44-F 7.3-6.9m(8H); 4.7-4.3m(3H); 4.2q (2H); 3.5-2.9m(3H); 2.8-2.3m(4H); 1.9-1.4m(2H); 2.2s(3H); 1.2t(3H) 122 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 7.2-6.5m(8H); 4.7-4.3m(3H); 3.8- 2.9m(5H); 4.0s(3H); 2.8-2.3m(4H) 1.9-1.4m(2H); 1.1t(3H) 123 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 7.2-6.5m(8H); 4.7-4.3m(3H); 4.2q (2H); 3.8-2.9m(5H); 4.0s(3H); 2.8-2.3m(4H); 1.9-1.4m(2H); 1.3t (3H); 1.1t(3H) 124 1 H H " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2-6.8m(8H); 4.7-4.3m(3H); 4.0- 2.9m(4H); 2.8-2.3m(4H); 2.3s (3H); 1.9-1.4m(2H); 1.0d(6H) 125 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2-6.8m(8H); 4.7-4.3m(3H); 4.2q (2H); 4.0-2.9m(4H); 2.8-2.3m(4H); 2.3s(3H); 1.9-1.4m(2H); 1.3t(3H); 1.0d(6H) 126 1 H H " CH.sub.2CHCH.sub.2 H CH.sub.2 CH.sub.2CH(CH.sub.3).sub.2 7.2s(4H); 5.8m(1H); 5.0-4.3m (7H); 3.5-2.9m(3H); 2.8-2.3m(2H); 1.9-1.4m(5H); 1.0d(6H) 127 1 H H " CH.sub.3 H CH.sub.3 7.2s(4H); 4.7-4.3m(3H); 3.5-2.9m (3H); 2.8-2.3m(2H); 2.3s(3H); 1.1d(6H) 128 1 H H " ##STR44## H CH.sub.2SC.sub.6 H.sub.5 7.3-6.9m(9H); 4.7-4.3m(3H); 3.5-2.9m(6H); 1.1-0.6m(4H) 129 1 H H " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-N(CH.sub.3).sub.2 7.2-6.4m(8H); 4.7-4.3m(3H); 3.5-- 2.9m(5H); 2.9s(6H); 2.8-2.3m (4H); 1.9-1.4m(2H); 1.1t(3H) 130 1 H C.sub.2 H.sub.5 " n-C.sub.4 H.sub.9 CH.sub.3 CH.sub.2CH.sub.2C.sub.6 H.sub.33-CN 7.6-7.0m(8H); 4.7-4.3m(3H); 4.2q (2H); 3.8-2.9m(5H); 2.8-2.3m(4H); 1.9-1.4m(6H); 1.3t(3H); 1.0t(3H) 131 1 H H " CH.sub.2CH.sub.2CH.sub.3 H ##STR45## 8.6-7.2m(8H); 4.7-4.3m(3H); 3.8-2.9m(5H); 2.8-2.3m(4H); 1.9-1.4m(4H); 1.0t(3H) 132 1 H H " CH.sub.3 H ##STR46## 7.3-6.8m(8H); 4.7-4.3m(3H); 3.5-2.9m(3H); 2.3s(3H); 2.8-2.3m(4H)1.9-1.4m (2H) 133 1 H H " ##STR47## H ##STR48## 8.0s(1H); 7.2s(4H); 4.7-4.3m(3H)4.0-2.9m(4H); 2.9-2.3m(4H); 3.9s(3H); 1.9-1.2m(8H) 134 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.3(OCH.sub.2 O)3.4 7.2-6.2m(7H); 5.0s(2H); 4.7-4.3m (3H); 4.2q(2H); 3.9-2.9m(5H); 2.9-2.3m(4H); 1.9-1.4m(2H); 1.3t(3H) 135 1 H H " CH.sub.3 CH.sub.3 CH.sub.2CH.sub.2C.sub.6 H.sub.4OC.sub.6 H.sub.54 7.2-6.7m(13H); 4.7-4.3m(3H); 4.0-2.9m(2H); 2.9-2.3m(2H) ; 2.4s (3H); 1.9-1.4m(2H); 1.1d(3H) 136 0 H H " CH.sub.3 -- CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2s(9H); 4.7-4.3m(4H); 2.9-2.3m (4H); 2.3s(3H); 1.9-1.4m(2H) 137 0 H C.sub.2 H.sub.5 " CH.sub.3 -- CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2s(9H); 4.7-4.3m(4H); 4.2q(2H) 2.9-2.3m(4H); 2.3s(3H)1.9-1.4m (2H); 1.3t(3H) 138 0 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 -- CH.sub.2CH.sub.2C.sub.6 H.sub.44-F 7.3-6.9m(8H); 4.7-4.3m(4H); 4.2q (2H); 3.6-2.9m(2H); 2.9-2.3m(4H); 1.9-1.4m(2H); 1.3t(3H); 1.0t(3H) 139 0 H H " CH(CH.sub.3).sub.2 -- ##STR49## 7.3-6.8m(7H); 4.7-4.3m(4H); 4.0-3.5m(1H); 2.9-2.3m(4H); 1.9-1.4m(2H); 1.1d(6H) 140 0 H C.sub.2 C H.sub.5 " CH(CH.sub.3).sub.2 -- CH.sub.2CH.sub.2.sub.6 H.sub.3(OCH.sub.3).sub.23.4 7.3-6.2m(7H); 4.7-4.3m(4H); 4.2q (2H); 4.0-3.5m(1H); 4.0s(6H); 2.9-2.3m(4H); 1.9-1.4m(2H); 1.3t (3H); 1.1d(6H) 141 0 H H " CH.sub.2CHCH.sub.2 -- CH.sub.2CH.sub.2C. sub.6 H.sub.42-CH.sub.3 7.2s(8H); 5.8m(1H); 5.0-4.2m(6H) 2.9- 2.3m(4H); 2.2s(3H); 1.9-1.4m(2H) 142 0 H C.sub.2 H.sub.5 " ##STR50## -- CH.sub.2 CH.sub.2C.sub.6 H.sub.52-Cl4-OCH.sub.3 7.2-6.6m(7H); 4.6-4.3m(4H); 4.2q(2H); 4.0-3.5m(1H); 4.0s(3H);2.9-2.3m(4H); 1.9-1.3m(10H ); 1.3t(3H) 143 0 H H " C.sub.4 H.sub.9 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.32.6-Cl.sub.2 7.4-6.8m(7H); 4.7-4.3m(4H); 3.8-3.1m(2H); 2.9-2.3m(4H); 1.9-1.4m(8H); 1.0t(3H) 144 1 H H ##STR51## CH.sub.3 H CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2-6.5m(8H); 4.7-4.3m(3H);4.0s(3H); 3.5-2.9m(3H); 2.8-2.3m(4H); 1.9-1.4m(2H); 2.2s(3H) 145 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2-6.5m(8H); 4.7-4.3m(3H); 4.2q (2H); 4.0s(3H); 3.6-2.9m(5H); 2.8-2.3m(4H); 2.2s(3H); 1.9-1.4m (2H); 1.2t(3H) 146 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.3-6.5m(7H); 4.7-4.3m(3H); 4.0s (3H); 3.6-2.9m(5H); 2.8-2.3m (4H); 1.9-1.4m(2H); 1.0t(3H) 147 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H CH.sub.2CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.3-6.5m(7H); 4.7-4.3m(3H); 4.2q (2H); 4.0s(3H); 4.0-2.9m(4H); 2.8-2.3m(4H); 2.2s(3H); 1.3t (3H); 1.0d(6H) 148 1 H H " CH.sub.2CCH H CH.sub.2C H.sub.2C.sub.6 H.sub.44-CH.sub.3 7.3-6.5m(7H); 4.7-4.0m(5H); 3.5-2.9m(3H); 4.0m(3H); 2.8-2.3m (4H); 2.2s(3H); 1.9-1.4m(3H) 149 1 H H " ##STR52## CH.sub.3 CH.sub.2CH.sub.2CH(CH.sub.3).sub.2 6.8-6.4m(3H); 4.7-4.3m(3H); 3.8-2.9m(4H); 4.0m(3H); 2.8-2.3m(2H); 1.9-1.4m(6H); 1.0d(15H) 150 1 H H " ##STR53## H CH.sub.2CH.sub.2C.sub.6 H.sub.44-Cl 7.3-6.5m(7H); 4.7-4.3m(3H);3.8-2.9m(4H); 4.0s(3H); 2.8-2.3m( 4H); 1.9-1.4m(2H); 1.1-0.6m(4H) 151 1 H H " C.sub.2 H.sub.5 H ##STR54## 8.0s(1H); 7.6-6.5m(8H); 4.7-4.3m(3H); 3.8-2.9m(5H); 4.0s(3H);2.8-2.3m(4H ); 1.2t(3H) 152 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H ##STR55## 7.3-6.5m(8H); 4.7-4.3m(3H); 4.2q(2H); 4.0s(3H); 3.8-2.9m(5H);2.8-2.3m(4H ); 2.2s(3H); 1.9-1.4m(2H); 1.3t(3H); 1.1t(3H) 153 1 H H " CH(CH.sub.3).sub.2 H ##STR56## 7.3-6.5m(8H); 4.7-4.3m(3H); 4.0s(3H); 4.0-2.9m(4H); 2.8-2.3m(4H);1.1d(6H ) 154 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2 CH.sub.2 SC.sub.6 H.sub.5 7.3-6.5m(8H); 4.7-4.3m(3H); 4.2q (2H); 1.0s(3H); 3.7-2.7m(5H); 2.7-2.3m(2H); 2.3s(3H); 1.9-1.4m (2H); 1.3t(2H) 155 1 H H " CH.sub.3 H CH.sub.2NHCOC.sub.6 H.sub.5 7.8-6.5m(8H); 4.7-1.3m(3H); 4.0s (3H); 3.5-2.8m(5H); 2.7-2.3m(2H); 2.4s(3H) 156 1 H H ##STR57## CH.sub.3 H CH.sub.2 CH.sub.2C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(1H); 3.5-2.9m(5H); 2.8-2.4m(2H); 2.3s(3H);1.9-1.3m(14H) 157 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2 CH.sub.2C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(1H); 4.2q (2H); 3.5-2.9m(5H); 2.8-2.4m(2H); 2.3s(3H); 1.9-1.3m(14H); 1.2t(3H) 158 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.3-6.9m(4H); 4.7-4.3m(1H); 3.8- 2.9m(7H); 2.8-2.4m(2H); 1.9-1.3m (14H); 1.1t(3H) 159 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.3-6.9m(4H); 4.7-4.3m(1H); 4.2q (2H); 3.8-2.9m(7H); 2.8-2.4m(2H) 1.9-1.3m(14H); 1.3t(3H); 1.1t(3H) 160 1 H H " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 6.9-6.4m(4H); 4.7-4.3m(1H); 3.8- 2.9m(7H); 4.0s(3H); 2.8-2.4m(2H); 1.9-1.3m(14H); 1.1t(3H) 161 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 6.9-6.4m(4H); 4.7-4.3m(1H); 4.2q (2H); 4.0s(3H); 3.8-2.9m(7H); 2.8-2.4m(2H); 1.9-1.3m(14H); 1.3t (3H); 1.1t(3H) 162 1 H H " CH(CH.sub.3).sub.2 H CH.sub.2CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); 4.7-4.3m(1H); 3.9-2.9m (6H); 2.8-2.4m(2H); 2.2s(3H); 1.9-1.3m(14H); 1.0d(6H) 163 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H CH.sub.2CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); 4.7-4.3m(1H); 4.2q (2H); 3.9-2.9m(6H ); 2.8-2.4m(2H); 2.2s(3H); 1.9-1.3m(14H); 1.2t (3H); 1.0d(6H) 164 1 H H " CH.sub.2CHCH.sub.2 H ##STR58## 5.8m(1H); 5.0-4.2m(5H); 3.9-2.8m(5H); 1.9-1.2m(27H) 165 1 H H " CH.sub.3 H C.sub.2 H.sub.5 4.7-4.3m(1H); 3.5-2.9m(5H); 2.4s (3H); 1.9-1.3m(14H); 0.9t(3H) 166 1 H H " ##STR59## H CH.sub.2 SOC.sub.6 H.sub.5 7.2-6.8m(5H); 4.7-4.3m(1H);3.8-2.9m(8H); 1.9-1.3m(18H); 167 1 H H " C.sub.2 H.sub.5 CH.sub.3 CH.sub.2 NHCOC.sub.6 H.sub.5 7.7-7.1m(5H); 4.7-4.3m(1H); 3.8-2.9m(8H); 1.9-1.3m(12H); 1.0d + t(6H) 168 1 H C.sub.2 H.sub.5 " n-C.sub.3 H.sub.7 H CH.sub.2CH.sub.2C.sub.6 H.sub.32-NO.sub.24-NHCOCH.sub.3 8.1-7.4m(3H); 4.7-4.3m(1H); 4.2q (2H); 3.8-2.9m(7H); 2.9-2.4m(2H) ; 1.9-1.3m(16H); 2.3s(3H); 1.3t (3H); 0.9t(3H) 169 1 H H " CH.sub.3 CH.sub.3 ##STR60## 7.5-6.7m(2H); 4.7-4.3m(1H);3.9-2.9m(4H); 3.7s(3H); 2.8-2.4m (2H); 1.9-1.4m(14H); 2.3s(3H);1.0d(3H) 170 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 C.sub.6 H.sub.4C.sub.6 H.sub.5 7.4-7.0m(9H); 4.7-4.3m(1H); 4.2q (2H); 3.8-2.9m(7H); 2.8-2.4m(2H); 1.9-1.4m(12H); 1.3t(3H); 1.0t(3H) 171 1 H H " CH.sub.3 CH.sub.3 CH.sub.2CH.sub.2C.sub.6 H.sub.3(OCH.sub.3).sub.22.5 6.9-6.2m(3H); 4.7-4.3m(1H); 4.0s (6H); 3.8-2.9m(4H); 2.8-2.4m(2H) ; 1.9-1.4m(14H); 2.3s(3H); 1.0d(3H) 172 1 H H " C.sub.2 H.sub.5 H ##STR61## 8.0s(1H); 7.6-6.8m(5H); 4.7-4.3m(1H); 3.8-2.9m(7H); 2.8-2.4m(2H);1.9-1.4 m(12H); 1.1t(3H) 173 1 H H " ##STR62## H CH.sub.2SO.sub.2C.sub.6 H.sub.5 7.6-7.0m(5H); 4.7-4.3m(1H),3.8-2.7m(8H); 1.9-1.4m(12H);1.0-0.6m( 4H) 174 0 H H " CH.sub.3 -- CH.sub.2 CH.sub.2 C.sub. 6 H.sub.6 7.2s(5H); 4.7-4.3m(2H); 3.8-2.9m (2H); 2.8-2.4m(2H); 1.9-1.4m(14H); 2.4s(3H) 175 0 H C.sub.2 H.sub.5 " CH.sub.3 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.3m(2H); 4.2q(2H) 3.8-2.9m(2H); 2.8-2.4m(2H); 1.9- 1.4m(14H); 2.4s(3H); 1.3t(3H); 176 0 H H " C.sub.2 H.sub.5 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-F 7.4-6.9m(4H); 4.7-4.3m(2H); 3.8- 2.9m(4H); 2.8-2.4m(2H); 1.9-1.4m (14H); 1.0t(3H) 177 0 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 -- ##STR63## 7.4-6.8m(3H); 4.7-4.3m(2H);3.9-3.0m(3H); 4.2q(2H); 2.8-2.4m(2H); 1.9-1.4m(14H); 1.3t(3H);1.0d(6H) 178 0 H H " CH.sub.2CH CH.sub.2 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.3 (OCH.sub.3).sub.23.4 6.9-6.2m(3H); 5.8m(1H); 4.9-4.1m (6H); 3.7-3.0m(2H); 4.0s(6H); 2.8-2.4m(2H); 1.9-1.4m(14H) 179 0 H C.sub.2 H.sub.5 " ##STR64## -- CH.sub.2CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); 4.7-4.3m(1H); 4.2q(2H)3.8-2.9m(3H); 2.8-2.4m(2H); 2.2s(3H); 1.9-1.4m(22H); 1.3t(3H) 180 0 H H " n-C.sub.3 H.sub.7 -- CH.sub.2CH.sub.2C.sub.6 H.sub.32.6-Cl.sub.2 7.4-6.9m(3H); 4.7-4.3m(1H); 3.8-2.9m (4H); 2.8-2.4m(2H); 1.9-1.4m (16H); 1.0t(3H) 181 1 H H ##STR65## CH.sub.3 H CH.sub.2CH.sub.2 C.sub.6 H.sub.5 7.2-6.5m(9H); 4.9t(1H); 3.8-3.0m(3H); 2.9-2.4m(4H); 2.4s(3H);1.9-1.4m(2H) 182 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2CH.sub.2C.sub.6 H.sub. 5 7.2-6.5m(9H); 4.9t(1H); 4.2q(2H) 3.8-3.0m(3H); 2.9-2.4m(4H); 2.4s (3H); 1.9-1.4m(2H); 1.2t(3H) 183 1 H H " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-F 7.2-6.5m(8H); 4.9t(1H); 3.8-3.0m (5H); 2.9-2.4m(4H); 1.9-1.4m(2H); 1.2t(3H)
##STR66## n R.sup.1 R.sup.1' R.sup.2 -R.sup.3 R.sup.4 R.sup.5 R.sup.6 184 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-F 7.2-6.5m(8H); 4.9t(1H); 3.8-3.0m (5H); 4.2q(2H); 2.9-2.4m(4H); 1.9-1.4m(2H); 1.2t(3H); 1.0t(3H)185 1 H H " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2-6.5m(9H); 4.9t(1H); 3.8-3.0m (5H); 2.9-2.4m(4H); 1.9-1.4m(2H); 1.1t(3H) 186 1 H C.sub.2 H.sub.5 ##STR67## C.sub.2 H.sub.5 H CH.sub.2CH.sub.2 C.sub.6 H.sub.5 7.2-6.5m(9H); 4.9t(1H); 3.8-3.0m(5H); 4.2q(2H); 2.9-2.4m(4H); 1.9-1.4m(2H); 1.3t(3H); 1.1t(3H) 187 1 H H " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.4OCH.sub.34 7.2-6.4m(8H); 4.9t(1H); 4.0s(3H)3.8-3.0m (5H); 2.9-2.4m(4H); 1.9-1.4m(2H); 1.1t(3H) 188 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.4OCH.sub.34 7.2-6.4m(8H); 4.9t(1H); 4.2q(2H) 4.0s(3H); 3.8-3.0m(5H); 2.9-2.4m(4H); 1.9-1.4m(2H); 1.3t(3H); 1.1t(3H) 189 1 H H " CH(CH.sub.3).sub.2 H CH.sub.2CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2-6.5m(8H); 4.9t(1H); 3.8-3.0m(4H); 2.9-2.4m(4H); 2.2s(3H); 1.9-1.4m(2H); 1.0d(6H) 190 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H CH.sub.2CH.sub.2C.sub.6 H.sub.42-Cl.sub.3 7.2-6.5m(8H); 4.9t(1H); 3.8-3.0m(4H); 2.9-2.4m(4H); 2.2s(3H); 4.0q(2H); 1.9-1.4m(2H); 1.2t(3H); 1.0d(6H) 191 1 H H " CH.sub.2CCH H CH.sub.2CH.sub.2CH.sub. 3 7.2-6.5m(4H); 4.9t(1H); 3.8-3.0m(5H); 2.9-2.6m(2H); 1.9-1.4m(5H ); 1.0t(3H) 192 1 H C.sub.2 H.sub.5 " CH.sub.2CHCH.sub.2 CH.sub.3 CH.sub.2CH.sub.2CH(CH.sub.3).sub.2 7.2-6.5m(4H); 5.8m(1H); 5.0-4.2m(5H); 3.8- 3.0m(3H); 2.9-2.6m(2H); 4.2q(2H);1.9-1.4m(5H), 1.2t(3H); 1.0d(6H) 193 1 H H ##STR68## ##STR69## H CH.sub.2 SC.sub.6 H.sub.5 7.3-6.5m(9H); 4.9t(1H); 3.5-3.0m(4H);2.9-2.4m(4H); 1.0-0.6m(4H) 194 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 OC.sub.6 H.sub.5 7.2-6.4m(9H); 4.9t(1H); 4.2q(2H) 3.9- 3.0m(6H); 3.0-2.6m(2H); 1.9-1.4m(2H); 1.2t(3H); 1.0d(6H) 195 1 H H " CH.sub.3 H ##STR70## 8.0s(1H); 7.5-6.5m(9H); 4.9t(1H); 4.0-3.0m(3H); 3.0-2.6m(4H); 2.4s(3H) 196 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H ##STR71## 8.0s(1H); 7.5-6.5m(9H); 4.9t(1H) 4.2q(2H); 3.9-2.9m(5H); 3.0-2.6m(4H); 1.1t(3H) 197 1 H H " C.sub.2 H.sub.5 H ##STR72## 8.6-6.5m(8H); 4.9t(1H); 3.9-2.9m(5H); 2.9-2.5m(4H);1.9-1.4(2H); 1.1t(3H) 198 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2-6.5m(9H); 4.9t(1H); 3.9-2.9m(5H); 2.9- 2.5m(4H); 1.9-1.4m(4H); 1.1t(3H) 199 1 H H " C.sub.2 H.sub.5 H CH.sub.2 C.sub.6 H.sub.5 7.2-6.5m(9H); 4.9t(1H); 3.9-2.9m(5H); 2.9-2.5m(4H); 1.1t(3H) 200 1 H H " CH(CH.sub.3).sub.2 CH.sub.3 CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2-6.5m(9H); 4.9t(1H); 3.9-2.9m(3H); 2.9- 2.5m(4H); 1.9-1.4m(2H); 1.0d+t(9H) 201 0 H C.sub.2 H.sub.5 " CH.sub.3 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2-6.5m(9H); 4.9-4.4m(2H); 4.2q(2H); 2.9- 2.5m(4H); 2.4s(3H); 1.9-1.4m(2H); 1.2t(3H) 202 0 H H " CH.sub.3 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2- 6.5m(9H); 4.9-4.4m(2H); 2.9-2.5m(4H); 2.4s(3H); 1.9-1.4m(2H) 203 0 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.2-6.5m(8H); 4.9-4.4m(2H); 3.8-3.1m(2H); 4.2q(2H); 2.9-2.5m(4H); 1.9-1.4m(2H); 1.2t(3H); 1.0t(3H) 204 0 H H " C.sub.2 H.sub.5 -- CH.sub.2CH.sub.2C.sub.6 H.sub.44-F 7.2-6.5m(8H); 4.9-4.4m(2H); 3.8- 3.1m(2H); 2.9-2.5m(4 H); 1.9-1.4m(2H); 1.0t(3H) 205 0 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 7.2-6.3m(8H); 4.9-4.4m(2H); 4.0-3.6m(1H); 4.2q(2H); 4.0s(3H); 2.9-2.5m(4H); 1.9-1.4m(2H); 1.2t(3H); 1.0d(6H) 206 0 H H " CH(CH.sub.3).sub.2 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-OCH.sub.3 7.2-6.3m(8H); 4.9-4.4m(2H); 4.0s(3H); 4.0-3.6m(1H); 2.9-2.5m(4H); 1.9- 1.4m(2H); 1.0d(6H) 207 0 H H " CH.sub.2CHCH.sub.2 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.3 (OCH.sub.2 O)3.4 7.2-6.2m(7H); 5.8m(1H); 5.0s(2H) 4.9-4.0m (6H); 2.9-2.5m(2H); 1.9-1.4m(2H) 208 1 H H ##STR73## C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2s(5H); 4.8-4.4m(1H); 3.9-3.0m(8H); 3.2s(3H); 2.9-2.5m(2H); 1.9-1.4m(12H); 1.1t(3H) 209 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.5 7.2s(5H); 4.8-4.4m(1H); 4.2q(2H); 3.2s(3H); 3.9-3.0m (8H); 2.9-2.5m(2H); 1.9-1.4m(12H); 1.3t(3H); 1.1t(3H) 210 1 H H " CH.sub.3 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-F 7.4-6.9m(4H); 4.7-4.4m(1H); 3.9-3.0m(6H); 3.2s(3H); 2.9-2.5m(2H) 2.3s(3H); 1.9-1.4m(12H) 211 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-F 7.4-6.9m(4H); 4.7-4.4m(1H); 3.9-3.0m (6H); 3.2s(3H); 4.2q(2H); 2.9-2.5m(2H); 2.3s(3H); 1.9-1.4m(12H); 1.2t(3H) 212 1 H H " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.42-OCH.sub.3 7.0-6.5m(4H); 4.7-4.4m(1H); 3.9s(3H); 3.9-3.0m(8H); 3.2s(3H); 2.9- 2.5m(2H); 1.9-1.4m(12H); 1.0t(3H) 213 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H CH.sub.2CH.sub.2C.sub.6 H.sub.32.6-Cl.sub.2 7.2-6.9m(3H); 4.7-4.4m(1H); 4.0- 3.1m(7H); 4.2q(2H); 3.2s(3H); 2.9-2.5m (2H); 1.9-1.4m(12H) 1.2t(3H); 1.0d(6H); 214 1 H H " CH(CH.sub.3).sub.2 H CH.sub.2 NHCOC.sub.6 H.sub.5 7.8-7.3m(5H); 4.7-4.4m(1H); 3.9-3.0m(9H); 3.2s(3H); 1.9-1.4m(10H); 1.0d(6H) 215 1 H C.sub.2 H.sub.5 " CH(CH.sub. 3).sub.2 H CH.sub.2 NHCOCH.sub.3 4.7-4.4m(1H); 4.0-3.0m(9H); 3.2s(3H); 2.4s(3H); 1.9-1.4m(10H); 4.2q(2H); 1.2t(3H); 1.0d(6H) 216 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H ##STR74## 4.7-4.4m(1H); 4.2q(2H); 3.8-3.0m(8H); 3.2s(3H); 1.9-1.4m(23H); 1.2t(3H); 1.0t(3H) 217 1 H H " CH.sub.2CHCH.sub.2 H ##STR75## 8.0s(1H); 7.6-6.6m(5H); 5.8m(1H);5.0m(5H); 4.7-4.4m(1H); 3.9-3.0m(6H); 2.9-2.4m(2H); 3.2s(3H); 1.9-1.4m(10H) 218 1 H H " ##STR76## H CH.sub.2 SOC.sub.6 H.sub.5 7.6-7.0m(5H); 4.7-4.4m(1H); 3.9-2.9m(9H); 3.2s(3H); 1.9-1.4m(16H) 219 1 H H " CH.sub.2CCH H CH.sub.2 NHC.sub.6 H.sub.5 7.2-6.5m(5H); 4.7-4.0m(3H); 3.8- 2.9m(6H); 2.9-2.6m(2H); 3.2s(3H); 1.9-1.4m(11H) 220 1 H C.sub.2 H.sub.5 " CH.sub.2CCCH.sub.3 H CH.sub.2 CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.7-4.0m(3H); 4.2q(2H) 3.8- 2.9m(6H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.3m+s(17H); 1.2t(3H) 221 1 H H ##STR77## C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2-6.3m(8H); 4.9t(1H); 3.9s(3H);3.9-3.0m(5H); 2.9-2.4m(4H); 1.9-1.4m(2H); 1.1t(3H) 222 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2-6.3m(8H); 4.9t(1H); 4.2q(2H) 3.9s(3H); 3.9-3.0m(5H); 2.9-2.4m(4H); 1.9- 1.4m(2H); 1.2t(3H); 1.0t(3H) 223 1 H H " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-F 7.2-6.3m(7H); 4.9t(1H); 3.9s(3H); 3.9-3.0m(4H); 2.9-2.4m(4H); 1.9-1.4m (2H); 1.0d(6H) 224 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.2-6.3m(7H); 4.9t(1H); 4.2q(2H); 3.9s(3H); 3.9-3.0m(4H); 2.9-2.4m (4H); 1.9-1.4m(2H); 1.3t(3H); 1.0d(6H); 225 1 H H " CH.sub.3 CH.sub.3 ##STR78## 7.3-6.5m(6H); 4.9t(1H); 3.9s(3H);3.9-3.0m(2H); 2.4s(3H); 2.9-2.4m(4H);1. 9-1.4m(2H), 1.0d(3H) 226 1 H H " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.32.6-Cl.sub.2 7.3-6.3m(6H); 4.9t(1H); 3.9s(3H) 3.9-3.0m (5H); 2.9-2.4m(4H); 1.9-1.4m(2H); 1.2t(3H) 227 1 H H " CH.sub.2 CH.sub.2 CH.sub.3 H CH.sub.2CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.3-6.3m(7H); 4.9t(1H); 3.9s(3H) 3.9-3.0m (5H); 2.9-2.4m(4H); 2.2s(3H); 1.9-1.4m(4H); 1.0t(3H) 228 1 H H " CH.sub.2CHCH.sub.2 H CH.sub.2CH.sub.2C .sub.6 H.sub.3(OCH.sub.3).sub.23.4 7.4-6.1m(6H); 5.8m(1H); 5.0-4.3m(5H); 3.9s(9H); 3.9-3.0m(3H); 2.9-2.4m(4H); 1.9-1.4m(2H) 229 1 H C.sub.2 H.sub.5 " ##STR79## H CH.sub.2 CH.sub.2C.sub.6 H.sub.42-Cl4-NO.sub.2 8.2-6.4m(7H); 4.9t(1H); 4.2q(2H) 3.9s(3H);3.9-3.0m (4H); 2.9-2.4m(4H); 1.9-1.2m(8H); 1.2t(3H) 230 1 H H " C.sub.2 H.sub.5 H ##STR80## 7.4-6.3m(8H); 4.9t(1H); 3.9s(3H) 3.9-3.0m(5H); 2.9-2.4m(4H); 1.1t(3H) 231 1 H H " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2CH(CH.sub.3).sub.2 7.3-6.4m(8H); 4.9t(1H); 3.9s(3H) 3.9-3.0m (5H); 2.9-2.6m(2H); 1.9-1.4m(5H); 1.2t(3H); 1.0d(6H) 232 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H CH.sub.2 H.sub.3 7.3-6.4m(3H); 4.9t(1H); 4.2q(2H); 3.9s(3H); 3.9-3.0m(4H); 2.9-2.6m(2H); 1.9- 1.4m(2H); 1.2t(3H); 1.0d+t(9H) 233 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 SC.sub.6 H.sub.5 7.3-6.4m(8H); 4.9t(1H); 4.2q(2H); 3.9s(3H); 3.9-3.0m(5H); 2.9-2.6m(2H); 1.9-1.4m(2H);1.2t(3H); 1.0t(3H) 234 1 H H " CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3 CH.sub.3 CH.sub.2 CH.sub.2 NHCOC.sub.6 H.sub.5 7.6-6.4m(8H); 4.9t(1H); 3.9s(3H); 3.9-3.0m(6H); 3.0-2.7m(2H); 1.9-1.4m(6H); 1.0d+t(6H) 235 1 H C.sub.2 H.sub.5 " CH.sub.3 CH.sub.3 n-C.sub.6 H.sub.13 7.3-6.5m(3H); 4.9t(1H); 4.2q(2H); 3.9s (3H); 3.9-3.0m(2H); 2.9-2.6m(2H); 2.4s(3H); 1.9-1.4m(10H); 1.2t(3H); 1.0d+t(6H) 236 0 H H " C.sub.2 H.sub.5 -- CH.sub. 2 CH.sub.2 C.sub.6 H.sub.5 7.2-6.4m(8H); 4.9-4.4m(2H); 3.9s (3H); 3.9-3.0m(2H); 3.0-2.6m(4H); 1.9- 1.4m(2H); 1.0t(3H) 237 0 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.3-6.4m(7H); 4.9-4.4m(2H); 3.9s(3H); 4.2q(2H); 4.0-3.6m(1H); 3.0-2.6m(4H); 1.9-1.4m(2H); 1.2t(3H); 1.0d(6H) 238 0 H H " CH.sub.2CHCH.sub.2 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 7.3-6.2m(7H); 5.8m(1H); 5.0-4.2m(6H); 3.9s(6H); 3.0-2.6m(4H); 1.9-1.4m(2H) 239 0 H H " CH(CH.sub.3).sub.2 -- ##STR81## 7.3-6.4m(6H); 4.9-4.4m(2H); 3.9s(3H);3.9-3.5m(1H); 3.0-2.6m(4H); 1.9-1.4m(2H); 1.1d(6H) 240 0 H C.sub.2 H.sub.5 " ##STR82## -- CH.sub.2 CH.sub.2C.sub.6 H.sub.3 (OCH.sub. 3).sub.22.5 7.3-6.2m(6H); 4.9-4.4m(2H); 3.9s(9H);3.9-3.5m(1H); 3.0-2.6m(4H); 1.9-1.4m(8H); 4.2q(2H); 1.2t(3H) 241 1 H H " CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.4m(1H); 3.9-3.0m(4H); 2.9-2.6m(2H); 2.3s(3H); 1.9-1.4m(13H) 242 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.4m(1H); 4.2q(2H) 3.9-3.0m (4H); 2.9-2.6m(2H); 2.3s (3H); 1.9-1.4m(13H); 1.2t(3H) 243 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-F 7.3-6.9m(4H); 4.8-4.4m(1H); 3.9-3.0m (6H); 2.9-2.6m(2H); 1.9-1.4m(13H); 1.0t(3H) 244 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-F 7.3-6.9m(4H); 4.8-4.4m(1H); 4.2q(2H); 3.9-3.0m(6H); 2.9-2.6m(2H); 1.9-1.4m (13H); 1.2t(3H); 1.0t(3H) 245 1 H H " CH(CH.sub. 3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-F 7.3-6.9m(4H); 4.8-4.4m(1H); 3.9-3.0m(5H); 2.9-2.6m(2H); 1.9-1.4m( 13H); 1.0d(6H) 246 1 H C.sub.2 H.sub.5 ##STR83## CH(CH.sub.3).sub.2 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-F 7.3-6.9m(4H); 4.8-4.4m(1H); 4.2q(2H);3.9-3.0m(5H);2.9-2.6m(2H); 1.9-1.4m(13H); 1.2t(3H); 1.0d(6H) 247 1 H H " CH.sub.2CHCH.sub.2 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 7.0-6.3m(4H); 5.8m(1H); 5.0-4.2m(5H); 3.9- 3.0m(4H); 3.9s(3H); 2.9-2.6m(2H); 1.9-1.4m(13H) 248 1 H C.sub.2 H.sub.5 " CH.sub.2CHCH.sub.2 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 7.0-6.3m(4H); 5.8m(1H); 5.0-4.2m(5H); 4.2q(2H); 3.9-3.0m(4H); 3.9s(3H); 2.9- 2.6m(2H); 1.9-1.4m(13H); 1.2t(3H) 249 1 H H " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-OCH.sub. 3 7.0-6.3m(4H); 4.8-4.4m(1H); 3.9-3.0m(6H); 2.9-2.4m (4H); 1.9-1.4m(13H); 1.0t(3H) 250 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 7.0-6.3m(4H); 4.8-4.4m(1H); 4.2q(2H); 3.9-3.0m(6H); 2.9-2.4m(4H); 1.9- 1.4m(13H); 1.2t(2H); 1.0t(3H) 251 1 H H " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); 4.8-4.4m(1H); 3.9-3.0m(6H); 2.9- 2.4m(4H); 2.1s(3H); 1.9-1.4m(13H); 1.0t(3H) 252 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); 4.8-4.4m(1H); 4.2q(2H) 3.9- 3.0m(6H); 2.9-2.4m(4H); 2.1s(3H); 1.9- 1.4m(13H); 1.2t(3H); 1.0t(3H) 253 1 H H " CH.sub.2CCH H CH.sub.2CH.sub.2C.sub.6 H.sub.4 2-CH.sub.3 7.2s(4H); 4.8-4.0m(3H); 3.9-3.0m(4H); 2.9-2.4m (4H); 2.1s(3H); 1.9-1.4m(14H); 1.0t(3H) 254 1 H C.sub.2 H.sub.5 " CH.sub.2CCH H CH.sub.2 CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); 4.8-4.0m(5H); 4.2q(2H) 3.9-3.0m(4H); 2.9-2.4m(4H); 2.1s(3H); 1.9-1.4m(14H); 1.2t(3H); 1.0t(3H) 255 1 H H " C.sub.2 H.sub.5 H CH.sub.2 SC.sub.6 H.sub.5 7.2s(5H); 4.8-4.4m(1H); 3.9-3.0m(6H); 2.9-2.4m(4H); 1.9-1.4m(11H); 1.1t(3H) 256 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 SOC.sub.6 H.sub.5 7.5-7.0m(5H); 4.8-4.4m(1H); 4.2q(2H); 3.9- 3.0m(6H); 2.9-2.4m(4H); 1.9-1.4m(11H); 1.2t(3H); 1.0t(3H) 257 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 SO.sub.2 C.sub.6 H.sub.5 7.5-7.0m(5H); 4.8-4.4m(1H); 4.2(2H); 3.9-3.0m (6H); 2.9-2.4m(4H); 1.9-1.4m(11H); 1.2t(3H); 1.0t(3H) 258 1 H H " C.sub.2 H.sub.5 H CH.sub.2 NHCOC.sub.6 H.sub.5 7.7-7.2m(5H); 4.7-4.4m(1H); 3.9-3.0m(8H); 2.9-2.4m(2H); 1.9-1.4m(11H); 1.0t(3H) 259 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 NHC.sub.6 H.sub.5 7.1-6.5m(5H); 4.7-4.4m(1H); 3.9-3.0m(6H); 2.9-2.4m(4H); 1.9-1.4m(13H); 1.0t(3H) 260 1 H H " C.sub.2 H.sub.5 H ##STR84## 7.2-6.8m(3H); 4.7-4.4m(1H); 3.9-3.0m(6H);2.9-2.4m(4H); 1.9-1.4m(13H); 1.0t(3H) 261 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3 4.7-4.4m(1H); 3.9-3.0m(6H); 2.9-2.4m(2H); 1.9-1.4m(17H); 1.0t(6H) 262 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.3 (OCH.sub.3).sub.23.4 6.9-6.2m(3H); 4.7-4.4m(1H); 3.9s(6H); 3.9-3.0m(6H); 2.9-2.4m((4H); 1.9-1.4m(13H); 1.0t(3H) 263 1 H H " C.sub.2 H.sub.5 H CH.sub.2 OC.sub.6 H.sub.5 7.0-6.5m(5H); 4.7-4.4m(1H); 3.9-3.0m(8H); 2.9- 2.4m(2H); 1.9-1.4m(11H); 1.0t(3H) 264 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 OC.sub.6 H.sub.5 7.0-6.5m(5H); 4.7-4.4m(1H); 3.9-3.0m(8H); 2.9- 2.4m(2H); 1.9-1.4m(13H); 1.0t(3H) 265 1 H H " CH(CH.sub.3).sub.2 H ##STR85## 8.0s(1H); 7.6-6.8m(5H); 4.7-4.4m(1H); 3.9-3.0m(5H); 2.9-2.4m(4H); 1.9-1.4m(11H); 1.0d(6H) 266 0 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.3m(2H); 3.9-3.0m(3H); 2.9- 2.4m(2H); 1.9-1.4m(13H); 1.0t(3H) 267 0 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.2-6.8m(4H); 4.8-4.3m(2H); 4.2q(2H); 3.9- 3.0m(2H); 2.9-2.4m(2H) ; 1.9-1.4m(13H); 1.2t(3H); 1.0d(6H) 268 0 H H " CH.sub.2CHCH.sub. 2 -- CH.sub.2CH.sub.2C.sub.6 H.sub.5(OCH.sub.2 O)3.4 6.9-6.2m(3H); 5.8m(1H); 5.0s(2H); 5.0-4.2m (6H); 3.9-3.4m(1H); 2.9-2.4m(2H); 1.9-1.4m(13H) 269 0 H C.sub.2 H.sub.5 " CH.sub.2 CH.sub.2 CH.sub.3 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.4OCH.sub.34 7.0-6.4m(4H); 4.8-4.3m(2H); 4.2q(2H); 3.9- 3.0m(3H); 3.9s(3H); 2.9-2.5m(2H); 1.9- 1.4m(15H); 1.2t(3H); 1.0t(3H) 270 0 H H " ##STR86## -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); 4.8-4.3m(2H); 3.9-3.1m(2H); 2.9-2.5m(2H); 2.1s(3H); 1.9-1.4m(19H) 271 1 H H ##STR87## C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub. 6 H.sub.5 7.2s(5H); 4.8-4.4m(1H); 3.9-3.0m(7H); 3.2s(3H);2.9-2.4m(2H); 1.9-1.4m(12H); 1.0t(3H) 272 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.4m(1H); 4.2q(2H); 3.9-3.0m (7H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m(12H); 1.2t(3H); 1.0t(3H) 273 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.4m(1H); 4.2q(2H); 3.9-3.0m (5H); 3.2s(3H); 2.9-2.4m(2H); 2.3s(3H); 1.9- 1.4m(12H); 1.2t(3H) 274 1 H H " CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.4m(1H); 3.9-3.0m(5H); 3.2s(3H); 2.9-2.4m(2H); 2.3s(3H); 1.9-1.4m(12H) 275 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.4-6.9m(4H); 4.8-4.4m(1H); 3.9-3.0m(7H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m(12H); 1.0t(3H) 276 1 H C.sub. 2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.4-6.9m(4H); 4.8-4.4m(1H); 3.9-3.0m(7H); 4.2q(2H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m(12H); 1.2t(3H); 1.0t(3H) 277 1 H H " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.4-6.9m(4H); 4.8-4.4m(1H); 3.9-3.0m(6H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m(12H); 1.0d(6H) 278 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.4-6.9m(4H); 4.8-4.4m(1H); 3.9-3.0m(6H); 4.2q(2H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m(12H); 1.2t(3H); 1.0d(6H) 279 1 H C.sub.2 H.sub.5 " CH.sub.2CHCH.sub.2 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 7.0-6.4m(4H); 5.8m(1H); 5.0-4.2m(5H); 4.2q(2H); 3.9s(3H); 3.9-3.0m(5H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m(12H); 1.2t(3H) 280 1 H H " CH.sub.2CHCH.sub.2 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 7.0-6.4m(4H); 5.8m(1H); 5.0-4.2m(5H); 3.9s(3H); 3.9-3.0m(5H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m( 12H) 281 1 H H " C.sub.2 H.sub.5 CH.sub.3 CH.sub.2 CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 7.0-6.4m(4H); 4.8-4.4m(1H); 3.9-3.0m(6H); 3.9s(3H); 3.2s(3H); 2.9-2.4m(2H); 1.9- 1.4m(12H); 1.0d+t(6H) 282 1 HC.sub.2 H.sub.5 " C.sub.2 H.sub.5 CH.sub.3 CH.sub.2 CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 7.0-6.4m(4H); 4.8-4.4m(1H); 4.2q(2H); 3.9- 3.0m(6H); 3.9s(3H); 3.2s(3H); 2.9-2.4m (2H); 1.9-1.4m(12H); 1.2t(3H); 1.0d+t(6H) 283 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); 4.8-4.4m(1H); 3.9-3.0m(7H); 3.2s(3H); 2.9- 2.4m(2H); 2.1s(3H); 1.9-1.4m(12H); 1.0t(3H) 284 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2C.sub.6 H.sub.42-CH.sub.2 7.2s(4H); 4.8-4.4m(1H); 4.2q(2H);3.9-3.0m(7H); 3.2s(3H); 2.9-2.4m(2H); 2.1s(3H); 1.9-1.4m(12H) 1.2t(3H); 1.0t(3H) 285 1 H H " CH.sub.2CCH H CH.sub.2 CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); 4.8-4.4m(1H); 4.3-3.0m(7H); 3.2s (3H); 2.9-2.4m(2H); 2.1s(3H); 1.9-1.4m(13H) 286 1 H C.sub.2 H.sub.5 " CH.sub.2CCH H CH.sub.2 CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.2s(4H); 4.8-4.4m(1H); 4.3-3.0m(9H); 3.2s(3H); 2.9-2.4m(2H); 2.1s(3H); 1.9-1.4m(13H); 1.2t(3H) 287 1 H H " C.sub.2 H.sub.5 H CH.sub.2 SC.sub.6 H.sub.5 7.2s(5H); 4.8-4.4m(1H); 3.9-3.0m(7H); 3.2s(3H); 2.9-2.4m( 2H); 1.9-1.4m(10H); 1.0t(3H) 288 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 SOC.sub.6 H.sub.5 7.4-7.0m(5H); 4.8-4.4m(1H); 4.2q(2H); 3.9-3.0m (7H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m(10H); 1.2t (3H); 1.0t(3H)
##STR88## n R.sup.1 R.sup.1' R.sup.2 -R.sup.3 R.sup.4 R.sup.5 R.sup.6 289 1 H C.sub.2 H.sub.5 ##STR89## C.sub.2 H.sub.5 H CH.sub.2 SO.sub.2 C.sub.6 H.sub.5 7.6-7.0m(5H); 4.8-4.4m(1H); 4.2q(2H); 3.9-3.0m(7H); 3.2s(3H); 3.1-2.6m(2H); 1.9-1.4m(10 H); 1.2t(3H); 1.0t(3H) 290 1 H H " C.sub.2 H.sub.5 H CH.sub.2 NHCOC.sub.6 H.sub.5 7.9-7.3m(5H); 4.8-4.4m(1H); 3.9-2.8m(9H); 3.2s (3H); 1.9-1.4m(10H); 1.0t(3H) 291 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 NHC.sub.6 H.sub.5 7.0-6.4m(5H); 4.8-4.4m(1H); 3.9-2.8m(9H); 3.2s (3H); 1.9-1.4m(12H); 1.0t(3H) 292 1 H H " C.sub.2 H.sub.5 H ##STR90## 7.2-6.7m(3H); 4.8-4.4m(1H); 3.9-3.1m(7H); 3.2s(3H); 2.9-2.5m(2H) 1.9-1.4m(12H); 1.0t(3H) 293 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 CH.sub.3 4.8-4.4m(1H); 3.9-3.1m(7H); 3.2s(3H); 1.9-1.4m(14H); 1.0t(6H) 294 1 H H " C.sub.2 H.sub.5 CH.sub.3 CH.sub.2 CH.sub.2CH(CH.sub.3).sub.2 4.8-4.4m(1H); 3.9-3.1m(6H); 3.2s(3H); 1.9- 1.4m(15H); 1.0t+d(12H) 295 1 H H " ##STR91## H CH.sub.2 CH.sub.2C.sub.6 H.sub.3 (OCH.sub.3).sub.23.4 6.9-6.2m(3H); 3.9s(6H); 3.9-3.1m(6H); 3.2s(3H);2.9-2.4m(2H); 1.9- 1.4m(20H) 296 1 H H " CH(CH.sub.3).sub.2 H CH.sub.2 OC.sub.6 H.sub.5 7.0-6.6m(5H); 3.9-3.1m(8H); 3.2s(3H); 1.9- 1.4m(10H); 1.0d(6H) 297 1 H H " C.sub.2 H.sub. 5 H CH.sub.2 CH.sub.2 OC.sub.6 H.sub.5 7.1-6.6m(5H); 4.8-4.4m(1H); 3.9-3.1m(9H); 3.2s(3H); 2.0-1.3m(12H); 1.0t(3H) 298 1 H H " CH.sub.3 H ##STR92## 8.0s(1H); 7.6-6.7m(5H); 4.8-4.4m(1H); 3.9-3.1m(5H); 3.2s(3H); 2.9-2.4m(2 H); 2.3s(3H);1.9-1.4m(10H) 299 1 H H " CH(CH.sub.3).sub.2 H ##STR93## 8.6-7.4m(4H); 4.8-4.4m(1H); 3.9-3.1m(6H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m(12H); 1.0d(6H) 300 1 H H " CH.sub.3 H ##STR94## 7.3s(5H); 4.8-4.4m(1H); 3.9-3.1m(5H); 3.2s(3H);2.9-2.4m(2H); 2.3s(3H); 2.1s(3H); 1.9-1.4m(12H) 301 0 H H " C.sub.2 H.sub.5 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.3m(2H); 3.9-3.1m(4H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m(12H); 1.0t(3H) 302 0 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.3m(2H); 4.2q(2H); 3.9- 3.1m(4H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m(12H); 1.2t(3H); 1.0t(3H) 303 0 H H " C.sub.2 H.sub.5 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.44-F 7.4-6.9m(4H); 4.8-4.3m(2H); 3.9-3.1m (4H); 3.2s(3H); 2.9-2.4m(2H); 1.9- 1.4m(12H); 1.0t(3H) 304 0 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.3 (OCH.sub.2 O)3.4 6.9-6.2m(3H); 5.0s(2H); 4.8-4.3m(2H); 4.2q(2H); 3.9-3.1m(3H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m(12H); 1.0d(6H) 305 0 H H " CH.sub.2CHCH.sub.2 -- CH.sub.2CH.sub.2C.sub.6 H.sub.32.6-Cl 7.4-7.0m(3H); 5.8m(1H); 5.0-4.1m(6H); 3.9- 3.1m(2H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m(12H) 306 0 H C.sub.2 H.sub.5 " CH.sub.2 CH.sub.2 CH.sub.3 -- CH.sub.2 CH.sub.2C.sub.6 H.sub.4OCH.sub.3 7.0-6.4m(4H); 4.8-4.3m(2H); 4.2q(2H); 3.9-3.1m (4H); 3.9s(3H); 3.2s(3H); 2.9-2.4m(2H); 1.9- 1.4m(14H); 1.2t(3H); 1.0t(3H) 307 0 H H " CH.sub.2CCH -- ##STR95## 7.2-6.7m(3H); 4.8-4.0m(4H); 3.9-3.1m(2H); 3.2s(3H); 2.9-2.4m(2H); 1.9-1.4m(13H) 308 0 H H " ##STR96## -- CH.sub.2 CH.sub.2 C.sub.6 H.sub.3Cl4-CN 7.9-7.4m(3H); 4.8-4.3m(2H); 3.9-3.1m(3H); 2.9-2.4m(2H); 1.9-1.4m(12H); 1.1-0.6m(4H) 309 0 H H " CH.sub.3 -- ##STR97## 8.6-7.4m(4H); 4.8-4.3m(2H); 3.9-3.1m(2H); 2.9-2.4m(2H); 2.3s(3H); 1.9-1.4m(12H) 310 1 H H ##STR98## CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 13.4s(1H); 7.7s(1H); 7.2s(5H); 4.7-4.3m(3H); 3.9-3.0m(3H); 2.9-2.4m(4H); 2.2s(3H); 1.9-1.4m(2H ) 311 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 13.4s(1H); 7.7s(1H); 7.2s(5H); 4.7-4.3m(3H); 4.2q(2H); 3.9-3.0m(3H); 2.9-2.4m(4H); 4.2s(3H); 1.9-1.4m(2H); 1.2t(3H) 312 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 13.4s(1H); 7.7s(1H); 7.2s(5H); 4.7-4.3m(3H); 3.9-3.1m(5H); 2.9-2.4m(4H); 1.9-1.4m(2H); 1.0t(3H) 313 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 13.4s(1H); 7.7s(1H); 7.2s(5H); 4.7-4.3m(3H); 4.2q(2H); 3.9-3.1m(5H); 2.9-2.4m(4H); 1.9- 1.4m(2H); 1.2t(3H); 1.0t(3H) 314 1 H H " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 13.4s(1H); 7.7s(1H); 7.2s(5H); 4.7-4.3m(3H); 3.9- 3.1m(4H); 2.9-2.4m(4H); 1.9-1.4m(2H); 1.0d(6H) 315 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 13.4s(1H); 7.7s(1H); 7.2s(5H); 4.7-4.3m(3H); 4.2q(2H); 3.9-3.0m(4 H); 2.9-2.4m(4H); 1.9- 1.4m(2H); 1.2t(3H); 1.0d(6H)316 1 H H " CH.sub.2 CH.sub.2 CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-F 13.4s(1H); 7.7s(1H); 7.4-6.9m(4H); 4.7-4.3m(3H); 3.9-3.0m(5H); 2.9-2.4m(4H); 1.9-1.4m(4H); 1.0t(3H) 317 1 H H " CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.3(OCH.sub.3).sub.23.4 13.4s(1H); 7.7s(1H); 6.9-6.2m(3H); 4.7-4.3m (3H); 3.9-3.0m(5H); 3.9s(6H); 2.9-2.4m(4H); 1.9-1.4m(6H); 1.0t(3H) 318 1 H H " ##STR99## H CH.sub.2 CH.sub.2 CH.sub. 2 CH.sub.3 13.4s(1H); 7.7s(1H); 4.7-4.3m(3H); 3.9-3.0m(4H); 2.9-2.4m(2H); 1.9-1.4m(6H); 1.1-0.5t+m(7H) 319 1 H H " CH.sub.2CCH H CH.sub.2SC.sub.6 H.sub.5 13.4s(1H); 7.7s(1H); 7.2s(5H); 4.8-4.0m(5H); 3.9-3.0m(3H) ; 2.9-2.4m(4H); 1.8s(1H) 320 1 H H " CH.sub.2CHCH.sub.2 CH.sub.3 CH.sub.2 CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 13.4s(1H); 7.7s(1H); 6.8-6.3m(4H); 5.8m(1H); 5.0-4.1m(7H); 3.9s(3H); 3.9-3.0m(2H); 2.9- 2.4m(4H); 1.0d(3H) 321 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 NHCOC.sub.6 H.sub.5 13.4s(1H); 7.9-7.4m(6H); 4.7-4.3m(3H); 4.2q(2H); 3.9-3.1m(7H); 2.9-2.5m(2H); 1.3t(3H); 1.0t(3H) 322 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 OC.sub.6 H.sub.5 13.4s(1H); 7.7s(1H); 7.1-6.6m(5H); 4.7-4.3m(3H); 3.9-3.1m(7H); 2.9-2.5m(2H); 1.9-1.4m( 2H); 1.0t(3H) 323 1 H H ##STR100## CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 4.9-4.4m(3H); 3.9-3.1m(3H);3.0-2.4m(4H); 2.3s(3H); 1.9-1.4m(2H) 324 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 4.9-4.4m(3H); 4.2q(2H); 3.9-3.1m(3H); 3.0-2.4m(4H); 2.3s(3H); 1.9- 1.4m(2H); 1.2t(3H) 325 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 4.9-4.4m(3H); 3.9-3.1m(5H); 3.0-2.4m(4H); 1.9-1.4m(2H); 1.0t(3H) 326 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 4.9-4.4m(3H); 4.2q(2H); 3.9-3.1m(5H) 3.0-2.4m(4H); 1.9-1.4m(2H); 1.2t(3H); 1.0t(3H) 327 1 H H " CH(CH.sub.3).s ub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 4.9-4.4m(3H); 3.9-3.1m(4H); 3.0-2.4m(4H); 1.9-1.4m(2H); 1.0d(6H) 328 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 4.9-4.4m(3H); 4.2q(2H); 3.9-3.1m(4H); 3.0-2.4m(4H); 1.9-1.4m(2H); 1.2t(3H); 1.0d(6H) 329 1 H H " CH.sub.2CHCH.sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 5.8m(1H); 5.0-4.2m(7H); 3.9- 3.1m(3H); 3.0-2.4m(4H); 1.9-1.4m(2H) 330 1 H H " CH.sub.2CCH H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 5.0-4.2m(5H); 3.9-3.1m(3H); 3.0-2.4m(4H); 1.9-1.4m(3H) 331 1 H H " ##STR101## H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 4.8-4.3m(3H); 3.9-3.1m(4H);3.0-2.4m(4H); 1.9-1.2m(8H) 332 1 H H ##STR102## CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3- 6.9m(7H); 4.9-4.4m(3H); 3.9-3.0m(3H);3.0-2.4m(4H); 2.3s(3H); 1.9-1.4m(2H) 333 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 4.9-4.4m(3H); 3.9-3.1m(5H); 3.0-2.4m(4H); 1.9-1.4m(2H); 1.0t(3H) 334 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 4.9-4.4m(3H); 4.2q(2H); 3.9-3.1m(3H); 3.0-2.4m(4H); 2.3s(3H); 1.9-1.4m(2H); 1.2t(3H) 335 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 4.9-4.4m(3H); 4.2q(2H); 3.9-3.1m(5H); 3.0-2.4m(4H); 1.9- 1.4m(2H); 1.2t(3H); 1.0t(3H) 336 1 H H " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 4.9-4.4m(3H); 3.9-3.1m(4H); 3.0-2.4m(4H); 1.9-1.4m(2H); 1.0d(6H) 337 1 H C.sub.2 H.sub.5 " CH(CH.sub.3 ).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 4.9-4.4m(3H); 4.2q(2H); 3.9-3.1m(4H); 3.0-2.4m(4H); 1.9-1.4m(2H); 1.2t(3H); 1.0d(6H) 338 1 H H " CH.sub.2CHCH.sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 5.8m(1H); 5.0-4.2m(7H); 3.9-3.1m(3H); 3.0-2.4m(4H); 1.9-1.4m(2H) 339 1 H H " CH.sub.2CCH H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 5.0-4.2m(5H); 3.9-3.1m(4H); 3.0-2.4m(4H); 1.9-1.4m(3H) 340 1 H H " ##STR103## H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.9m(7H); 4.8-4.3m(3H); 3.9-3.1m(4H);3.0-2.4m(4H); 1.9-1.4m(10H) 341 1 H H ##STR104## CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(7H); 4.8-4.4m(3H); 3.9-3.1m(3H);3.0-2.4m(4H); 2.3s(3H); 1.9-1.4m(2H) 342 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(7H); 4.8-4.3m(3H); 4.2q(2H); 3.9- 3.1m(3H); 3.0-2.4m(4H); 2.3s(3H); 1.9- 1.4m(2H);1.2t(3H) 343 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(7H); 4.8-4.3m(3H); 3.9-3.1m(5H); 3.0- 2.4m(4H); 1.9-1.4m(2H); 1.0t(3H) 344 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(7H); 4.8-4.3m(3H); 4.2q(2H); 3.9- 3.1m(5H); 3.0-2.4m(4H); 1.9-1.4m(2H); 1.2t(3H); 1.0t(3H) 345 1 H H " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(7H); 4.8-4.4m(3H); 3.9-3.1m(4H); 3.0-2.4m(4H); 1.9-1.4m(2H); 1.0d(6H) 346 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(7H); 4.8-4.4m(3H); 4.2q(2H); 3.9- 3.1m(4H); 3.0-2.4m(4H); 1.9-1.4m(2H); 1.3t(3H); 1.0d(6H) 347 1 H H " n-C.sub.3 H.sub.7 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(7H); 4.8-4.3m(3H); 3.9-3.1m(5H); 3.0-2.4m(4H); 1.9-1.4m(4H); 1.05t(3H) 348 H H H CH.sub.2CH(OCH.sub.3)CH.sub.2 CH.sub.3 H H 4.8-4.3m( 1H); 3.6-3.0m+s(7H); 2.3t(2H); 2.2s(3H) 1.9-1.3m(2H) 349 H H C.sub.2 H.sub.5 CH.sub.2CH(OCH.sub.3)CH.sub.2 CH.sub.3 H H 4.8-4.3m(1H); 4.2q(2H); 3.6-3.0m+s(7H); 2.3t(2H); 2.2s(3H); 1.9-1.4m(2H); 1.2t(3H) 350 H H H CH.sub.2CH(OCH.sub.3)CH.sub.2 C.sub.2 H.sub.5 H H 4.8-4.3m(1H); 3.8-3.0m+s(9H); 2.3t(2H); 1.9-1.4m(2H); 1.2t(3H) 351 H H H CH.sub.2CH(OCH.sub.3)CH.sub.2 CH(CH.sub.3).sub.2 H CH.sub.3 4.8-4.3m(1H); 3.8-2.9m+s(10H); 1.9- 1.4m(2H); 1.03d(9H) 352 H H C.sub.2 H.sub.5 CH.sub.2CH(OCH.sub.3)CH.sub.2 C.sub. 2 H.sub.5 H CH.sub.3 4.8-4.3m(1H); 4.2q(2H); 3.8-2.9m+s(11H); 1.9-1.4m(2H); 1.2t(3H) 1.0d+t(6H) 353 H H H CH.sub.2CHCH C.sub.2 H.sub.5 H H 6.4-5.5m(3H); 4.3-3.1m(6H); 2.3t (2H); 1.0t(3H) 354 H H C.sub.2 H.sub.5 CH.sub.2CHCH CH.sub.2CHCH.sub.2 H H 6.4-5.5m(4H); 4.9-3.1m(10H); 4.2q(2H); 2.3t(2H); 1.2t(3H) 355 H H H CH.sub.2CHC H C.sub.2 H.sub.5 H CH.sub.3 6.5-5.5m(3H); 4.3-3.0m(7H); 1.0d+t(6H) 356 H H H CH(CH.sub.3)CH.sub.2CH.sub.2 CH.sub.3 H H 4.8-4.2m(1H); 3.6-2.9m(4H ); 2.4s (3H); 2.3t(2H); 1.9-1.4m(3H); 1.0d(3H) 357 H H C.sub.2 H.sub.5 CH(CH.sub.3)CH.sub.2CH.sub.2 C.sub.2 H.sub.5 H H 4.8-4.3m(1H); 4.2q(2H); 3.8-3.0m(6H); 2.3t (2H); 1.9-1.4m(3H); 1.2t(3H); 0.95d+t(6H) 358 H H H CH(CH.sub.3)CH.sub.2CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3 H CH.sub.3 4.8-4.3m(1H); 3.8-2.9m(7H); 1.9- 1.4m(5H); 1.0t+2d(9H) 359 H H C.sub.2 H.sub.5 CH(CH.sub.3)CH.sub.2CH.sub.2 C C CH.sub.2H H CH.sub.3 4.8-4.0m(5H); 3.8-2.9m(5H); 1.9- 1.4m(4H); 1.02d(6H) 360 H H H CH.sub.2 CH(C.sub.6 H.sub.5)CH.sub.2 CH.sub.3 H H 7.3-6.9m(5H); 4.8-4.3m(1H); 3.6- 2.9m(5H); 2.3t(2H); 2.2s(3H); 1.9-1.4m(2H) 361 H H H CH.sub.2 CH(C.sub.6 H.sub.5)CH.sub.2 C.sub.2 H.sub.5 H CH.sub.3 7.3-6.9m(5H); 4.8-4.3m(1H); 3.6- 2.8m(8H); 1.9-1.4m(2H); 1.05d(3H) 362 1 H H CH(C.sub.6 H.sub.5)CH.sub.2CH.sub.2 C.sub.2 H.sub.5 H H 7.3-6.9m(5H); 4.8-4.3m(1H); 3.8- 2.9m(7H); 2.3t(2H) 1.9-1.4m(2H); 1.0t(2H) 363 1 H H CH(C.sub.6 H.sub.5)CH.sub.2CH.sub.2 CH(CH.sub.3).sub.2 H H 7.3-6.9m(5H); 4.8-4.3m(1 H); 3.8- 2.9m(6H); 2.3t(2H)1.9-1.4m(2H); 1.0d(6H) 364 1 H H CH(C.sub.6 H.sub.5)CH.sub.2CH.sub.2 ##STR105## H CH.sub.3 7.3-6.9m(5H); 4.8-4.3m(1H); 3.7-2.8m(7H); 1.9-1.3m(8H); 1.0d(3H) 365 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.4 CH.sub.3 H H 4.8-4.3m(1H); 3.6-2.8m(4H); 4.2q(2H); 2.4s (3H); 2.3t(2H); 1.9-1.4m(6H); 1.2t(3H) 366 1 H H (CH.sub.2).sub.4 CH.sub.3 H CH.sub.3 4.8-4.3m(1H); 3.6-2.8m(5H); 2.4s (3H); 1.9-1.4m(6H); 1.1d(3H) 367 1 H H (CH.sub.2).sub.4 C.sub.2 H.sub.5 H H 4.8-4.3m(1H); 3.6-2.8m(6H); 2.3t (2H); 1.9-1.4m(6H); 1.1t(3H) 368 1 H H (CH.sub.2).sub.4 CH(CH.sub.3).sub.2 H CH.sub.3 4.8-4.3m(1H); 3.8-2.8m(6H); 1.9- 1.4m(6H); 1.0d(9H) 369 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.4 CHCCH H H 4.8-4.2m(3H); 3.8-2.9m(4H); 4.2q (2H); 2.3t(2H); 1.9-1.4m(7H); 1.2t(3H) 370 1 H H (CH.sub.2). sub.4 C.sub.4 H.sub.9 H CH.sub.3 4.8-4.3m(1H); 3.8-2.9m(7H); 1.9- 1.4m(10H); 1.0d+t(6H) 377 1 H H (CH.sub.2).sub.5 CH.sub.3 H H 4.8-4.3m(1 H); 3.6-2.8m(4H); 2.4s (3H); 2.3t(2H); 1.9-1.4m(8H) 378 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.5 CH.sub.3 H H 4.8-4.0m(1H); 3.6-2.8m(4H); 2.4s (3H); 2.3t(2H); 1.9-1.4m(8H); 1.2t(3H) 379 1 H H (CH.sub.2).sub.5 C.sub.2 H.sub.5 H H 4.8-4.3m(1H); 3.8-2.8m(6H); 2.3t (2H); 1.9-1.4m(8H); 1.0t(3H) 380 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.5 C.sub.2 H.sub.5 H H 4.8-4.3m(1H); 4.2q(2H); 3.8-2.8m(6H); 2.3t(2H); 1.9-1.4m(8H); 1.2t(3H); 1.0t(3H) 381 1 H H (CH.sub.2).sub.5 CH(CH.sub.3). sub.2 H CH.sub.3 4.8-4.3m(1H); 3.8-2.8m(6H); 1.9- 1.4m(8H); 1.03d (9H) 382 1 H H (CH.sub.2).sub.5 CH.sub.2CHCH.sub.2 H CH.sub.3 5.8m(1H); 5.0-4.1m(5H); 3.8-2.9m (5H); 1.9-1.4m(8H); 1.0d(3H) 383 1 H C.sub.2 H.sub.5 (CH.sub.2).sub.5 ##STR106## H CH.sub.3 4.7-4.3m(1H); 4.2q(2H); 3.7-3.0m(6H);1.9-1.4m(8H); 1.0-1.5d+m (7H); 1.2t(3H) 384 1 H H (CH.sub.2).sub.5 -n-C.sub.4 H.sub.9 H H 4.7-4.3m(1H); 3.9-3.0m(6H); 2.3t (2H); 1.9-1.4m(12H); 1.0t(3H) 385 1 H H ##STR107## CH.sub.3 H H 7.1-6.6m(3H); 4.8-4.3m(3H); 3.9s(3H); 3.8-3.0m(2H); 2.9-2.4m(4H) 2.3s(3H) 386 1 H C.sub.2 H.sub.4 " C.sub.2 H.sub.5 H H 7.1-6.6m(3H); 4.8-4.3m(3H); 4.2q(2H); 3.9s(3H); 3.8-3.0m(4H); 2.9-2.4m (4H); 1.2t(3H); 1.0t(4H) 387 1 H H " C.sub.2 H.sub.5 H CH.sub.3 7.1-6.6m(3H); 4.8-4.3m(3H); 3.9s(3H); 3.8-3.0m(5H); 2.9-2.4m(2H); 1.0d+t(6H) 388 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H CH.sub.3 7.1-6.6m(3H); 4.8-4.3m(3H); 3.9s(3H); 3.9- 3.1m(4H); 4.2q(2H); 2.9-2.4m(2H); 1.2t(3H); 1.0d(9H) 389 1 H H " CH.sub.2CHC H.sub.2 H CH.sub.3 7.1-6.6m(3H); 5.8m(1H); 5.0-4.3(5H); 3.9s (3H); 3.8-2.9m(3H); 2.8-2.4m(2H); 1.05d(3H) 390 1 H H ##STR108## CH.sub.3 H H 4.7-4.3m(1H); 3.6-2.9m(4H); 2.3t(2H); 2.2s(3H);1.9-1.4m(12H ) 391 1 H H " C.sub.2 H.sub.5 H H 4.7-4.3m(1H); 3.8-2.9m(6H); 2.3t (2H); 1.9-1.4m(12H); 1.1t(3H) 392 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H H 4.7-4.3m(1H); 4.2q(2H); 3.8-2.9m(6H); 2.3t(2H); 1.9-1.4m(12H); 1.3t(3H); 1.1t(3H) 393 1 H H " CH(CH.sub.3).sub.2 H H 4.7-4.3m(1H); 4.0-3.1m(5H); 2.3t (2H); 1.9-1.4m(12H); 1.0d(6H) 394 1 H H " CH.sub.2CHCH.sub.2 H CH.sub.3 5.8q(1H); 5.0-4.1m(5H); 3.8-2.9 m(3H); 1.9-1.4m(12H); 1.0d(3H) 395 1 H H " ##STR109## H 4.7-4.3m(1H); 3.9-2.9m(5H); 2.3t(2H); 1.9-1.4m(18H) 396 1 H H ##STR110## CH.sub.3 H H 7.2-6.6m(4H); 4.9t(1H); 3.8-3.1m(2H); 2.9-2.2m(4H); 2.3s(3H) 397 1 H H " C.sub.2 H.sub.5 H H 7.2-6.6m(4H); 4.9t(1H); 3.8-3.1 m(4H); 2.9-2.2m(4H); 1.1t(3H) 398 1 H H " C.sub.2 H.sub.5 H CH.sub.3 7.2-6.6m(4H); 4.9t(1H); 3.8- 2.8m(3H); 2.9-2.2m(2H); 1.0t+d(6H) 399 1 H H " CH(CH.sub.3).sub.2 H H 7.2-6.6m(4H); 4.9t(1H); 3.9-2.9m (3H); 2.9-2.2m(4H); 1.0d(6H)
##STR111## n R.sup.1 R.sup.1' R.sup.2 -R.sup.3 R.sup.4 R.sup.5 R.sup.6 400 1 H H " CH.sub.2CCH H H 7.2-6.6m(4H); 4.9t(1H); 4.3-3.2m (4H); 2.9-2.2m(4H); 1.8s(1H) 401 1 H H " CH.sub.2CHCH.sub.2 H CH.sub.3 7.2-6.6m(4H); 5.8m(1H); 5.0-4.2m (5H); 3.9-2.9m(3H); 1.0d(3H) 402 1 H H ##STR112## CH.sub.3 H H 4.8-4.3m(1H); 3.8-2.9m + s(8H);2.3t(2H); 2.2s(3H); 1.9-1.4m(10H) 403 1 H H " C.sub.2 H.sub.5 H H 4.8-4.3m(1H); 3.8-2.9m + s(10H); 2.3t(2H); 1.9-1.4m(10H); 1.0t(3H) 404 1 H H " C.sub.2 H.sub.5 H CH.sub.3 4.8-4.3m(1H); 3.8-2.8m + s(11H); 1.9-1.4m(10H); 1.0d + t(6H) 405 1 H H " CH(CH.sub.3).sub.2 H H 4.8-4.3m(1H); 3.8-2.9m + s(9H); 2.3t(2H); 1.9-1.4m(10H); 1.0d(6H) 406 1 H H " ##STR113## H CH.sub.3 4.8-4.3m(1H); 3.8-2.9m + s(10H);1.9-1.4m(16H); 1.0d(6H) 407 1 H H ##STR114## CH.sub.3 H H 4.9-4.4m(1H); 4.0-3.1m(3H); 2.3t(2H); 2.2s(3H); 1.9-1.4m(11 H) 408 1 H H " C.sub.2 H.sub.5 H H 4.9-4.4m(1H); 4.0-3.1m(5H); 2.3t (2H); 1.9-1.4m(11H) 1.1t(3H) 409 1 H H " CH(CH.sub.3).sub.2 H H 4.9-4.4m(1H); 4.0-3.1m(4H); 2.3t (2H); 1.9-1.4m(11H); 1.0d(6H) 410 1 H H " C.sub.2 H.sub.5 H CH.sub.3 4.9-4.4m(1H); 4.0-3.0m(7H); 1.9- 1.4m(11H); 1.0d + t(6H) 411 1 H H " CH.sub.2CHCH.sub.2 H CH.sub.3 5.8m(1H); 5.1-4.3m(5H); 4.0-3.2m (4H); 1.9-1.4m(11H); 1.0d(3H) 412 1 H H ##STR115## CH.sub.3 H H 4.9-4.4m(1H); 4.0-3.1m + s(7H); 2.4s(3H); 2.3t(2H); 1.9-1.4m(9H) 413 1 H H " C.sub.2 H.sub.5 H H 4.9-4.4m(1H); 4.0-3.1m + s(9H); 2.3t (2H); 1.9-1.4m(9H); 1.0t(3H) 414 1 H H " CH(CH.sub.3) .sub.2 H H 4.9-4.4m(1H); 4.0-3.1m + s(8H); 2.3t(2H); 1.9-1.4m(9H); 1.0d(6H) 415 1 H H " C.sub.2 H.sub.5 H CH.sub.3 4.9-4.4m(1H); 4.0-3.0m + s(11H); 1.9-1.4m(9H); 1.0d + t(6H)416 1 H H " CH(CH.sub.3).sub.2 H CH.sub.3 4.9-4.4m(1H); 4.0-3.0m + s(10H); 1.9-1.4m(9H); 1.0d(9H) 417 1 H H ##STR116## CH.sub.3 H H 13.4s(1H); 7.7s(1H); 4.9-4.3m(3H); 3.9-3.1m(2H); 2.3t(3H);2 .4s(3H); 2.9-2.4m(2H) 418 1 H H " C.sub.2 H.sub.5 H H 13.4s(1H); 7.7s(1H); 4.8-4.3m (3H); 3.8-3.1m(4H); 2.9-2.5m(2H); 2.3t(2H); 1.0t(3H) 419 1 H H " CH(CH.sub.3).sub.2 H H 13.4s(1H); 7.7s(1H); 4.8-4.3m (3H); 4.0-3.1m(3H); 2.9-2.5m(2H); 2.3t(2H); 1.0d(6H) 420 1 H H " C.sub.2 H.sub.5 H CH.sub.3 13.4s(1H); 7.7s(1H); 4.8-4.3m (3H); 4.0-3.0m(5H); 2.9-2.5m(2H); 1.0d + t(6H) 421 1 H H " ##STR117## H H 13.4s(1H); 7.7s(1H); 4.8-4.3m(3H); 3.7-3.0m(3H); 2.9-2.5m(2H); 2.3t( 2H); 1.0-0.5m(4H) 422 1 H H ##STR118## CH.sub.3 H H 7.3-6.9m(2H); 4.9-4.4m(3H); 3.9-3.1m(2H), 2.3t(2H); 2.2s(3H);2.9-2.2m(2H) 423 1 H H " C.sub.2 H.sub.5 H H 7.3-6.9m(2H); 4.9-4.4m(3H); 3.9- 3.1m(4H); 2.3t(2H); 2.9-2.4m (2H); 1.1t(3H) 424 1 H H " C.sub.2 H.sub.5 H H 7.3-6.9m(2H); 4.9-4.4m(3H); 3.9- 3.0m(5H); 2.9-2.4m(2H); 1.1t + d(6H) 425 1 H H " CH(CH.sub.3).sub.2 H CH.sub.3 7.3-6.9m(2H); 4.9-4.4m( 3H);3.9-3.0m(4H); 2.9-2.4m(2H); 1.0d(9H) 426 1 H H " CH(CH.sub.3).sub.2 H H 7.3-6.9m(2H); 4.9-4.4m(3H); 3.9-3.0m(3H); 2.9-2.4m(2H); 2.3t(2H); 1.0d(6H) 427 1 H H ##STR119## CH.sub.3 H H 7.3-6.9m(2H); 4.9-4.4m(3H);3.9-3.1m(2H); 2.3t(2H); 2.2s(3H); 2.9-2.2m(2H) 428 1 H H " C.sub.2 H.sub.5 H H 7.3-6.9m(2H); 4.9-4.4m(3H); 3.9-3.1m(4H); 2.3t(2H); 2.9-2.4m (2H); 1.1t(3H) 429 1 H H " C.sub.2 H.sub.5 H CH.sub.3 7.3-6.9m(2H); 4.9-4.3m(3H); 3.9-3.0m(5H); 2.9-2.4m(2H); 1.1t + d(6H) 430 1 H H " CH(CH.sub.3).sub.2 H H 7.3-6.9m(2H); 4.8-4.4m(3H); 3.8-3.0m(3H); 2.9-2.4m(2H); 2.3t(2H); 1.0d(6H) 431 1 H H " CH(CH.sub.3).sub.2 H CH.sub.3 7.3-6.9m(2H) ; 4.9-4.4m(3H); 3.9-3.1m(4H); 2.9-2.4m(2H); 1.0d(9H). 432 1 H H ##STR120## C.sub.2 H.sub.5 H H 7.2s(2H); 4.9- 4.4m(3H); 3.9-3.1m(4H); 2.3t(2H); 2.9-2.4m(2H);1.0t(3H) 433 1 H H " C.sub.2 H.sub.5 H CH.sub.3 7.2s(2H); 4.9-4.4m(3H); 3.9-3.0m (5H); 2.9-2.4m(2H); 1.1t + d(6H) 434 1 H H " CH(CH.sub.3).sub.2 H H 7.2s(2H); 4.9-4.4m(3H); 3.9-3.2m (3H); 2.9-2.4m(2H); 2.3t(2H); 1.0d(6H) 435 1 H H " CH(CH.sub.3).s ub.2 H CH.sub.3 7.2s(2H); 4.9-4.4m(3H); 3.9-3.1m (4H); 2.9-2.4m(2 H); 1.1d(9H) 436 1 H H ##STR121## CH.sub.3 H H 4.8-4.2m(3H); 3.6-3.0m(2H); 2.7-2.2m(4H); 2.4s(3H) 437 1 H C.sub.2 H.sub.5 " CH.sub.3 H H 4.8-4.2m(5H); 3.6-3.0m(2H); 2.7- 2.2m(4H); 2.4s(3H); 1.2t(3H) 438 1 H H " C.sub.2 H.sub.5 H CH.sub.3 4.8-4.2m(3H); 3.7-3.0m(5H); 2.7- 2.4m(2H); 1.0t + d(6H) 439 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H H 4.8-4.4m(3H); 4.2m(2H); 3.9- 3.0m(4H); 2.7-2.4m(2H); 1.0d (9H); 1.2t(3H) 440 1 H H " CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.2m(3H); 3.9- 3.0m(3H); 2.9-2.2m(4H); 1.9- 1.4m(2H); 2.3s(3H); 441 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 4.8-4.3m(3H) 4.2q (2H); 3.9-3.0m(5H); 2.9-2.2m (4H); 1.9-1.4m(2H); 1.2t(3H); 1.0t(3H) 442 1 H H " CH.sub.2 CHCH.sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-F 7.4-6.9m(4H); 5.8m(1H); 5.1-4.2 (5H); 3.9-3.0m(3H); 2.9-2.2m (4H); 1.9-1.4m(2H) 443 1 H C.sub.2 H.sub.5 " CH.sub.2CCH H CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-OCH.sub.3 6.9-6.3m(4H); 4.8-4.0m(5H); 3.9- 3.1m(3H); 3.9s(3H); 2.9-2.2m (4H); 1.9-1.4m(3H); 1.2t(3H); 4.2q(2H) 444 1 H H " ##STR122## CH.sub.3 ##STR123## 8.0s(1H); 7.6-6.8m(5H); 4.8-4.0m(3H); 3.8-3.1m(3H); 2.9-2.2m(4H); 1.9-1.4m(6H); 1.0d(3H) 445 1 H H ##STR124## CH.sub.3 H CH.sub.3 5.0-4.3m(2H); 3.6-3.0m(3H); 2.9-2.2m(2H); 2.3s(3H); 1.2d(3H); 1.0d(3H) 446 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H C.sub.2 H.sub.5 5.0-4.3m(2H); 4.2q(2H); 3.9-3.1m (5H); 2.9-2.2(2H); 1.9-1.4m(2H); 1.2d + t(6H); 1.0t(6H) 447 1 H H " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 5.0-4.3m(2H); 3.8-3.0m (4H); 2.9-2.2m(4H); 1.9-1.4m (2H); 1.2d(3H); 1.0d(6H) 448 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.2s(5H); 5.0-4.3m(2H); 3.8-3.0m (5H); 2.9-2.2m(4H); 1.9-1.4m (2H); 1.2d(3H); 1.0t(3H) 449 1 H H " CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-F7.4-6.9m(4H); 5.0-4.3m(2H); 3.8-3.0m(3H); 2.9-2.2m(4H); 2.3s (3H); 1.9-1.4m(2H); 1.2d(3H) 450 1 H H " C.sub.2 H.sub.5 H H 5.0-4.3(2H); 3.8-3.0m(4H); 2.9- 2.2m(4H); 1.2d(3H); 1.0t(3H); 451 1 H H " CH(CH.sub.3).sub.2 H H 5.0-4.3m(2H); 3.9-3.1m(3H); 2.9- 2.2m(4H); 1.2d(3H); 0.9d(6H) 452 1 H C.sub.2 H.sub.5 " CH.sub.3 CH.sub.3 CH.sub.3 5.0-4.3m(2H); 4.2q(2H); 3.9-3.1m (2H); 2.9-2.2m(2H); 2.4s(3H); 1.2d + t(6H); 1.0d(6H) 453 1 H H ##STR125## CH.sub.3 H H 7.4-6.8m(5H); 6.0s(1H); 4.7-4.3m (1H); 3.6-3.0t(2H); 2.9-2.2m (4H); 2.4s(3H) 454 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.3 7.4-6.8m(5H); 6.0s(1H); 4.7-4.3 (1H); 4.2q(2H); 3.6-3.0m(5H); 2.9-2.2m(2H); 1.2t(3H); 1.0d + t(3H) 455 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.4-6.8m(10H); 6.0s(1H); 4.7- 4.3m(1H); 3.8-3.0m(5H); 2.9- 2.2m(4H); 1.9-1.4m(2H); 1.0t(3H) 456 1 H H " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.4-6.8m(10H); 6.0s(1H); 4.7-4.3m (1H); 3.8-3.0m(4H); 2.9-2.2m (4H); 1.9-1.4m(2H); 1.0d(6H) 457 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-F 7.5-6.8m(9H); 6.0s(1H); 4.7-4.3m (1H); 4.2q(2H); 3.8-3.0m(3H); 2.9-2.2m(4H); 2.3s(3H); 1.9-1.4 m(2H); 1.2t(3H) 458 1 H H " CH.sub.2 CH.sub.2 CH.sub.3 H CH.sub.2 CH.sub.2C.sub.6 H.sub.42-CH.sub.3 7.5-6.9m(9H); 6.0s(1H); 4.7-4.3m (1H); 3.8-3.0m(5H); 2.9-2.2m (4H); 2.1s(3H); 1.9-1.4m(4H); 1.0t(3H) 459 1 H C.sub.2 H.sub.5 " ##STR126## H ##STR127## 7.5-6.9m(10H); 6.0m(1H); 4.7-4.3m(1H); 3.8-3.0m(4H); 4.2q(2H);2.9-2.2m(4 H); 1.2t(3H); 1.0-0.5m(4H) 460 1 H H ##STR128## CH.sub.3 H H 7.1-6.4m(4H); 6.0s(1H); 4.7-4.3m(1H); 3.6-3.0t(2H); 2.9-2.2m(4H); 2.4s(3H) 461 1 H C.sub.2 H.sub.5 " CH.sub.3 H H 7.1-6.4m(4H); 6.0s(1H); 4.7- 4.3m(1H); 4.2q(2H); 3.6-3.0t (2H); 2.9-2.2m(4H); 2.4s(3H); 1.2t(3H) 462 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.4m(9H); 6.0s(1H); 4.7-4.3m (1H); 3.8-3.0m(5H); 2.9-2.2m (4H); 1.9-1.4m(2H); 1.0t(3H) 463 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.4m(9H); 6.0s(1H); 4.7-4.3m (1H); 4.2q(2H); 3.8-3.0m(3H); 2.9-2.2m(4H); 1.9-1.4m(2H); 2.2 s(3H); 1.2t(3H) 464 1 H H " CH(CH.sub.3).sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.5 7.3-6.4m(9H); 6.0s(1H); 4.7-4.3m (1H); 3.8-2.9m(4H); 2.9-2.2m (4H); 1.9-1.4m(2H); 1.0d(6H) 465 1 H H " CH.sub.2CHCH.sub.2 H CH.sub.2 CH.sub.2 C.sub.6 H.sub.44-F 7.3-6.4m(8H); 6.0-5.6m(2H); 5.0-4.1m(5H); 3.6-3.1m(3H); 2.9-2.2m(4H); 1.9-1.4m(2H) 466 1 H C.sub.2 H.sub.5 " CH.sub.2 CH.sub.2 CH.sub.3 H CH.sub.2 CH.sub.2C.sub.6 H.sub.44-OCH.sub.3 7.1-6.3m(8H); 6.0s(1H); 4.7-4.3m (1H); 4.2q(2H); 3.9s(3H); 3.8-3.0m(5H); 2.9-2.2m(4H); 1.9-1.4m(2H); 1.2t(3H); 1.0t(3H) 467 1 H H " C.sub.2 H.sub.5 H C.sub.2 H.sub.5 7.1-6.5m(4H); 6.0s(1H); 4.7-4.3m (1H); 3.8-3.0m(5H); 2.9-2.4m (2H); 1.9-1.4m(2H); 1.0t(6H) 468 1 H H " C.sub.2 H.sub.5 H n-C.sub.4 H.sub.9 7.1-6.5m(4H); 6.0s(1H); 4.7-4.3m (1H); 3.8-3.0m(5H); 2.9-2.4m (2H); 1.9-1.4m(6H); 1.0t(6H) 469 1 H H " C.sub.2 H.sub.5 H ##STR129## 7.3-6.5m(7H); 6.0s(1H); 4.7-4.3m(1H); 3.8-3.0m(5H); 2.9-2.4m(4H); 1.9-1.4m(2H); 1.0t(3H) 470 1 H H " C.sub.2 H.sub.5 H CH.sub.2 CH.sub.2C.sub.6 H.sub.32,6-Cl.sub.2 7.4-6.5m(7H); 6.0s(1H); 4.7- 4.3m(1H); 3.8-3.0m(5H); 2.9- 2.4m(4H); 1.9-1.4m(2H); 1.0t(3H) 471 1 H C.sub.2 H.sub.5 " ##STR130## CH.sub.3 ##STR131## 8.6-6.5m(8H); 6.0s(1H); 4.7-4.3m(1H); 4.2q(2H); 3.9-3.1m(4H);2.9-2.2m(4H ); 1.9-1.4m(10H);1.2t(3H); 1.0d(3H) 472 1 H H " CH.sub.3 H CH.sub.3 7.1-6.5m(4H); 6.0s(1H); 4.7-4.3m (1H); 3.6-3.1m(3H); 2.9-2.4m (2H); 2.3s(3H); 1.0d(3H) 473 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.3 7.1-6.5m(4H); 6.0s(1H); 4.7-4.3m (1H); 4.2q(2H); 3.6-3.1m(3H); 2.9-2.4m(2H); 2.3s(3H); 1.0d(3H) 474 1 H C.sub.2 H.sub.5 ##STR132## C.sub.2 H.sub.5 H H 13.4s(1H); 7.7s(1H); 4.9-4.3m(3H); 4.2q(2H); 3.9-3.1m(4H);2.9-2.5m(2H); 2.3t(2H); 1.2t(3H); 1.0t(3H) 475 1 H C.sub.2 H.sub.5 ##STR133## C.sub.2 H.sub.5 H H 7.3-6.9m(2H); 4.9-4.4m(3H); 4.2q(2H); 3.9-3.1m(4H); 2.3t(2H); 2.9-2.4m(2H); 1.2t(3H);1.0t(3H) 476 1 H C.sub.2 H.sub.5 ##STR134## C.sub.2 H.sub.5 H H 7.3-6.9m(2H); 4.8-4.4m(3H);4.2q(2H); 3.9-3.1m(4H) 2.9-2.5m(2H); 2.3t(2H); 1.2t(3H); 1.0t(3H) 477 1 H C.sub.2 H.sub.5 ##STR135## CH.sub.3 H H 4.7-4.3m(1H); 4.2q(2H); 3.6-2.9m(4H); 2.3t(2H); 2.2s(3H); 1.9-1.4m(12H); 1.1t(3H) 478 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H CH.sub.3 4.7-4.3m(1H); 4.2q(2H); 3.8-2.9m (7H); 1.9-1.4m(12H); 1.2t (3H); 1.1d + t(6H) 479 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H H 4.7-4.3m(1H); 4.2q(2H); 4.0-3.1m (5H); 2.3t(2H); 1.9-1.4m(12H); 1.2t(3H); 1.0d(6H) 480 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.3 4.7-4.3m(1H); 4.2q(2H); 3.8-2.9m (5H); 2.2s(3H); 1.9-1.4m(12H); 1.2t(3H); 1.1d(3H) 481 1 H C.sub.2 H.sub.5 ##STR136## CH.sub.3 H H 7.2-6.6m(4H); 4.9t(1H); 4.2q(2H); 3.8-3.1m(2H); 2.9-2.2m(4H )2.3s(3H); 1.2t(3H) 482 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H H 7.2-6.6m(4H); 4.9t(1H); 4.2q (2H); 3.8-3.1m(4H); 2.9-2.2m(4H) 1.2t(3H); 1.0t(3H) 483 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H H 7.2-6.6m(4H); 4.9t(1H); 4.2q (2H); 3.9-2.9m(3H); 2.9-2.2m (4H); 1.2t(3H); 1.0d(6H) 484 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.3 7.2-6.6m(4H); 4.9t(1H); 4.2q (2H); 3.8-3.1m(2H); 2.9-2.3m(3H) 2.3s(3H); 1.2t(3H); 1.0d(3H) 485 1 H C.sub.2 H.sub.5 ##STR137## CH.sub.3 H H 4.8-4.3m(1H); 4.2q(2H); 3.8-2.9m + s(8H); 2.3s(3H); 2.2t(2H);1.9-1.4m(10H); 1.2t(3H) 486 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H H 4.8-4.3m(1H); 4.2q(2H); 3.8- 2.9m + s(10H); 2.2t(2H); 1.9-1.4m(10H); 1.2t(3H); 1.0t(3H) 487 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H H 4.8-4.3m(1H); 4.2q(2H); 3.9-2.9m + s(9H); 2.2t(2H); 1.9-1.4m (10H); 1.2t(3H); 0.9d(6H) 488 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.3 4.8-4.3m(1H); 4.2q(2H); 3.9-2.9m + s(9H); 2.3s(3H); 1.9-1.4m (10H); 1.2t(3H); 1.0d(3H) 489 1 H C.sub.2 H.sub.5 ##STR138## CH.sub.3 H H 4.9-4.4m(1H); 4.2q(2H); 4.0-3.1m(3H); 2.3t(2H); 2.2s(3H); 1.9-1.4m(11H); 1.2t(3H) 490 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H H 4.9-4.4m(1H); 4.2q(2H); 4.0-3.1m (5H); 2.3t(2H); 1.9-1.4m(11H); 1.2t(3H); 1.0t(3H) 491 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H H 4.9-4.4m(1H); 4.2q(2H); 4.0-3.1m (4H); 2.3t(2H); 1.9-1.4m(11H); 1.2t(3H); 1.05d(6H) 492 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.3 4.9-4.4m(1H); 4.2q(2H); 4.0-3.0m (4H); 2.2s(3H); 1.9-1.4m(11H); 1.2t(3H); 1.0d(3H) 493 1 H C.sub.2 H.sub.5 ##STR139## CH.sub.3 H H 4.9-4.4m(1H); 4.2q(2H); 4.0-3.1m + s(7H); 2.4s(3H); 2.3t(2H);1.9-1.4m(9H); 1.2t(3H) 494 1 H C.sub.2 H.sub.5 " C.sub.2 H.sub.5 H H 4.9-4.4m(1H); 4.2q(2H); 4.0-3.1m + s(9H); 2.3t(2H); 1.9-1.4m (9H); 1.2t(3H); 1.0t(3H) 495 1 H C.sub.2 H.sub.5 " CH(CH.sub.3).sub.2 H H 4.9-4.4m(1H); 4.2q(2H); 4.0-3.1m + s(8H); 2.3t(2H); 1.9-1.4(9H) 1.2t(3H); 0.9d(6H) 496 1 H C.sub.2 H.sub.5 " CH.sub.3 H CH.sub.3 4.9-4.4m(1H); 4.2q(2H); 4.0- 2.9m + s(8H); 2.3s(3H); 1.9-1.4 m(9H); 1.2t(3H); 1.0d(3H)
Claims (13)
1. A compound of the formula I ##STR140## in which n is a whole number between 0 and 3 inclusive;
R1 and R1', being the same or different, are hydrogen; alkyl or alkenyl having 1-8 C atoms; phenyl or benzyl, each unsubstituted or monosubstituted by methyl, halogen, methoxy or nitro;
R2 and R3 together with the C and N atoms carrying them form a 2-azabicyclo[3.3.0]octane ring system, which is unsubstituted, monosubstituted or distubstituted by hydroxyl, alkoxy having 1-3 C atoms, alkyl having 1-3 C atoms or phenyl;
R4 is hydrogen; alkyl, alkenyl, alkadienyl, alkynyl, alkeninyl or alkadiynyl having 1-8 C atoms; cycloalkyl having 3-6 C atoms; phenyl, benzyl, phenethyl or phenylpropyl, each of which is unsubstituted, monosubstituted or disubstituted by halogen, hydroxyl, acetoxy, carboxy, carboxamido, sulfonamido, nitro, methyl ethyl, methoxy, ethoxy or methylenedioxy;
R5 is hydrogen; alkyl having 1-5 C atoms; hydroxyl or alkoxy having 1-3 C atoms;
R6 is hydrogen; alkyl having 1-12 C atoms; cycloalkyl having 3-12 C atoms; alkenyl having 2-12 C atoms; phenyl or naphthyl, each of which is unsubstituted, monosubstituted or disubstituted by halogen, hydroxyl, acetoxy, carboxy, carboxamido, sulfonamido, nitro, methyl, ethyl, methoxy, ethoxy or methylenedioxy; alkyl having 1-6 C atoms, which is monosubstituted by halogen, hydroxyl, alkoxy having 1-3 C atoms, phenoxy, amino, dialkylamino having 1-6 C atoms, alkanoylamino having 1-3 C atoms, mercapto, alkylthio having 1-3 C atoms, phenylthio, phenylsulfinyl, phenylsulfonyl, phenyl biphenylyl, or naphthyl, the phenyl or naphthyl each being unsubstituted, monosubstituted or disubstituted by halogen, methyl, ethyl, methoxy, ethoxy, nitro, amino, methylamino, dimethylamino, acetylamino, cyano, methylenedioxy or sulfonamido; heteroaryl selected from the group consisting of pyridyl, thienyl, indolyl, benzothienyl, imidazolyl, pyrazolyl and thiazolyl, said heteroaryl being unsubstituted mono-substituted or disubstituted by halogen, methyl, ethyl, methoxy, ethoxy, nitro, amino, methylamino dimethylamino, acetylamino, cyano, methylenedioxy, sulfonamido or phenyl; or physiologically tolerable salts thereof.
2. The compound as claimed in claim 1, wherein
n is a whole number from 0 to 2, inclusive,
R1 and R1' are hydrogen, alkyl or alkenyl having 1 to 4 C atoms, or benzyl unsubtituted or substituted in the phenyl nucleus by methyl, halogen, methoxy or nitro;
R4 is hydrogen, straight-chain or branched alkyl, alkenyl or alkinyl having 1 to 5 C atoms, cycloalkyl having 3 to 6 C atoms, phenyl, benzyl or phenethyl;
R5 is hydrogen, methyl, ethyl, hydroxyl, methoxy or benzyl;
R6 is hydrogen, alkyl having 1 to 8 C atoms or phenyl which can be monosubstituted or disubstituted by methyl, halogen, methoxy, acetoxy or nitro; or alkyl with 1-4 C atoms substituted by halogen, hydroxyl, methoxy, ethoxy, phenoxy, amino, methylamino, dimethylamino, anilino, acetylamino, benzamido, mercapto, phenylthio, phenylsulfinyl, phenylsulfonyl; phenyl, which is unsubsituted, monosubstituted or disubstituted by halogen, methyl, ethyl, methoxy, ethoxy, nitro, amino, methylamino, dimethylamino, acetylamino, cyano, methylenedioxy or sulfonamido, biphenylyl; or heteroaryl which is unsubstitued or substituted by halogen, methyl, methoxy and phenyl.
3. The compound as claimed in claim 1, wherein
n is 0 or 1,
R1 and R1' are hydrogen, methyl ethyl, n-butyl, t-butyl, benzyl or p-nitrophenyl,
R4 is methyl, ethyl, n-propyl, n-butyl, isopropyl, isobutyl, cyclopropyl, cyclobutyl, allyl, butenyl, propargyl, butinyl or tert.-butyl;
R5 is hydrogen, methyl or benzyl;
R6 is hydrogen, straight-chain or branched alkyl or alkenyl having 1 to 6 C atoms or cycloalkyl having 3 to 6 C atoms; or alkyl having 1 to 3 C atoms which is substituted by phenoxy, ethoxy, methoxy, dimethylamino, anilino, benzamido, phenylthio, phenylsulfinyl, phenylsulfonyl; phenyl which is unsubstituted, monosubstituted or disubstituted by halogen, methyl, methoxy, nitro, amino, methylamino, dimethylamino, acetylamino, cyano or methylenedioxy, biphenylyl; or heteroaryl which is optionally substituted by chlorine, methyl, methoxy or phenyl.
4. The compound as claimed in claim 2, wherein the carbon atom which carries the substituent R3 has the S-configuration.
5. The compound as claimed in claim 3, wherein the carbon atom which carried the substituent R3 has the S-configuration.
6. The compound as claimed in claim 1, wherein
n is 1, R1 is hydrogen,
R4 is ethyl, R5 is hydrogen, R6 is β-phenylethyl and the carbon atom which carries the substituent R3 has the S-configuration.
7. The compound as claimed in claim 1, wherein n is 1, R1 is hydrogen, R2 and R3, together with the C and N atoms carrying them, are the 2-azabicyclo[3.3.0]octane system, R4 is ethyl, R5 is hydrogen and R6 denotes β-phenylethyl.
8. Hypotensive composition containing a hypotensively effective concentration of a compound defined in claim 1 and a carrier therefor.
9. Hypotensive dosage unit containing from about 20 mg. to about 3 g. of a compound defined in claim 1.
10. Hypotensive dosage unit containing from about 50 mg. to about 1 g. of a compound defined in claim 1.
11. A method of treatment which comprises administering to a patient suffering from hypertension a hypotensively effective amount of a compound defined in claim 1.
12. The compound as claimed in claim 1 which is [N-Ethyl-N-(4-phenyl-2-carboethoxybutyl)-carbamoyl]-cis-endo-2-azabicyclo[3.3.0]octane-3-carboxylic acid.
13. A compound of the formula I as claimed in claim 1 which is [N-Ethyl-N-(4-phenyl-2-carboxybutyl)-carbamoyl]-cis-endo-2-azabicyclo[3.3.0]octane-3-carboxylic acid.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19813134933 DE3134933A1 (en) | 1981-09-03 | 1981-09-03 | "UREA DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE MEDICINES THEREOF AND THE USE THEREOF" |
DE3134933 | 1981-09-03 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US06/413,663 Division US4515803A (en) | 1981-09-03 | 1982-09-01 | Substituted derivatives of octahydroindole-2-carboxylic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
US4624962A true US4624962A (en) | 1986-11-25 |
Family
ID=6140800
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US06/413,663 Expired - Fee Related US4515803A (en) | 1981-09-03 | 1982-09-01 | Substituted derivatives of octahydroindole-2-carboxylic acids |
US06/697,340 Expired - Fee Related US4624962A (en) | 1981-09-03 | 1985-02-01 | Substituted derivatives of 2-azabicyclo-[3.3.0]octanes |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US06/413,663 Expired - Fee Related US4515803A (en) | 1981-09-03 | 1982-09-01 | Substituted derivatives of octahydroindole-2-carboxylic acids |
Country Status (16)
Country | Link |
---|---|
US (2) | US4515803A (en) |
EP (1) | EP0074070A1 (en) |
JP (1) | JPS5855451A (en) |
KR (1) | KR880002707B1 (en) |
AU (1) | AU558623B2 (en) |
CA (1) | CA1307000C (en) |
DE (1) | DE3134933A1 (en) |
DK (1) | DK393482A (en) |
ES (1) | ES8306110A1 (en) |
FI (1) | FI823026L (en) |
GR (1) | GR76898B (en) |
HU (1) | HU190698B (en) |
NO (1) | NO822974L (en) |
NZ (1) | NZ201779A (en) |
PT (1) | PT75497B (en) |
ZA (1) | ZA826420B (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4855486A (en) * | 1986-05-30 | 1989-08-08 | Kalbag Suresh M | Blocked, marked amino acids |
US5043346A (en) * | 1988-04-22 | 1991-08-27 | Hoechst Aktiengesellschaft | Amino acid esters, pharmaceuticals containing them, and the use thereof in learning disorders |
US5231084A (en) * | 1986-03-27 | 1993-07-27 | Hoechst Aktiengesellschaft | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons |
US5231080A (en) * | 1985-10-15 | 1993-07-27 | Hoechst Aktiengesellschaft | Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease |
US5232928A (en) * | 1989-07-25 | 1993-08-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Tetrahydroisoquinoline amides |
US5380872A (en) * | 1992-07-14 | 1995-01-10 | Glaxo Inc. | Modulators of cholecystokinin |
US5403856A (en) * | 1984-04-12 | 1995-04-04 | Hoechst Aktiengesellschaft | Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
US5500434A (en) * | 1986-10-02 | 1996-03-19 | Hoechst Aktiengesellschaft | Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
US5747504A (en) * | 1984-04-12 | 1998-05-05 | Hoechst Aktiengesellschaft | Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
US5968980A (en) * | 1994-12-14 | 1999-10-19 | Santen Pharmaceutical Co., Ltd. | 1,3-dialkylurea derivative |
WO2000053576A1 (en) * | 1999-03-11 | 2000-09-14 | Ajinomoto Co., Inc. | Gelling or coagulating agents for liquid organic media |
US20030166706A1 (en) * | 2002-03-01 | 2003-09-04 | Kilgore Kenneth S. | Method of treating osteoarthritis |
US9624234B2 (en) | 2012-01-25 | 2017-04-18 | Novartis Ag | Heterocyclic compounds and methods for their use |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4565819A (en) * | 1979-12-07 | 1986-01-21 | Adir | Substituted imino diacids, their preparation and pharmaceutical compositions which contain them |
DE3177311D1 (en) * | 1980-08-30 | 1994-06-09 | Hoechst Ag | Amino acid derivatives, processes for their preparation, compositions containing them and their use. |
US4866087A (en) * | 1982-01-21 | 1989-09-12 | Merck & Co., Inc. | Carboxyalkyl urea compounds and derivatives thereof useful as angiotensin converting enzyme inhibitors and as antihypertensives |
US4665087A (en) * | 1982-02-22 | 1987-05-12 | Ciba-Geigy Corporation | 1-(carbamyl, thiocarbamyl, and iminocarbamyl)-indoline derivatives |
US4623729A (en) * | 1982-07-22 | 1986-11-18 | E. R. Squibb & Sons, Inc. | Acylalkylaminocarbonyl substituted amino and imino acid compounds |
US4742067A (en) * | 1982-07-22 | 1988-05-03 | E. R. Squibb & Sons, Inc. | Acylalkylaminocarbonyl substituted amino and imino acid compounds |
GB8333514D0 (en) * | 1983-12-16 | 1984-01-25 | Erba Farmitalia | Tetrahydrothiazolo(5 4-c)pyridine derivatives |
USH642H (en) | 1984-08-20 | 1989-06-06 | E. R. Squibb & Sons, Inc. | Substituted urido amino and imino acids and esters |
US4880938A (en) * | 1986-06-16 | 1989-11-14 | Merck & Co., Inc. | Amino acid analogs |
US5089638A (en) * | 1986-06-16 | 1992-02-18 | Merck & Co., Inc. | Amino acid analogs as CCK-antagonists |
US5252317A (en) * | 1986-11-10 | 1993-10-12 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Amplifier molecules for diagnosis and therapy derived from 3,5-bis[1-(3-amino-2,2-bis (aminomethyl)-propyl) oxymethyl] benzoic acid |
US5567411A (en) * | 1986-11-10 | 1996-10-22 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group |
DE3839127A1 (en) * | 1988-11-19 | 1990-05-23 | Hoechst Ag | PYRROLIDONE-2-CARBONIC ACID DERIVATIVES WITH PSYCHOTROPER EFFECT |
US5648333A (en) * | 1988-11-24 | 1997-07-15 | Hoechst Aktiengesellschaft | Peptides having bradykinin antagonist action |
DE3911357A1 (en) * | 1989-04-07 | 1990-10-18 | Nokia Unterhaltungselektronik | Method for mutually adjusting two components of a display device |
US5413999A (en) * | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
US5354738A (en) * | 1992-09-04 | 1994-10-11 | G. D. Searle & Co. | Platelet aggregation inhibitors |
BE1007183A3 (en) * | 1993-06-18 | 1995-04-18 | Solvay | Ureines DERIVED ALPHA, OMEGA-diamino AND METHOD FOR THEIR PREPARATION. |
KR100376150B1 (en) * | 1994-11-04 | 2003-11-01 | 산텐 세이야꾸 가부시키가이샤 | 1,3-dialkylurea derivatives containing hydroxy groups |
BR9815881A (en) * | 1998-06-03 | 2002-07-23 | Gpi Nil Holding Inc | Urea and carbamates of non-heterocyclic carboxylic acids and isoesters of carboxylic acid |
DE19830556A1 (en) * | 1998-07-08 | 2000-01-13 | Basf Ag | Process for the preparation of carbonyldiimidazoles |
EP1604656A1 (en) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS) |
US20070004805A1 (en) * | 2005-07-01 | 2007-01-04 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
CN103420856B (en) * | 2013-07-25 | 2015-07-01 | 凯莱英医药集团(天津)股份有限公司 | Salmeterol preparation method |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE135387C (en) * | 1901-03-02 | 1902-11-06 | Drying device for copier machines | |
DE2624094A1 (en) * | 1975-05-29 | 1976-12-02 | Sumitomo Chemical Co | N-CARBAMOYL-N-PHENYLAMINO ACID DERIVATIVES, METHOD FOR THEIR PRODUCTION AND HERBICIDAL AGENTS |
DE2907601A1 (en) * | 1978-03-01 | 1979-09-06 | Squibb & Sons Inc | HEXAHYDRO-1-MERCAPTOACYL-1H-AZEPINE-2-CARBONIC ACID COMPOUNDS |
DE2914059A1 (en) * | 1978-04-08 | 1979-10-25 | Santen Pharma Co Ltd | 4-THIAZOLIDINCARBONIC ACIDS, THE METHOD OF MANUFACTURING THEREOF AND MEDICINAL PRODUCTS CONTAINING THEM |
EP0011813A1 (en) * | 1978-11-22 | 1980-06-11 | Motion Control, Inc. | Non-invasive chemical species delivery apparatus |
US4284779A (en) * | 1977-01-17 | 1981-08-18 | E. R. Squibb & Sons, Inc. | Amino acid derivatives |
EP0149589A2 (en) * | 1984-01-17 | 1985-07-24 | FIAT AUTO S.p.A. | Joint with non-homokinetic rotation with variable phasing particularly for a control of the camshaft for internal combustion engine |
EP0149605A1 (en) * | 1983-07-25 | 1985-07-31 | Polsam, Inc. | Elasticized overlay |
EP0161684A1 (en) * | 1984-05-17 | 1985-11-21 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Method of forming a carbide layer |
EP0161745A2 (en) * | 1984-02-29 | 1985-11-21 | Papillon Colour Laboratories Limited | Photographic contrast masking with a photochromic body |
EP0218549A2 (en) * | 1985-10-11 | 1987-04-15 | HUBER & SUHNER AG KABEL-, KAUTSCHUK-, KUNSTSTOFF-WERKE | Waveguide device |
EP0237231B1 (en) * | 1986-03-14 | 1990-11-22 | Glasstech, Inc. | Glass sheet press bending system |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1290760B (en) * | 1964-05-26 | 1969-03-13 | Me Kox Ind | Plant briquette |
DE1291405B (en) * | 1965-05-04 | 1969-03-27 | Magrini Fab Riun Scarpa | Compressed gas circuit breaker |
DE1262409B (en) * | 1965-08-04 | 1968-03-07 | Hoerner Fa Eugen | Programmer |
GB1576511A (en) * | 1977-03-29 | 1980-10-08 | Parcor | Thieno(2,3 - c) and (3,2 - c) pyridines process for their preparation and therapeutic applications thereof |
MC1220A1 (en) * | 1977-10-28 | 1979-07-20 | Hoffmann La Roche | NEW DERIVATIVES OF IMIDAZOLIDINE |
JPS55145667A (en) * | 1979-04-28 | 1980-11-13 | Tanabe Seiyaku Co Ltd | Tetrahydroisoquinoline derivative and its preparation |
US4294832A (en) * | 1979-04-28 | 1981-10-13 | Tanabe Seiyaku Co., Ltd. | Tetrahydroisoquinoline compounds and a pharmaceutical composition thereof |
JPS5615270A (en) * | 1979-07-17 | 1981-02-14 | Tanabe Seiyaku Co Ltd | Tetrahydroisoquinoline derivative and its preparation |
JPS5622769A (en) * | 1979-08-02 | 1981-03-03 | Tanabe Seiyaku Co Ltd | Tetrahydroisoquinoline derivative and its preparation |
IE52663B1 (en) * | 1980-04-02 | 1988-01-20 | Warner Lambert Co | Substituted acyl derivatives of octahydro-1h-indole-2-carboxylic acids |
US4344949A (en) * | 1980-10-03 | 1982-08-17 | Warner-Lambert Company | Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids |
US4311705A (en) * | 1980-10-06 | 1982-01-19 | E. R. Squibb & Sons, Inc. | Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines |
-
1981
- 1981-09-03 DE DE19813134933 patent/DE3134933A1/en not_active Withdrawn
-
1982
- 1982-08-27 ES ES515301A patent/ES8306110A1/en not_active Expired
- 1982-09-01 US US06/413,663 patent/US4515803A/en not_active Expired - Fee Related
- 1982-09-01 NZ NZ201779A patent/NZ201779A/en unknown
- 1982-09-01 KR KR8203944A patent/KR880002707B1/en active
- 1982-09-01 FI FI823026A patent/FI823026L/en not_active Application Discontinuation
- 1982-09-01 EP EP82108019A patent/EP0074070A1/en not_active Withdrawn
- 1982-09-01 GR GR69182A patent/GR76898B/el unknown
- 1982-09-02 HU HU822821A patent/HU190698B/en unknown
- 1982-09-02 DK DK393482A patent/DK393482A/en not_active Application Discontinuation
- 1982-09-02 CA CA000410659A patent/CA1307000C/en not_active Expired - Lifetime
- 1982-09-02 JP JP57151869A patent/JPS5855451A/en active Pending
- 1982-09-02 PT PT75497A patent/PT75497B/en not_active IP Right Cessation
- 1982-09-02 AU AU87930/82A patent/AU558623B2/en not_active Ceased
- 1982-09-02 ZA ZA826420A patent/ZA826420B/en unknown
- 1982-09-02 NO NO822974A patent/NO822974L/en unknown
-
1985
- 1985-02-01 US US06/697,340 patent/US4624962A/en not_active Expired - Fee Related
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE135387C (en) * | 1901-03-02 | 1902-11-06 | Drying device for copier machines | |
DE2624094A1 (en) * | 1975-05-29 | 1976-12-02 | Sumitomo Chemical Co | N-CARBAMOYL-N-PHENYLAMINO ACID DERIVATIVES, METHOD FOR THEIR PRODUCTION AND HERBICIDAL AGENTS |
US4284779A (en) * | 1977-01-17 | 1981-08-18 | E. R. Squibb & Sons, Inc. | Amino acid derivatives |
DE2907601A1 (en) * | 1978-03-01 | 1979-09-06 | Squibb & Sons Inc | HEXAHYDRO-1-MERCAPTOACYL-1H-AZEPINE-2-CARBONIC ACID COMPOUNDS |
DE2914059A1 (en) * | 1978-04-08 | 1979-10-25 | Santen Pharma Co Ltd | 4-THIAZOLIDINCARBONIC ACIDS, THE METHOD OF MANUFACTURING THEREOF AND MEDICINAL PRODUCTS CONTAINING THEM |
EP0011813A1 (en) * | 1978-11-22 | 1980-06-11 | Motion Control, Inc. | Non-invasive chemical species delivery apparatus |
EP0149605A1 (en) * | 1983-07-25 | 1985-07-31 | Polsam, Inc. | Elasticized overlay |
EP0149589A2 (en) * | 1984-01-17 | 1985-07-24 | FIAT AUTO S.p.A. | Joint with non-homokinetic rotation with variable phasing particularly for a control of the camshaft for internal combustion engine |
EP0161745A2 (en) * | 1984-02-29 | 1985-11-21 | Papillon Colour Laboratories Limited | Photographic contrast masking with a photochromic body |
EP0161684A1 (en) * | 1984-05-17 | 1985-11-21 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Method of forming a carbide layer |
EP0218549A2 (en) * | 1985-10-11 | 1987-04-15 | HUBER & SUHNER AG KABEL-, KAUTSCHUK-, KUNSTSTOFF-WERKE | Waveguide device |
EP0237231B1 (en) * | 1986-03-14 | 1990-11-22 | Glasstech, Inc. | Glass sheet press bending system |
Non-Patent Citations (2)
Title |
---|
Henning, et al., "Chemical Abstracts", vol. 99, 1983, col. 99:88067e. |
Henning, et al., Chemical Abstracts , vol. 99, 1983, col. 99:88067e. * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747504A (en) * | 1984-04-12 | 1998-05-05 | Hoechst Aktiengesellschaft | Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
US5403856A (en) * | 1984-04-12 | 1995-04-04 | Hoechst Aktiengesellschaft | Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
US5231080A (en) * | 1985-10-15 | 1993-07-27 | Hoechst Aktiengesellschaft | Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease |
US5231084A (en) * | 1986-03-27 | 1993-07-27 | Hoechst Aktiengesellschaft | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons |
US4855486A (en) * | 1986-05-30 | 1989-08-08 | Kalbag Suresh M | Blocked, marked amino acids |
US5721244A (en) * | 1986-10-02 | 1998-02-24 | Hoechst Aktiengesellschaft | Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
US5500434A (en) * | 1986-10-02 | 1996-03-19 | Hoechst Aktiengesellschaft | Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
US5043346A (en) * | 1988-04-22 | 1991-08-27 | Hoechst Aktiengesellschaft | Amino acid esters, pharmaceuticals containing them, and the use thereof in learning disorders |
US5232928A (en) * | 1989-07-25 | 1993-08-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Tetrahydroisoquinoline amides |
US5380872A (en) * | 1992-07-14 | 1995-01-10 | Glaxo Inc. | Modulators of cholecystokinin |
US5968980A (en) * | 1994-12-14 | 1999-10-19 | Santen Pharmaceutical Co., Ltd. | 1,3-dialkylurea derivative |
WO2000053576A1 (en) * | 1999-03-11 | 2000-09-14 | Ajinomoto Co., Inc. | Gelling or coagulating agents for liquid organic media |
US20030166706A1 (en) * | 2002-03-01 | 2003-09-04 | Kilgore Kenneth S. | Method of treating osteoarthritis |
US9624234B2 (en) | 2012-01-25 | 2017-04-18 | Novartis Ag | Heterocyclic compounds and methods for their use |
Also Published As
Publication number | Publication date |
---|---|
HU190698B (en) | 1986-10-28 |
FI823026L (en) | 1983-03-04 |
PT75497A (en) | 1982-10-01 |
DK393482A (en) | 1983-03-04 |
GR76898B (en) | 1984-09-04 |
DE3134933A1 (en) | 1983-03-31 |
ES515301A0 (en) | 1983-05-01 |
ZA826420B (en) | 1983-07-27 |
AU8793082A (en) | 1983-03-10 |
NO822974L (en) | 1983-03-04 |
CA1307000C (en) | 1992-09-01 |
KR880002707B1 (en) | 1988-12-26 |
EP0074070A1 (en) | 1983-03-16 |
FI823026A0 (en) | 1982-09-01 |
ES8306110A1 (en) | 1983-05-01 |
JPS5855451A (en) | 1983-04-01 |
AU558623B2 (en) | 1987-02-05 |
US4515803A (en) | 1985-05-07 |
NZ201779A (en) | 1986-01-24 |
KR840001556A (en) | 1984-05-07 |
PT75497B (en) | 1985-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4624962A (en) | Substituted derivatives of 2-azabicyclo-[3.3.0]octanes | |
US5158959A (en) | Decahydroisoquinoline carboxylic acids | |
US4935404A (en) | Phosphorus containing peptides, pharmaceutical compositions and method of treating collagenolytic conditions | |
US4404206A (en) | Substituted iminoacid derivatives, process for preparing them and their use as enzyme inhibitors | |
US4668797A (en) | Bicyclic aminoacids as intermediates and processes for their preparation | |
US4311697A (en) | Derivatives of mercaptoacyl prolines and pipecolic acids | |
US4311705A (en) | Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines | |
IE51918B1 (en) | Bicyclic compounds their production and use | |
US4381398A (en) | Amino-alcohol derivatives | |
US4395401A (en) | Renally active dipeptides | |
US4985407A (en) | Dipeptide compounds, processes for their preparation and compositions containing them | |
US4638010A (en) | Ester substituted aminoalkanoylureido amino and imino acid and ester compounds | |
US4622421A (en) | Phenylalkanoic acid derivatives and their use | |
US4594341A (en) | Perhydro-1,4-thiazepin-5-one and perhydro-1,4-thiazocin-5-one derivatives as antihypertensives | |
US4134991A (en) | Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid | |
US5162362A (en) | Octahydroindole-2-carboxylic acids | |
EP0019440B1 (en) | Benzimidazolone derivatives, process for their preparation and pharmaceutical compositions containing them | |
US4147796A (en) | 1-(3-Hydroxyalk-1-yl)-5-(carboxyalkyl)hydantoin derivatives | |
AU609406B2 (en) | Pharmaceutically useful derivatives of thiazolidine-4-carboxylic acid | |
US4587250A (en) | Thiazaspirane derivatives, process for their preparation, and medicaments | |
CA2234239C (en) | Indole carbamates as leukotriene antagonists | |
EP0093805A1 (en) | Octahydro-2-(omega-mercaptoalkanoyl)3-oxo-1H-isoindole-1-carboxylic acids and esters | |
US4456595A (en) | Carboxy and substituted carboxy aroly peptides | |
US4746676A (en) | Carboxyalkyl dipeptide compounds | |
EP0110484B1 (en) | Derivatives of aminopyridinecarboxylic acids, methods for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 19941130 |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |